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Deciphering Chronometabolic Dynamics Through Metabolomics, Stable Isotope
Tracers, And Genome-Scale Reaction Modeling
Abstract
Synchrony across environmental cues, endogenous genetic clocks, sleep/wake cycles, and metabolism
evoke physiological harmony for organismal health. Perturbation of this synchrony has been recently
correlated with a growing list of pathologies, which is alarming given the ubiquity of sleep deprivation,
mistimed light exposure, and altered eating schedules in modern society. Deeper insights into clocks,
sleep, and metabolism are necessary to understand these outcomes. In this work, extensive metabolic
profiles of circadian systems were obtained from the development of new liquid chromatography mass
spectrometry (LC-MS) metabolomics methods. These methods were applied to Drosophila melanogaster
to discern relative influences of environmental and genetic drivers of metabolic cycles. Unique sets of
metabolites oscillated with 24-hour circadian periods under light:dark (LD) and constant darkness (DD)
conditions, and ultradian rhythms were noted for clock mutant flies under LD, suggesting clockindependent metabolic cycles driven by environmental inputs. However, this metabolomic analysis does
not fully capture the inherently dynamic nature of circadian metabolism. These LC-MS methods were
adapted to analyze isotope enrichments from a novel 13C6 glucose injection platform in Drosophila.
Metabolic flux cycles were noted from glucose carbons into serine, glutamine and reduced glutathione
biosynthesis, and altered under sleep deprivation, demonstrating unique energy and redox demands in
perturbed sleep/wake cycles. Global isotopolome shifts were most notable in WT flies after lights-on,
suggesting a catabolic rush from glucose oxidation early in the active phase. As the scope of these
isotope tracer-based metabolomic analyses expand, attributing labeling patterns to specific reactions
requires consideration of genome-scale metabolic networks. A new computational approach was
developed, called the IsoPathFinder, which uncovered biosynthetic paths from glucose to serine, and
extends to glycine and glutathione production. Carbon flux into glutamine was predicted to occur through
the TCA cycle, supported by enzyme thermodynamics and circadian expression datasets. This tool is
presented as a new mechanism to simulate additional isotope tracer experiments, with broad applicability
beyond circadian research. Collectively, a new set of analytical and computational tools are developed to
both produce dynamic metabolomic data and improve data interpretability, with applications to uncover
new chronometabolic connections.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Pharmacology

First Advisor
Aalim M. Weljie

Subject Categories
Bioinformatics | Biology | Chemistry

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2547

DECIPHERING CHRONOMETABOLIC DYNAMICS THROUGH METABOLOMICS, STABLE
ISOTOPE TRACERS, AND GENOME-SCALE REACTION MODELING
Seth D. Rhoades
A DISSERTATION
in
Pharmacology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2017

Supervisor of Dissertation
_________________________
Aalim M. Weljie, Ph.D., Research Assistant Professor of Pharmacology

Graduate Group Chairperson
_________________________
Julie Blendy, Ph.D., Professor of Pharmacology

Dissertation Committee
Ian Blair, Ph.D., A.N. Richards Professor of Pharmacology
Harry Ischiropoulos, Ph.D., Research Professor of Pediatrics
Zachary Schug, Ph.D., Assistant Professor, Molecular and Cellular Oncogenesis
Amita Sehgal, Ph.D., John Herr Musser Professor of Neuroscience

DECIPHERING CHRONOMETABOLIC DYNAMICS THROUGH METABOLOMICS, STABLE
ISOTOPE TRACERS, AND GENOME-SCALE REACTION MODELING
COPYRIGHT
2017
Seth D. Rhoades

This work is licensed under the
Creative Commons AttributionNonCommercial-ShareAlike 3.0
License
To view a copy of this license, visit

https://creativecommons.org/licenses/by-nc-sa/3.0/us/

DEDICATION

This work is dedicated to my parents, Donna and Bruce. Words cannot adequately
describe the love you have demonstrated in working endlessly to provide me
opportunities to actualize my ambitions, and the deep thankfulness I feel for teaching me
about grit and grace, ethic and ethics, and passion and compassion.

“The greatest obstacle to discovery is not ignorance – it is the illusion of knowledge”
-Daniel J. Boorstin

iii

ACKNOWLEDGMENT

This work, and my training at the University of Pennsylvania, is the product of an
unparalleled web of collaboration. I have garnered both technical expertise and broadened
perspectives on performing impactful research, means of experimentation, and the future of
therapeutic discovery from excellent scientists too numerous to fully mention here. I would
especially like to thank Dr. Aalim Weljie, who took me in as his first doctoral student and
demonstrated extreme patience with me as I attempted to learn about new fields of metabolomics
and circadian rhythms. I am thankful for the space I was given to explore new techniques and
refine my own skills and interests, even if not always aligned with the lab objectives. I also want to
thank members of the Weljie lab, including Emily Mackay, Barry Slaff, Sidney Bolden, Saikumari
Krishnaiah, and Arjun Sengupta, for their help and support.
Of the numerous collaborations I maintained in the Weljie lab, the two most notable
scientists who contributed substantially to my training are Drs. Amita Sehgal and Garret
FitzGerald. I benefited greatly from the shared resources through Amita’s lab, with particular help
from Paula Haynes and Shirley Zhang, who aided many technical aspects of my experiments,
and I received tremendous guidance out of the regular with Amita, who possesses prodigious
knowledge of clocks and sleep. I am also extremely fortunate to work alongside Garret and
members of his lab. I have never met someone with such perspective on the impact of our work
as scientists, and foresight to the future of medicine. I am additionally grateful to participate in a
collaboration with Dr. Carsten Skarke, comprising work which sparked my career interests.
I also want to thank my thesis committee, Drs. Ian Blair, Harry Ischiropoulos, Amita
Sehgal, and Zachary Schug, who provided helpful guidance in my project. Finally, I am thankful
for the support and sincere friendships I have fostered with classmates in the Pharmacology
Graduate Group, as I would not have made it through graduate school without them.

iv

ABSTRACT
DECIPHERING CHRONOMETABOLIC DYNAMICS THROUGH METABOLOMICS, STABLE
ISOTOPE TRACERS, AND GENOME-SCALE REACTION MODELING
Seth D. Rhoades
Aalim M. Weljie, Ph.D.
Synchrony across environmental cues, endogenous genetic clocks, sleep/wake cycles,
and metabolism evoke physiological harmony for organismal health. Perturbation of this
synchrony has been recently correlated with a growing list of pathologies, which is alarming given
the ubiquity of sleep deprivation, mistimed light exposure, and altered eating schedules in modern
society. Deeper insights into clocks, sleep, and metabolism are necessary to understand these
outcomes. In this work, extensive metabolic profiles of circadian systems were obtained from the
development of new liquid chromatography mass spectrometry (LC-MS) metabolomics methods.
These methods were applied to Drosophila melanogaster to discern relative influences of
environmental and genetic drivers of metabolic cycles. Unique sets of metabolites oscillated with
24-hour circadian periods under light:dark (LD) and constant darkness (DD) conditions, and
ultradian rhythms were noted for clock mutant flies under LD, suggesting clock-independent
metabolic cycles driven by environmental inputs. However, this metabolomic analysis does not
fully capture the inherently dynamic nature of circadian metabolism. These LC-MS methods were
adapted to analyze isotope enrichments from a novel

13C
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glucose injection platform in

Drosophila. Metabolic flux cycles were noted from glucose carbons into serine, glutamine and
reduced glutathione biosynthesis, and altered under sleep deprivation, demonstrating unique
energy and redox demands in perturbed sleep/wake cycles. Global isotopolome shifts were most
notable in WT flies after lights-on, suggesting a catabolic rush from glucose oxidation early in the
active phase. As the scope of these isotope tracer-based metabolomic analyses expand,
attributing labeling patterns to specific reactions requires consideration of genome-scale
metabolic networks. A new computational approach was developed, called the IsoPathFinder,

v

which uncovered biosynthetic paths from glucose to serine, and extends to glycine and
glutathione production. Carbon flux into glutamine was predicted to occur through the TCA cycle,
supported by enzyme thermodynamics and circadian expression datasets. This tool is presented
as a new mechanism to simulate additional isotope tracer experiments, with broad applicability
beyond circadian research. Collectively, a new set of analytical and computational tools are
developed to both produce dynamic metabolomic data and improve data interpretability, with
applications to uncover new chronometabolic connections.
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CHAPTER 1 - Introduction
1.1 Intersection of circadian rhythms, sleep, and metabolism in health and disease
History and characterization of circadian rhythms
The ancient Greek philosopher Heraclitus famously coined the phrase ‘panta rhei’, or
‘everything flows’, which has since been expounded into the aphorism ‘the only thing constant is
change’. Indeed, life is flux for all organisms on this planet, encountering daily changes in light,
temperature, and food availability. Amidst a complex external environment, emergent patterns
arise from which most organisms have adapted mechanisms to internally anticipate and
synchronize with predictable environmental changes, ultimately conferring a survival advantage.
At the heart of these internal timekeeping mechanisms lie the circadian clock. This intrinsic
biological clock was deduced experimentally after the observations of daily leaf movements in
heliotrope plants under constant darkness by Jean-Jacques d’Ortous de Mairan in 1729 (de
Marian, 1729), leading to the development of the basic tenants of biological clocks by Pittendrigh
and Aschoff, namely persistent cyclic periods under constant conditions, entrainment to
environmental signals, and robustness against temperature changes (Pittendrigh, 1960, Aschoff,
1965). Strictly circadian processes refer to those which take place over a roughly 24-hour period
(Latin “circa diem” – about a day), although shorter periods are also known to exist (termed
ultradian rhythms). In higher organisms, molecular clocks consist of a hierarchy structure, where
input pathways receive and transmit environmental cues to a central oscillator, which in turn
generates rhythmic outputs to govern many metabolic, physiological, and behavioral processes at
an organismal level. For instance, mammals harbor a set of light-responsive retinal ganglion cells,
which project to the central pacemaker, the suprachiasmatic nucleus (SCN), via the
retinohypothalamic tract (Moore, 1982). Upon activation, the SCN expresses arginine
vasopressin (AVP) and vasoactive intestinal peptide (VIP), which are thought to be the main
synchronizing agents which correspond to a robust cyclic output, with projections to numerous
nuclei in the hypothalamus and thalamus (Maywood et al., 2011). These rhythmic outputs can
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synchronize circadian oscillators in other parts of the organism, commonly called the peripheral
clocks. The SCN can thus act as the conductor to the orchestra of cells and organs across both
the central nervous system and the periphery, evoking physiologic harmony during times of
organismal synchrony.
Our current understanding in the molecular basis of clocks originated from mutagenesis
studies in Drosophila melanogaster (Konopka and Benzer, 1971), fueling the discovery of
autoregulatory transcription-translation feedback loops (Glossop and Hardin, 2002). The
functional orthologs to Drosophila clocks have since been discovered in mammals, and have
been reviewed extensively (Lowrey and Takahashi, 2011, Figure 1.1). At the core of the
mammalian clock, proteins CLOCK and BMAL1 dimerize and bind to E-box promoter elements to
activate numerous clock-controlled genes (CCGs). Repressor proteins such as cryptochrome and
period (CRY1-2 and PER1-3) translocate back into the nucleus to suppress the CLOCK:BMAL1
complex, thus completing the feedback loop. Parallel loops also exist to control Bmal1
transcription. In particular, BMAL1 drives expression of Rev-Erbα/β and retinoic acid receptorrelated orphan receptors (RORs) which compete for binding to ROR elements to repress or
activate Bmal1 expression, respectively. Beyond these core loops, there exists a remarkable
complexity of additional inputs to the clock, including a plethora of post-translational modifications
(PTMs), protein degradation pathways, nuclear hormone receptors, metabolism, and epigenetics,
which can all couple to our most basic phenotypes of sleep and wake cycles.

2

Figure 1.1 Transcription-translation feedback loops of the core mammalian (A) and Drosophila
(B) circadian clocks. Mammalian circadian clock reprinted with permission from Yang et al., 2013;
Drosophila circadian clock reprinted with permission from Hardin, 2002.
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Circadian clocks and sleep
Sleep, broadly defined as a period of inactivity with an increased arousal threshold,
stereotypical body positions, and sleep rebound following periods of disruption or deprivation
(Hendricks et al., 2000), is a highly conserved process with two major regulatory mechanisms.
One mechanism, the S process, is a homeostatic drive for sleep which increases throughout the
active phase (i.e. the light phase for diurnal organisms) and is alleviated upon sleep onset
(Borbely, 1982). This process is empirically observed and understood, albeit with little
mechanistic underpinning. The other major mechanism, the C process, is the circadian control
over sleep/wake behaviors. Melatonin exhibits a robust diurnal secretion from the pineal gland,
driven by SCN and paraventricular nucleus (PVN) projections to elicit sleep (TeclemariamMesbah et al., 1999), which is countered by cortisol rhythms, from pulsatile secretions of
corticotropin-releasing hormone (CRH) out of the PVN to elicit morning arousal (Spencer et al.,
1998). Perturbations in these cycles, whether from suppressed melatonin production by light
exposure at night, or a perturbed hypothalamic-pituitary-adrenal (HPA) axis from stress or
pathologies, result in fragmented or lost sleep (Balbo et al., 2010).
Mutagenesis studies have yielded few genes which exert a dominant control on sleep
quality and quantity, implying a complex genetic sleep architecture (Yamamoto et al., 2008).
However, some notable polymorphisms in core clock genes impact sleep, including associations
of Per variants with sleep timing (Carpen et al., 2006, Archer et al., 2003). Additionally, genetic
mouse models of Clock, Bmal1, and Cry1/2 display altered sleep duration (Naylor et al., 2000,
Wisor et al., 2002, Laposky et al., 2005). These tantalizing connections of sleep phenotypes and
circadian clocks warrant deeper mechanistic experimentation, wherein lies an inextricable
connection of clocks with hormone production and metabolism.

Circadian clocks and metabolism
Circadian clocks and metabolism exhibit a complex bidirectional control, and has recently
been a subject of intense research in the circadian field. Transcriptomics in mice have
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demonstrated a striking enrichment of rhythms in rate-limiting enzymes across major metabolic
pathways, including glucose, fatty acid, amino acid, and bile acid metabolism (Panda et al.,
2002). Intriguingly, expression of many of these metabolic enzymes can display ultradian rhythms
of 8 or 12 hours (Hughes et al., 2009), which may align with shorter temporal patterns of feeding
and behavior. In addition to these extrinsic factors, there is also evidence that the cellautonomous circadian clocks drive metabolic oscillations. For example, corticosterone rhythms
were abolished in SCN-lesioned rats (Moore and Eichler, 1972), and circulating glucose,
triglycerides, and fatty acids have been shown to oscillate under fasting or fixed conditions such
as forced wakefulness or constant light (Scheer et al., 2009, la Fleur et al., 1999 and Dallmann et
al., 2012). Additionally, nicotinamide phosphoribosyl-transferase (NAMPT), the rate-limiting step
in the nicotinamide adenine dinucleotide (NAD+) salvage pathway, exhibits a strong circadian
rhythm, particularly in the liver (Ramsey et al., 2009). This clock-metabolism connection has
several critical effects, including an intracellular oscillation in redox potential, noted in
NAD+/NADH cycles. Redox rhythms can also exist as part of a highly conserved and ancient
clock mechanism, independently of transcription and translation. The peroxiredoxin proteins,
noted across eukaryotes and Archaea, produce an autonomous redox rhythm and suggest a
mechanism to deal with an increasingly oxidizing environment billions of years ago (Edgar et al.,
2012).
NAD+ also serves a critical role in reciprocal regulation of circadian clocks by metabolic
status. Sirtuin1 (SIRT1), an NAD+-dependent deacetylase, regulates clock function through
deacetylation of PER2 (Asher et al., 2008), while NAD+ levels themselves are intimately tied to
mitochondrial function and dictates AMP and ATP concentrations. Steady-state ATP
concentrations have been shown to oscillate in multiple tissues (Yamazaki et al., 1994), which
regulates AMP-dependent protein kinase (AMPK) activity. AMPK also impacts clock function by
phosphorylating CRY (Lamia et al., 2009), and can itself control NAMPT expression (Cantó et al.,
2009). Other metabolite-responsive effectors include SIRT6, peroxisome proliferator-activated
receptors (PPARs), and glycogen synthase kinase 3 beta (GSK3β), among others, which
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collectively comprise a diverse set of sensors to reciprocally impact the core clock (reviewed in
detail by Oosterman et al., 2015). It follows then that both diet and temporal feeding patterns may
have a profound impact on circadian rhythms. Animals fed a high fat diet (HFD) ad libitum display
dampened rhythms in core clock and metabolic genes, perturbed temporal feeding rhythms, and
lengthened free-running activity periods under constant darkness (Gill et al., 2015, Hatori et al.,
2012). Interestingly, limiting the window of HFD feeding, thus enforcing a feeding pattern,
restored physiological rhythms and improved metabolic outcomes. This time-restricted feeding
(tRF) paradigm has proved salubrious even when switching feeding to the normal resting phase,
and is sufficient to restore rhythms of many liver transcripts in Cry1/2 knockout mice (Vollmers et
al. 2009). While the phenotypes are convincing, the mechanism behind tRF is largely unclear.
Future studies need to consider why certain times of feeding seem more healthful than others,
how nutrients are processed differently vis-à-vis the clock, and whether the metabolic benefits are
simply a result of interspersed fasting periods. One emerging consensus from these experiments
is that while altered feeding rhythms can reset circadian clocks in the peripheral tissues,
particularly metabolically active tissues and nutrient-sensing regions of the brain, the SCN
remains largely unaffected by food and ultimately results in organismal desynchrony (Iwanaga et
al., 2005). Whether or not chronically desynchronized, but consistent, light and feeding rhythms
can still promote health remains to be rigorously demonstrated (Katewa et al., 2016), which is
particularly important when considering the proper management of altered sleep schedules, e.g.
shift work.
The selective advantage of circadian clocks, particularly for metabolic homeostasis,
resides in anticipation (Edery, 2000). To best allocate nutrients effectively, organisms must
prepare for anticipated bouts of feeding and fasting during active and rest phases respectively.
Reflected in both metabolite and enzyme analyses, glucose synthesis and release from glycogen
stores increase at the onset of the active phase, coupled with rhythmic insulin secretion and
pancreatic function (Bolli et al., 1984, Kida et al., 1980, Peschke and Peschke, 1998). Digestive
processes also increase at the beginning of the active phase, including lipid uptake, enzyme
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upregulation, gastrointestinal motility, and gastric blood flow (Pan and Hussain 2007, Kumar et
al., 1986). Conversely, organisms prepare for a fasting period by switching from oxidative
metabolism to nutrient storage towards the end of the active phase (la Fleur et al., 2001), which
may partly explain findings that postprandial glucose levels are higher after dinner than breakfast
(Jakubowicz et al., 2013). These sweeping shifts in major metabolic processes have begun to
paint a picture of how organisms adapt to their environment and food availability, and may
address some uncertainties in the mechanisms of tRF. Amidst the complex interplay of clocks,
feeding, and behavior, perhaps the most important role the clock can play in metabolism is to
temporally separate anabolic and catabolic processes, hypothesized as a mechanism to maintain
metabolic efficiency (Bass, 2012). While logical, this hypothesis needs further experimentation
through subcellular metabolite analysis and primary metabolic measurements, including
metabolic flux (McGinnis and Young, 2016). Our understanding of circadian metabolism has
grown tremendously in recent years, although secondary metabolic measures such as steady
state transcript or metabolite levels are inadequate to fully capture these dynamic systems.
Additional work is required to truly understand the pathological phenotypes that arise out of
perturbed circadian and sleep cycles, and to harness the ubiquitous nature of the clock in a
therapeutic manner.

Pathologies, modern lifestyles, and therapeutic opportunities
A temporal distribution in disease symptoms has been observed for hundreds of years,
dating back to daily fluctuations of asthmatic symptoms in the medieval times (Lemmer, 2009).
More recently, diurnal variation is known to exist for inflammatory response, infection
susceptibility, stroke, and myocardial infarctions (Kalsbeek et al., 2012, Reilly et al., 2007). These
patterns largely stem from normal clock functioning, considering the rhythms noted in immune
cells, circulating cytokines, blood pressure, and heart rate. Conversely, perturbing the clock
system has been implicated in numerous pathologies. Clock disruption has been reciprocally
implicated as both a driver and a consequence of tumorigenesis (Altman et al., 2015, Masri et al.,
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2016). Additionally, the amplitude of circadian cycles dampens with age and is associated with
increased activity at night and fragmented sleep in older individuals (Van Someren et al., 1997).
These findings have been corroborated by an accelerated aging phenotype in Bmal knockout
mice, although clock-specific versus clock-independent roles of circadian genes are difficult to
ascertain with one animal model (Kondratov et al., 2006). Age-dependent declines in clocks and
physiology may be additionally fueled by increased reactive oxygen species (ROS), which build
up in greater quantities as sleep becomes increasingly fragmented and redox balance
mechanisms decay (Inoué et al., 1995).
Perhaps more alarming and consequential to human health is the ubiquity of circadian
and sleep disruption in modern society. Around the beginning of the 19th century, affordable
artificial lights ushered in a shift in human lifestyles (Fouquet and Pearson, 2006). Light exposure
is now common around the clock, and social interactions can act as a non-photic timing cue at
any given moment through social media platforms (Wyse et al., 2014). In addition to increased
light-at-night, many human activities today are based indoors. Artificial light does not recapitulate
natural sunlight, leaving us with with brighter nights and dimmer days, further dampening
circadian clocks. Coupled with longer work hours and/or shift work, humans are largely
desynchronized with sunrise and sunset, particularly in urban settings. The recent National Health
Interview Survey reported roughly 30% of the American workforce obtain 6 hours of sleep or less
per night, with roughly 20% of workers engaging in some form of shift work (Luckhaupt et al.,
2010). Shift workers tend exhibit lower sleep quality and quantity (Esquirol et al., 2011, Jay et al.,
2006), and are likely to receive less sun exposure than day workers (Puttonen et al., 2010). While
causal links are not established, shift workers are also prone to fragmented feeding patterns and
less healthy eating, which likely contributes to correlations with metabolic syndrome and obesity
beyond already established connections of sleep deprivation and impaired glucose tolerance
(Scheer et al., 2009, Esquirol et al., 2011). While constant food availability has generally been
viewed as a boon for those with atypical work schedules, the aforementioned tRF studies
highlight the need to reconsider eating schedules. Adiposity, bodyweight, glucose, and lipid
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metabolism are the most common alterations in a recent meta-analysis of animal studies which
model feeding and sleep disruptions (Opperhuizen et al., 2015). Additionally, not all shift workers
develop sleep disorders, but such pathologies do exist, such as delayed and advanced sleep
phase disorders (Ando et al., 2002, Regestein and Monk, 1995), with relatively little information
on metabolic consequences of phase-shifted circadian clocks. More detailed mechanisms of
nutrient

processing

are

required

in

the

burgeoning

fields

of

chrononutrition

and

chronopharmacology to mitigate the metabolic detriments in shift work and habitual sleep
disruption.

1.2 Drosophila melanogaster as a model in chronometabolic studies
Clock mechanisms in Drosophila
The transcription-translation feedback loop in Drosophila exhibits similar features to the
mammalian clock, and has served as a vital model to delineate molecular mechanisms of clock
structures (reviewed in Hardin, 2011, Figure 1.1). The CLOCK/CYCLE (CLK/CYC) complex binds
to E-box elements to drive expression of many gene products, including period and timeless.
These protein products (PER and TIM) dimerize and translocate to the nucleus to repress
CLK/CYC activity. Phosphorylation of PER/TIM by GSK3B (known as shaggy in Drosophila) and
CASEIN KINASE 2 (CK2) promotes translocation back to the nucleus, however phosphorylation
of PER will by DOUBLETIME (DBT) promotes its binding to the E3 ubiquitin ligase
SUPERNUMERARY LIMBS (SLIMB), which leads to ubiquitination and proteolysis by the
proteasome, breaking the repressive arm of the clock. Although the molecular mechanisms of the
clock are similar, the two-stage mammalian process of SCN entrainment, followed by peripheral
clock entrainment, operates differently in flies. Most Drosophila cells which contain an oscillator
can either directly detect light or receive inputs from photoreceptor cells, demonstrated by lightentrainment of isolated wings and antennae (Plautz et al., 1997). Light rapidly resets the clock in
flies through the CRY photoreceptor, resulting in TIM degradation within 30 minutes of exposure
(Hunter-Ensor et al., 1996, Myers et al., 1996).
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150 cells in the fly brain contain a molecular clock, and some of these are known to
control locomotor activity rhythms (Taghert and Shafer, 2006). These cells are clustered into
lateral and dorsal neurons (LNs and DNs), of which the small ventral LNs (s-LNv) are necessary
for sustained locomotor activity in constant darkness (Helfrich-Förster, 1998). This central
oscillator has been shown to modulate the phase of oenocyte clocks, which regulate pheromone
production and lipid mobilization, and prothoracic gland clocks, which drive eclosion (Krupp et al.,
2008, Myers et al., 2003). However, clocks in the Malpighian tubules, which operates much like
the kidneys, and the fat body, exhibiting functions akin to the liver and adipose, can entrain to
light and food respectively, independent of the central clock (Giebultowicz 2000, Xu et al., 2011).
Thus, while the hierarchy of the clock in flies differs from mammals, circadian clocks ultimately
drive rhythms in most major physiological processes, including eclosion, olfaction, courtship,
locomotion, and sleep.

Drosophila in sleep research
Much like mammalian characteristics of sleep, flies display periods of behavioral
quiescence, sleep rebound following deprivation, and increased arousal thresholds (Hendricks et
al., 2000). Flies are diurnal, sleeping during darkness, and sleep itself is defined by periods of
quiescence lasting at least five minutes, and can enter deeper sleep phases lasting more than 15
minutes with electrophysiological patterns analogous to slow wave sleep in mammals (van
Alphen et al., 2013). Given these similarities, and the rapidity and relative accessibility of genetic
manipulation, Drosophila are a mainstay in sleep genetics research. Sleep/wake cycles form as a
complex integration of inputs, including hormones, neuropeptides, neurotransmitters, and
physiological perturbations such as feeding or starvation (Keene et al., 2010). Like mammals,
sleep homeostasis in flies largely stems from a balance of the monoamines dopamine, serotonin,
and octopamine (the invertebrate analogue of norepinephrine) (Livingstone and Tempel, 1983).
Drosophila genetics has augmented our understanding in the role of these monoamines to
regulate sleep and behavior. For instance, impaired dopamine reuptake in the synapse via a
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mutated dopamine transporter results in short-sleeping and hyperactive flies (Kume et al., 2005).
These fumin mutants display similar behavior to increased dopamine signaling via cocaine or
methamphetamine, and are countered by inhibitors in dopamine biosynthesis pathways to
increase sleep duration (Andretic et al., 2005). Dopaminergic pathways in the fly brain are under
control of light and circadian clocks through regulation of inhibitory dopamine receptors in the LNs
(Shang et al., 2011). Additional genetic manipulations in monoamine signaling have
demonstrated interactions with behavioral patterns to regulate learning, feeding, and metabolic
processes, corroborating the utility of Drosophila models to understand mammalian sleep
networks (reviewed in Nall and Sehgal, 2014). Additionally, Drosophila offers some insights into
the interaction of sleep and circadian processes with aging, as aged flies demonstrate perturbed
dopaminergic signaling and increasingly fragmented sleep with age (Kayser et al., 2014).
Circadian and aging physiology may also couple with metabolism, as clock mutants lose cycling
in ROS and antioxidant-defense enzymes (Krishnan et al., 2008). Drosophila may yet provide
much insight into the circadian-sleep-metabolic connection as our elucidation of conserved
metabolic mechanisms in flies grows.

Metabolism and nutrient response in Drosophila
Drosophila were among the earliest model organisms to demonstrate links between
metabolism and lifespan (Loeb and Northrop, 1917), and have recently regained interest in
dissecting mechanisms of metabolic homeostasis vis-à-vis diabetes and obesity (Leopold and
Perrimon, 2007). In addition to the major metabolic organs such as fat bodies, Malpighian
tubules, and oenocytes, flies also harbor the pars intercerebralis-corpora cardiac system, which
exhibits similar functions to the hypothalamus-pituitary system and pancreas (Bharucha, 2009).
Flies digest food through the crop and midgut, analogous to the stomach and intestine (Pitsouli
and Perrimon, 2008), although nutrients are then released into the hemolymph as part of an open
circulatory system, thus demanding unique mechanisms of nutrient distribution. Flies maintain
efficient nutrient transport by harboring a tubular heart structure and circulating trehalose, a
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disaccharide of glucose, to effectively increase sugar concentrations while maintaining osmolality
(Klowden, 2007). Flies respond to the presence of nutrients through secretion of insulin
(commonly referred to as Drosophila insulin-like-peptides, or dILPs) for glycogen and triglyceride
storage (Barbieri et al., 2003). Unlike mammals, flies express 8 dILPs, which vary in tissue
distribution but bind to one ubiquitous insulin-like receptor (Fernandez et al., 1995). dILP6 is most
notable, activating insulin-signaling pathways in the fat body to promote fat storage, similar to
mammalian systems (Saltiel and Kahn, 2001). Additional controls on dILP release include TORdependent sensing of amino acids and trehalose, and Mio/Mondo-dependent sensing of glucose,
a homolog to ChREBP (Geminard et al., 2009, Postic et al., 2007). The fat body also contains
insulin-responsive AKT pathways (Garofalo 2002). Conversely, the neurosecretory cells of the
corpora cardiaca secrete adipokinetic hormone (AKH), which acts much like glucagon to activate
fat body cells and promote glycogenolysis, trehalose production, and AMPK-dependent lipolysis
(Kim and Rulifson, 2004, Rayne and O’Shea, 1994, Staubli et al., 2002).
Conserved nutrient response mechanisms in flies have recently prompted efforts to
model diet-induced pathologies. Both genetic manipulation of dILPs and a high-fat diet can
disrupt glucose homeostasis and produce similar phenotypes to metabolic syndrome and
diabetes (Zhang et al., 2009, Birse et al., 2010, Musselman et al., 2011). These genetic and
dietary manipulations have also yielded cardiomyopathies, which was recently expounded to
demonstrate the benefits of tRF on diet-induced cardiac decline (Gill et al., 2015), implying
additional synergy of metabolic and circadian processes which can be modeled in Drosophila.

Clock and metabolic interactions in Drosophila
Circadian research greatly benefited from the advent of accessible and affordable
oligonucleotide arrays in the early 2000s. Multiple microarray analyses were performed in both
heads and bodies of flies, and later expanded into tissue-specific circadian analyses (ClaridgeChang et al., 2001, McDonald and Rosbash, 2001, Ceriani et al., 2002, Lin et al., 2002, Xu et al.,
2011). The complexity of these datasets prompted a meta-analysis to glean overlapping transcript
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oscillations, although at the time most of these hits were either part of the core clock or
uncharacterized (Keegen et al., 2007). Some annotated metabolic genes emerged as overlaps in
at least a subset of these studies, including histidine decarboxylase, aldolase, and UDPglycoslytransferase. Transcripts implicated in glucose metabolism and transport, as well as
neurotransmitter biosynthesis, also emerge across multiple studies, however the time of peak
expression is inconsistent. Additionally, fat body transcriptomics depicts an even more
complicated picture, where many genes peaked at different times from whole-body analyses
(unpublished). Unsurprisingly, the fat body responded to an enforced feeding pattern in the
background of a clk mutant strain much like liver transcripts in Cry1/2 knockout mice (Vollmers et
al., 2009), highlighting the possibility of conserved mechanisms of feeding entrainment. Although
phases differed across studies, multiple enzymes involved in reduced glutathione (GSH)
production oscillate, which serve to maintain levels of intracellular antioxidants and counter ROS
oscillations (Krishan et al., 2008, Beaver et al., 2012). GSH itself displays a temporal pattern,
though not as strongly as the biosynthetic enzymes, which may reflect an intracellular objective to
maintain steady-state concentrations. Clock mutant strains display impaired transcript oscillations
in GSH enzymes, and may explain increased ROS, peroxidated lipids, and accelerated aging and
neurodegeneration in these flies (Krishnan et al., 2009, Krishnan et al., 2012). While focused on
aging, a recent review highlights the role of peroxiredoxins in Drosophila to combat oxidative
stress and maintain ATP levels, creating a vital link to redox cycles which requires further
investigation (Orr et al., 2013). With a resurgence of metabolic studies in Drosophila, many
postulations can be made in the chronometabolic connections, however analyses commensurate
with these complex and dynamic systems must be employed to truly understand these
phenotypes.

Current methodology in Drosophila metabolism studies
Metabolic homeostasis is a complex process in any living system, which is difficult to
experimentally ascertain with experimental techniques in genetics, transcriptomics, and hormone
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assays. Assessing bulk changes in lipids and sugars can aid interpretation of metabolic response
to nutrient intake, which have been employed in Drosophila using colorimetric glycogen and
triglyceride (TAG) assays (Tennessen et al., 2012). Additional separations of lipid groups, for
example fatty acids and diacylglycerols (DAG) can be further measured using thin-layer
chromatography (TLC), which is particularly relevant for flies as DAGs comprise the major
circulating form of lipids in hemolymph (Hildebrandt et al., 2011). These assays, if done
meticulously, can be performed in dissected flies to discern tissue-specific lipid contents. Analysis
of sugars is typically confined to glucose and trehalose assays, which require careful enzymebased assays to separate glucose before and after trehalose digestion (Teleman et al., 2005).
Analysis of circulating sugars can be performed through isolation of the hemolymph, although
tissue-specific analyses likely fall out of accurate detection (Lee and Park, 2004). While still
considered a secondary metabolic analysis, measurements of energetics through steady-state
NAD+ or ATP concentrations can provide valuable information to infer the dynamics of fuel
oxidation and nutrient-switching. ATP assays do exist, but given chemical instability, has proven
difficult to measure accurately (Park et al., 2006).
More sophisticated technologies are required to detect specific sugars, lipids, and other
metabolites such as amino acids. Mass spectrometry (MS) and nuclear magnetic resonance
(NMR) are common analytical strategies in the burgeoning field of metabolomics. Coupling MS
techniques to chromatographic separation, including gas (GC-MS) or liquid (LC-MS), can
additionally broaden the scope of metabolite analysis. These approaches have largely remained
in the dark in Drosophila chronometabolic studies, however metabolomics has been employed in
aging and developmental biology (Thuy An et al., 2014, Hoffman et al., 2014, Laye et al., 2015,
Tennessen et al., 2014), and tissue-specific analyses has been performed to create spatial maps
of the fly metabolome (Chintapalli et al., 2013). Encouragingly, one study utilized NMR in whole
flies across circadian time to discern cycles in amino acids and energetic metabolites, offering
hope in a new analytical frontier to unveil the reciprocal regulation of clocks and metabolism
(Gogna et al., 2015). As these platforms expand in scope, the overwhelming complexity of
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rhythms in transcripts, proteins, PTMs, and epigenetics can be uprooted and replanted with a
deeper and more accurate phenotype of metabolite dynamics.

1.3 LC-MS metabolomics and multivariate statistical analysis
LC-MS metabolomics methodology
While metabolomics is considered a relatively new member of the high-throughout ‘omic
platforms, biofluid analysis has been performed since ancient China and the Middle ages to
detect high glucose levels or otherwise unusual smells and colors in urine (van der Greef and
Smilde, 2005, Nicholson and Lindon, 2008). More recently, the idea of metabolic ‘fingerprinting’
had been proposed by Roger Williams in the 1940s as a method to identity unique signatures
across healthy and diseased individuals using TLC (Williams, 1951). In time, advances in GC and
LC ushered in a new era of quantitative metabolite profiling (Horning and Horning, 1971, Pauling
et al., 1971). This new wealth of knowledge created new perspectives on metabolism, leading to
the first compilations of metabolic networks by Donald Nicholson (Nicholson, 1970), lauded by
Nobel laurate Ernst Boris Chain as one of the great achievements in biochemical research
(Chain, 1965). Continued developments in analytical chemistry have since enabled detection of
thousands more metabolites than thought to exist at the dawn of functional biochemistry,
revealing a yet incomplete picture of metabolic networks. Improved metabolomic analyses hold
great promise for the fields of food science, drug development, toxicology, and translational
medicine, as metabolites are thought to serve as a readout of both the actions of intrinsic enzyme
activities and exposures to extrinsic environmental factors.
The detection methods for current metabolomics’ technologies include GC-MS, LC-MS,
capillary electrophoresis (CE-MS), and NMR. While GC-MS analyses are still employed for
analyzing specific subsets of the metabolome, and CE-MS improvements are rapidly expanding
the breadth of metabolite analysis (Ramautar et al., 2009), LC-MS currently has the most
widespread use and is typically considered to provide the deepest metabolome coverage
(Theodoridis et al., 2012). The LC-MS metabolomics workflow considers all aspects of metabolite
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detection, from sample preparation to chromatographic separation and detection of metabolites
by the mass analyzer.
The first major step, sample extraction, requires careful consideration of the experimental
objectives (reviewed in Cajka and Fiehn, 2016). The mass or volume of the biological sample to
be extracted must be rationalized given mass spectrometers cannot accurately quantify
metabolites across the physiological range of concentrations, which may vary up to eight orders
of magnitude. Extraction methods may be tailored to specific classes of metabolites in
accordance with the predicted octanol/water partition coefficients, however this approach will
likely preclude holistic metabolite profiling. One common tradeoff is to perform a single extraction
to recover more metabolite classes simultaneously (e.g. lipophilic and polar metabolites), with the
added benefit of speed and simplicity. Single-extraction approaches can include organic solventprotein precipitation or biphasic liquid-liquid extractions such as the Bligh-Dyer approach, which
yields aqueous and organic layers amenable to separate LC-MS methods for small-molecules
and lipids (Bligh and Dyer, 1959). Unfortunately, no single method can recover all metabolites
effectively, however many options exist to suit the needs of the researcher.
Likewise, chromatographic separations can be tailored to enhance detection of specific
metabolites of interest. Direct-infusion MS is common, however chromatography enables the
separation of isobaric species (compounds of identical mass) and mitigates ion-suppression,
which refers to the competition metabolites face for ionization when simultaneously present in the
MS source (Blanksby and Mitchell, 2010). The most common bifurcation of chromatographic
methods in metabolomics is reverse-phase (RPLC) and hydrophilic interaction liquid
chromatography (HILIC), for analysis of nonpolar and polar metabolites respectively. RPLC is
typically achieved through C18 column chemistry, which binds strongly to hydrophobic
compounds, and a gradient of polar to nonpolar mobile phases, generating a temporal elution of
compounds off the solid phase with increasing hydrophobicity. RPLC traditionally has more
widespread use in analytical chemistry than HILIC, and is suitable for lipid profiling (lipidomics).
HILIC compound retention mechanisms operate slightly differently in principle, however opposing
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conditions generally hold true: solid phases consisting of silica or derivatized silica to retain polar
compounds, and mobile phase gradients from organic to aqueous solvents for compound elution
off the solid phase. Many variations of these approaches exist, reviewed in Cajka and Fiehn,
2016, including an array of mobile phase additives to enhance metabolite ionization, and
stationary phases of smaller particle sizes to improve chromatographic separation of compounds
with similar physiochemical properties. Workflows which utilize both RPLC and HILIC greatly
expand metabolome coverage, albeit at additional cost and time to perform multiple analyses.
MS detection adds another dimension of complexity to LC-MS workflows. For detection
on a mass spectrometer, metabolites must exist as a charged species through ionization in the
MS source. Multiple options exist for ionization, most classically through election impact (EI),
however for smaller and labile molecules, softer ionization techniques such as electrospray
ionization (ESI) are now common, which may operate to positively or negatively ionize molecules
(ESI+ or ESI- modes respectively).

MS metabolomic analyses are conceptually divided into

either targeted or untargeted approaches, where targeted approaches aim to accurately detect
specific metabolites with greater specificity and sensitivity, and untargeted approaches aim to
detect as many metabolites as possible, unbiasedly and without quantification. Targeted
approaches typically employ mass spectrometers capable of fragmentation (MS/MS), such as
triple quadrupole mass spectrometers (QqQ) or quadrupole/linear ion trap instruments. While
mass resolution is low on these instruments, specificity can be achieved through MS/MS by
analyzing the parent mass-to-charge ratio (m/z), followed by the daughter m/z(s) after imparting
energy on the molecule in the collision cell. This parent-to-daughter mass transition is commonly
called multiple reaction monitoring (MRM), and is the primary means to detect and quantify
metabolites in these instruments (Figure 1.2). With faster scan speeds and ion-polarity switching,
newer instruments can scan for hundreds of MRMs, increasing the scope of targeted
metabolomic analyses (Rhoades and Weljie, 2016, Yuan et al., 2012). Time-of-flights (TOFs),
and other high-resolution instruments such as Orbitraps, are most commonly used for untargeted
metabolomics to detect thousands of metabolic features. While powerful, these instruments on

17

their own are typically reserved for exploratory analyses and yield many m/z values without
metabolite identification. Extensive follow-up work, through either MS/MS or bioinformatics, is
required to identify m/z values as known metabolites. Some instruments combine high-resolution
and fragmentation analysis to collectively achieve selectivity, sensitivity, and mass accuracy. As
databases continue to improve metabolite identification from high-resolution MS metabolomics
datasets, the utility of untargeted metabolomics to probe biology is expected to grow.
Despite recent advancements, metabolomics invariably encounters a high diversity of
physiochemical properties across metabolite classes. Unlike genomics, where all genes can be
measured, metabolomics has yet to delineate the entire metabolome, which may contain tens of
thousands of metabolites (Wishart et al., 2013). Paired with the wide range of metabolite
concentrations found in biological samples, much work remains to develop equivalently diverse
and accurate analytical tools, in addition to building new computational workflows for highthroughput metabolite identification. Method development appropriated for multivariate detection,
coupled with multifactorial design principles (e.g. choice of mobile phase, LC gradient, MS
ionization parameters, etc.), generate a combinatorial complexity in optimization objectives.
Commensurate multivariate workflows, such as design of experiments (DoE), can guide the
analytical chemist to efficiently design complementary metabolomics methods with high
metabolome coverage, sensitivity, and accuracy (Gika et al., 2012).
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Figure 1.2 Mechanism of multiple reaction monitoring (MRM) and representation of an LCMS/MS chromatogram. Reprinted with permission from Domon and Aebersold, 2006.
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Design principles and statistical approaches to process and analyze metabolomic data
Large-scale metabolomic analyses must consider data acquisition, processing, and
analysis to obtain meaningful biological inference. While standardized workflows in LC-MS
metabolomics are lacking, representative procedures reviewed by Dunn and colleagues are most
common (Dunn et al., 2011). After sample extraction, samples are analyzed via LC-MS in a
randomized manner to avoid biases due to analytical drift, referring to the variance exhibited by
LC-MS methods across days or weeks of use. Quality control samples (QCs) are interspersed in
the run order, which can contain either a mix of metabolite standards, or consist of a pooled
sample of all biological samples under study. QC injections can then be used to inspect both
analytical drift and response variance. Drift can be corrected by regression fitting to the QC data
points, metabolite by metabolite. Additionally, any metabolites which display high variance, which
may arise if the signal-to-noise (S/N) is low, can be dropped from the dataset. Stringency in data
correction and filtering may depend on the objectives of the experiment, for example exploratory
preclinical analyses versus targeted and quantitative clinical analyses.
After data processing, multivariate or univariate methods may be used to discover
differences across experimental groups (Kotlowska, 2014). Univariate methods, such as t-tests,
may have utility in biomarker research, however given the dimensionality of metabolomics data,
must consider multiple testing correction, such as Bonferroni or false discovery rate adjustments
(Dunn, 1961, Benjamini and Hochberg, 1995). In reality, phenotypes are driven by relationships
of multiple variables. Two of the most common multivariate approaches in metabolomics are
principal components analysis (PCA) and orthogonal partial least squares discriminant analysis
(OPLS-DA) (Trygg et al., 2007). PCA is an unsupervised approach which seeks the maximum
variation among the metabolites (X variables) to derive new latent variables, or principal
components. PCA yields global structures in metabolomic data irrespective of biological groups,
and is often used as a preliminary analysis. OPLS-DA is a supervised approach, which aims to
derive latent variables from maximal covariance of the metabolites with biological groups (Y
variables). Metabolites which contribute to the largest group separation can then be used in a
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predictive manner for diagnostic or biomarker purposes (Mapstone et al., 2014), or overlaid onto
pathways or networks to understand metabolic mechanisms. Other approaches may be used,
including clustering analysis or Bayesian-based methods, however the ultimate objectives in
analyzing metabolomic datasets remain similar.

LC-MS metabolomics in chronobiology studies
Currently, there is a dearth of metabolomic data for sleep and circadian analyses in
Drosophila (Gogna et al., 2015), however metabolomics is quickly being adopted in other model
organisms and humans, recently reviewed in Brown, 2016, and Rhoades et al., 2017 (Figure 1.3).
Rhoades et al. compiled a meta-analysis of recent human studies, revealing overlapping
metabolite hits across multiple chromatographic and MS detection methods. These hits include
phosphatidylcholines, medium and long-chain acylcarnitines, and amino acids. Members of these
compound classes have been shown to oscillate in murine liver and adipose, with dependency on
a fully functional genetic clock (Eckel-Mahan et al., 2012, Castro et al., 2015). More causal links
of the clock to targeted metabolic outputs in mice have also been discovered, including unique
signaling roles of a specific lipid (PC 18:0/18:1) to regulate metabolic oscillations across tissues
(Liu et al., 2013), and functional roles for polyamines to maintain robust clock function during
aging (Zwighaft et al., 2015). The adipose clock has been shown to impact feeding behavior
through rhythmic release of lipids in a feedback mechanism to the hypothalamus (Paschos et al.,
2012). Tissue-specific clock manipulations in genetic mouse models have simultaneously
uncovered new connections between clocks and metabolism across tissues, while opening a
Pandora’s box of complicated mechanisms to maintain systemic metabolic homeostasis across
circadian time. Additional experimentation will further elucidate our understanding of this
complexity, however new approaches are required to derive interpretable phenotypes at an
organismal scale. Appropriate animal models are also necessary to advance this field, as in vitro
models of circadian rhythms do not faithfully recapitulate the complex interactions of
environmental exposures, feeding, behavior, and tissue-specific metabolism. Metabolomics holds
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promise to uncover the true depth of rhythmic metabolic outputs, as the enrichment of rhythms in
transcripts and their median fold-change in murine liver is 1.51 and 18.3%, respectively (Hughes
et al., 2009), compared to 1.98 and 50% in detectable metabolites under the same experimental
protocol (Krishnaiah et al., 2017). Overlapping metabolite rhythms to mice and humans have yet
to be demonstrated in Drosophila, but given conserved mechanisms of sleep, circadian rhythms,
and nutrient-sensing pathways, many opportunities exist to further explore these chronometabolic
connections.
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Figure 1.3 Timeline of metabolomics in chronometabolic studies, both current approaches and
future directions. From Rhoades et al., 2017.
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Statistical tests to discern periodicity in data
Assessing rhythmic patterns in time-series data requires appropriate statistical tests. True
oscillations, resembling a sine wave, can be tested with rank-based correlations of monotonic
sequences, most frequently performed in the circadian field using JTK_CYCLE (Hughes et al.,
2010). Wavelet tests provide additional information relevant for circadian rhythms, including the
peak of oscillation (phase) and height (amplitude), which can directly answer both when a
metabolic process is most active and the relative strength of the rhythm. Experimental design
plays a critical role in deciphering periodicity with statistical significance. Ideally, sampling
frequency would be high such that a wave can be clearly formed across time, however is rare in
practice due to cost and resource constraints. Reasonable compromises of time resolution and
resource allocation include sampling every two or four hours, which is sufficient to test across 24hour cycles. However, shorter sampling times would be required for ultradian rhythm analysis, as
4-hour sampling resolution would be insufficient to find 8-hour cycles. Recent work has shown
increased resolution also provides increased statistical power, as true positive rates were
dramatically higher in one-hour sampling compared to two or four hours (Krishnaiah et al., 2017).
JTK_CYCLE is commonly executed such that waves are either fit to replicates within one day of
sampling, or replicates spread across multiple days. Care must be taken in testing rhythmicity to
mitigate day-to-day biases, which may be mitigated with data permutations. Additionally,
monotonic changes across time, for example metabolic shifts in concert with changes in cell
culture media, must be separated from circadian-dependent temporal patterns (Sengupta et al.,
2016). Alternative approaches such as time-dependent analysis of variance (ANOVA) or pairwise
univariate testing may also be necessary as diurnal metabolic outputs may not exhibit classic
waveform patterns.

1.4 Application of stable isotope tracers in metabolism research
Definitions and usages of stable isotopes
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Isotopes, most simply, refer to forms of the same element with different numbers of
neutrons. The most commonly used element in isotope-based metabolic studies is carbon, with
12C

comprising 98.9% of all carbon on Earth, and the heavier

remaining 1.1%.

14C

13C

carbon comprising the roughly

carbon also exists, and while it is unstable and radioactive, serves important

purposes in metabolic studies. In the middle of the 20th century, radioisotopes, including 14C, were
frequently utilized to trace metabolic networks, which Nobel laurate Ernst Boris Chain describes
as resulting in ‘an almost explosive expansion of the field of the study of metabolic pathways’
(Chain, 1965). At the time, radioisotopes were effective given their ease of detection, but were
largely nonspecific for probing larger swaths of metabolism. Today, heavy isotopes still pervade
metabolic research, with stable

13C

tracers recently entering metabolomics for pathway discovery

on the heels of improved MS and NMR instrumentation (Giavalisco et al., 2008). Stable isotopes
are also used for quantification of endogenous metabolites on GC and LC-MS platforms, as they
are easily identifiable by an atomic mass unit (amu) shift of 1.00335 for each

13C

atom.

Metabolites may vary many orders of magnitude and suffer from ion suppression by coeluting
species off the chromatographic column (Shi, 2003), therefore to obtain accurate quantitation,
metabolites may be analyzed with a known concentration of an internal standard (most commonly
a stable isotope form of the compound of interest). In theory, any ion suppression effects on the
endogenous metabolite will also apply to the internal standard, thereby yielding a reference
compound for accurate quantification.
A renaissance in metabolic tracers has spawned a new interest in metabolic flux analysis.
While metabolomics itself adds a layer of understanding to biological systems, static profiling of
metabolite levels does not provide dynamics of metabolite flow. For instance, if a metabolite
concentration is high, one cannot be certain of either an increased flux from a producing enzyme,
or decreased flux through a consuming reaction (Creek et al., 2012). Additionally, if one were to
think of a metabolite as a node in a complex graph network of metabolism, the concentration
alone would be an obfuscation of numerous metabolic processes. Fluxes are thought to be the
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most fundamental assessment of metabolic phenotypes, and is the focus of intense research
efforts for both basic biology and therapeutic discovery applications.

Applications of stable isotopes in intracellular flux analysis
Isotope-tracer studies are most commonly performed in vitro, given uptake and effluxes
of labeled metabolites are more accessible than in vivo (Figure 1.4). These experiments are
suitable for comparative analysis of metabolic activity, for example healthy cell lines to genetic
knockdowns or cancer (Fan et al., 2013). Although the flux of atoms through enzymes cannot be
directly measured per se, the detection of isotope incorporation into metabolites downstream from
a known input tracer is a viable alternative. Through repeated sampling of the cell culture media,
the rates of change in isotopically labeled metabolites can be calculated and comprises the most
basic form of metabolic flux modeling. The addition of intracellular isotope analysis adds
significant biological insight, albeit with increased complexity (Sauer, 2006).
referring to all six carbons of glucose consisting of

13C

13C

6

glucose,

(also called uniformly labeled glucose), is

one common tracer for flux analysis through central energy metabolism, although other tracers
may be used to probe secondary metabolism (Winder et al., 2011). Labeled metabolites, called
isotopologues, are typically measured on GC or LC-MS to generate the mass distribution vector
(MDV). The MDV describes the relative abundance of a given isotopologue, from zero to n
labeled carbons. For instance, a 0.10 enrichment of an M+1 isotopologue implies ten percent of
the total metabolite signal consists of that metabolite with one labeled carbon. This approach
considers parent m/z values without positional information of the labeled carbon, which would
require MS/MS or NMR. Isotopologues which differ in the position of the

13C

atom(s) are called

isotopomers, and can provide considerably greater reaction specificity over isotopologues alone.
Inevitably, analytical detection of full isotopomer distributions with larger molecules becomes
unwieldy as each parent isotopologue contains

isotopomers (Buescher et al., 2015), which is

nontrivial in MS/MS methods but has been performed with aspartate (Choi et al., 2012). Before
drawing biological inference from MDVs, data processing measures must be taken to correct for
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the abundance of natural isotopes, including the 1.1% natural abundance of

13C.

For more than

one labeled carbon, these calculations become increasingly complex. Fortunately, isotopecorrection procedures have been made available and are part of routine metabolic flux workflows
(Moseley, 2010).
Stationary flux analysis underlies most published flux analyses, and refers to the
assumption that upon measurement, the isotope enrichment for a given metabolite is in
equilibrium. This assumption holds reasonably well for pathways with high flux and turnover,
notably glycolysis, which can reach steady-state labeling within minutes (Buescher et al., 2015).
Isotopic steady-state is independent of the metabolite levels themselves, meaning MDV
measurements are adequate to gauge pathway activities in a relative manner (Zamboni et al.,
2009). If the pathways contributing to an MDV are known, relative comparisons may be made
even in situations of non-steady state, for example in amino acid metabolism, which may take
days to reach isotopic equilibrium (Buescher et al., 2015). However, if pool sizes of a metabolite
are dramatically different across biological conditions, the MDVs alone may yield misleading
information. For instance, if a given isotopologue enrichment is one percent in condition A and ten
percent in condition B, but the pool size of that metabolite is ten-fold in condition A, then the flux
of atoms into that metabolite pool is roughly equivalent, even if the MDV differs. Quantifying the
metabolite concentration and MDV at high temporal resolution before and after reaching isotopic
equilibrium provides the most accurate estimation of flux, however is difficult experimentally,
analytically, and computationally.
Even if isotopic equilibrium is not attained, the metabolite pool sizes themselves must
remain in steady-state to estimate metabolic flux (Zamboni et al., 2005, Weitzel et al., 2013). If
this assumption does not hold, nonstationary flux analysis must be considered, reviewed in detail
by Wiechert and Nöh, 2013. These analyses are additionally complex and currently out of reach
for mammalian systems. However, the rigor required for tracer studies can be largely dictated by
the biological question, as relative pathway activities may be adequate to discern metabolic
differences across experimental groups. Of note, any given isotopologue likely derives from
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multiple sources, especially in secondary metabolism, and may require positional carbon
information to attribute labeling patterns to specific reaction activities. Some of these concerns of
reaction specificity may be mitigated by utilizing multiple tracers, for example combinations of
glucose, palmitate, and amino acids. Recent advances in metabolomics data processing
algorithms can abstract isotope enrichments in high-resolution untargeted LC-MS datasets,
opening new possibilities for discovery of active metabolic networks (Huang et al., 2014,
Capellades et al., 2016). While great advancements have been made in the metabolic flux field,
much work remains to rigorously derive quantitative flux measurements and understand complex
labeling patterns. Vis-à-vis uncertainties in the interpretation of isotopologue sources, future work
will need to focus on building reaction networks for isotope labeling patterns with atom-level
resolution. While atom-mapping reactions exist, such as in the MetaCyc database (Caspi et al.,
2016), there are currently no methods to map isotopologues onto models of metabolism at a
genome scale (Chokkathukalam et al., 2014).
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Figure 1.4 Depiction of isotopologues and isotopomers, exemplified by 13C6 glucose to isotope
enrichments in alanine.
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Stable isotopes in vivo
Stable isotopes serve important roles in animal and human research, with the latter
explained in detail by Wolfe and Chinkes, 2005. Fan et al. utilized a bolus injection of

13C

6

glucose in a mouse model of lung cancer as a proof-of-principle to track relative changes in
isotopologue patterns across multiple tissues (Fan et al., 2011). However, repeated sampling
from mice is difficult (Castro-Perez et al., 2011), and otherwise would require many mice to
generate a sufficient time-series of isotopologue patterns to calculate reaction rates. Justification
of isotope tracing in animals is questionable for exploratory analyses given the limited
interpretability of these datasets. Conversely, for human studies, considerable effort has been
made to correctly model reaction kinetics for well-defined pathways. Infusions are the preferred
mechanism of isotope delivery, as obtaining isotopic equilibrium is easier than through injection
boluses. (Suh et al., 2003). In situations where physiological steady-state is perturbed, such as
feeding or exercise paradigms, isotopic steady-state will no longer hold, and additional
calculations of isotopologue rates of appearance and disappearance must be considered (Steele,
1959). These calculations generally consider the tracer to exist in a single compartment, such as
blood, with instantaneous and homogenous mixing. Single-compartment models are useful,
however may falter as tissues metabolize and resynthesize nutrients to be released back into the
bloodstream. Models which consider multiple compartments do exist, but require repeated
biopsies from each considered tissue with sufficient temporal resolution.
Despite

tremendous

advancements

in

modern

MS

and

NMR

metabolomics

instrumentation, the detection of stable isotopes in vivo requires significantly higher
concentrations than radioactive isotopes. Large doses of stable isotopes may perturb
physiological steady-state, yielding a state of isotopic disequilibrium. Additionally, compartmental
models may yield spurious information if physiological perturbations alter the tracer’s volume of
distribution. Regardless, advancements in isotope detection and reaction modeling have provided
valuable information for carbohydrate, lipid, and amino acid oxidation. Beyond glucose, palmitate
and glycerol isotopes have uncovered lipid oxidation rates (Greenough et al., 1969), and
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phenylalanine, tyrosine, and alanine have analyzed both amino acid catabolism and protein
anabolism rates (Engelen et al., 2012, Hartl et al., 1990). While some assumptions in in vivo
tracer kinetic modeling may not hold, they serve reasonably well to discern real metabolic
phenotypes.

Applications of isotope tracers in chronobiology to date
Isotope tracer studies have widespread usage in vitro for cancer metabolism research,
and in humans to gauge metabolic responses to exercise and feeding, however few studies exist
which leverage stable isotopes in chronobiology. Metabolism of isotopically labeled glutamate has
been shown to depend on the relative levels of gamma-aminobutyric acid (GABA) and glutamine
in astrocytes and neurons, suggesting control of sleep/wake cycles through a metabolic
mechanism (Qu et al., 2001, McKenna and Sonnewald, 2005). Pharmacological inhibition of
GABA transaminase, which alters GABA and glutamate levels, results in a perturbed metabolic
homeostasis of the TCA cycle and energetic metabolites (Maguire et al., 2015). This effect
derives in part through increased transfer of glutamate carbons to lactate, demonstrated via in
vitro labeling analyses of cultured Drosophila neurons fed

13C

5

glutamate, and likely arises from

compensation for impaired GABA metabolism.
One recent study reported impaired lipid synthesis in timeless mutants, measured
through

14C

incorporation into bulk lipids from

14C-glucose

added to fly media (Katewa et al.,

2016). This effect is only visible under a tRF paradigm, bringing into question the clockdependent versus independent roles of timeless, as this effect was not tested in other clock
mutants. Isotope-feeding studies have also been performed in flies on high-sugar diets to
understand dietary influences on fat body metabolism (Musselman et al., 2013). Ancillary to the
study objectives, isotope enrichments in fatty acids, triglycerides, and trehalose reached an
isotopic equilibrium roughly 24 hours after transfer off the food containing

13C

6

glucose. This

observation is important in designing future labeling studies. Given sugars and lipids are known to
oscillate with 24 hour periods (Scheer et al., 2009, la Fleur et al., 1999, Dallmann et al., 2012),
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flux modeling on shorter timer scales would require nonstationary flux analysis, which is currently
infeasible in whole organisms (Weichert and Nöh, 2013). Qualitative comparisons of isotope
enrichments may be adequate to discern cycles in metabolic flux, however acute labeling
experiments would be required to attain appreciate sampling resolution for rhythmicity tests.
Forcing flies to acutely consume a large meal of a labeled nutrient would likely require starvation
protocols, which may confound results considering perturbing the activator and repressive arms
of the clock can have opposing effects on the starvation response (Xu et al., 2008), however
acute feeding through e.g. an injection bolus may circumvent this concern.
Diurnal nutrient adsorption of glucose and small peptides have been observed at
light:dark transitions in wild-type and clock mutant mice through an in situ loop mechanism in the
jejunum (Pan and Hussain, 2009). Decay from the

14C

tracers were detected in the portal vein

one hour after infusion to discover increased adsorption of both sugars and peptides in wild-type
mice at the onset of the active phase. Temporal patterns in adsorption were lost in clock mutants,
which also demonstrated an overall increased and decreased adsorption of sugars and peptides
respectively. This study marks an important step forward to demonstrate true nutrient processing
changes across time under control of the circadian clock, beyond secondary predictions made
from expression or enzyme abundance. Future studies should continue to expand the scope of
isotope tracing in defining the dynamics of circadian metabolism. As previously mentioned, many
oscillating metabolites from previous metabolomics analyses derive from lipid and amino acid
metabolism. Tracing experiments should be appropriated to corroborate these hits by probing
relative activities of relevant pathways, even if non-steady state metabolic conditions prevent
quantitative metabolic flux in vivo. Additionally, meaningful inferences must be made from
labeling patterns in these secondary metabolic processes, which will require expanded metabolic
models and computational approaches which operate at a genome scale.

New era of genome-scale networks and in silico metabolic flux
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With the advent of whole-genome sequencing, comprehensive metabolic networks can
be constructed to consider all metabolites and reactions in an organism (Feist et al., 2009). This
compendium of reactions can be converted to a genome-scale stoichiometric matrix,
mathematically considering all reactants and products. These network reconstruction efforts
underlie the field of constraint-based modeling (CBM) (reviewed in Bordbar et al., 2014), which
differs from inference-based approaches to build networks de novo from patterns in experimental
data (reviewed in Bonneau, 2008). CBM is a computational approach to understand dynamics of
metabolism, signaling, and transcriptional regulation by imposing constraints on the metabolic
network and predicting a set of possible flux values for each reaction. Constraints may include
thermodynamics, diffusion limits, and ‘omic datasets to improve flux predictions (Weisz, 1973,
Shlomi et al., 2008). Thus, a whole genome-scale metabolic model for any given organism can
serve as the scaffold upon which context-specific models can be generated, such as tissuespecific networks.
CBM is currently on the cusp of wider usage in biomedical research, and has been used
for drug target discovery and the exploration of new reaction mechanisms (Frezza et al., 2011,
Fischer and Sauer, 2003). One appealing development in genome-scale flux predictions is the
objective to restore the flux vector in aberrant metabolism to a healthy state through knockout
simulations (Yizhak et al., 2013). Additionally, individualized human kinetic models combine
enzyme kinetics and personalized ‘omic datasets, which hold promise for tailoring personalized
medicines to control metabolism (Bordbar et al., 2015). Genome-scale models continue to
improve in accuracy and annotation, and our current understanding of canonical biochemistry
pathways from mid-20th century research is already in flux as metabolic simulations continue to
expand further from the hub of central carbon metabolism (Sauer, 2006). With the rapid
expansion of computing power in the 21st century, probing metabolic networks through complex
experimental designs, such as isotope tracer approaches, will become increasingly feasible and
interpretable. One current design feature missing from CBM simulations is tracking individual
carbon fates in metabolic networks, however metabolic simulations at atom-resolution are within

33

reach, and are expected to bring science closer to unearthing the complete cellular metabolome
once thought to be solved in Nicholson’s early metabolic maps (Nicholson, 1970).

1.5. Overview
The associations of sleep and circadian disruption with poor metabolic outcomes warrant
further investigations of causality. The exploration of translatable biological mechanisms hinges
on the appropriate applications of cutting-edge technologies across model organisms. Powerful
genetic tools and systems-level discovery platforms have provided tremendous insight into the
basic mechanisms of clock and sleep processes in Drosophila, however chronometabolic
connections remain largely unexplored. Drosophila provide a tractable model to separate
environmental and endogenous clock-induced metabolomic changes, which cannot be
adequately modeled in vitro. An underlying extension of this metabolomics approach, irrespective
of model organism, is the hypothesis that steady-state cycles will translate to cyclic metabolic
flux. With a resurgence in isotope tracers, in tandem with annotated genome-scale reaction
networks, new technologies can be developed to detect transitory metabolism amidst circadian
cycles. Improved MS instrumentation can now provide rich isotopologue datasets, however much
work remains to process and interpret such complicated data. Specifically, tools must be
developed to consider the possible routes through metabolic networks which produce observable
isotope enrichments.
The results of these objectives are outlined in the proceeding chapters. The LC-MS
metabolomics methods necessary to discern systems-level metabolic cycles are developed in
Chapter 2 through a design of experiments approach. The LC-MS methods developed in Chapter
2 are then applied to Drosophila in Chapter 3, through a collaboration with Dr. Amita Sehgal at
the University of Pennsylvania, to separate metabolite rhythms driven by environmental cues
from endogenous clocks. Additionally, comparisons are made to previous metabolomics
experiments to gauge conserved metabolite cycles across species. Chapter 4 expands the LCMS methods developed in Chapter 2 to detect isotope enrichments from a
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13C

6

glucose tracer.

Through continued collaboration with Dr. Sehgal, a new platform is developed to introduce stable
isotope tracers to Drosophila to uncover novel in vivo metabolic flux cycles. Herein are described
bespoke computational workflows to process and analyze time-series isotopologue datasets, in
addition to dissecting the impact of sleep restriction on rhythms in metabolic flux. As detailed in
section 1.4, limitations in sampling resolution and non-steady state conditions in flies preclude
quantitative flux analysis, however relative pathway activities can still be ascertained. To address
the limited interpretability of isotopologue datasets, both from Chapter 4 and broadly in metabolic
flux analysis, new computational tools are developed to model reactions in genome-scale
networks at atomic resolution, followed by construction of paths from the glucose tracer to
downstream isotopologues of interest, which is described in Chapter 5. This tool is also presented
as a new approach to simulate and design isotope tracer studies, with utility beyond
chronometabolism.
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CHAPTER 2 - Comprehensive optimization of LC-MS metabolomics methods
using design of experiments (COLMeD)
Adapted from published work:
Rhoades SD, Weljie AM. Comprehensive optimization of LC-MS metabolomics methods
using design of experiments (COLMeD). Metabolomics. 2016;2:183.

2.1. Abstract
Both reverse-phase and HILIC chemistries are deployed for LC-MS metabolomics
analyses, however HILIC methods lag behind reverse-phase methods in reproducibility and
versatility.

Comprehensive

metabolomics

analysis

is

additionally

complicated

by

the

physiochemical diversity of metabolites and array of tunable analytical parameters. Our aim was
to rationally and efficiently design complementary HILIC-based polar metabolomics methods on
multiple instruments using Design of Experiments (DoE). We iteratively tuned LC and MS
conditions on ion-switching triple quadrupole (QqQ) and quadrupole-time-of-flight (qTOF) mass
spectrometers through multiple rounds of a workflow we term COLMeD (Comprehensive
optimization of LC-MS metabolomics methods using design of experiments). Multivariate
statistical analysis guided our decision process in the method optimizations. LC-MS/MS tuning for
the QqQ method on serum metabolites yielded a median response increase of 161.5%
(p<0.0001) over initial conditions with a 13.3% increase in metabolite coverage. The COLMeD
output was benchmarked against two widely used polar metabolomics methods, demonstrating
total ion current increases of 105.8% and 57.3%, with median metabolite response increases of
106.1% and 10.3% (p<0.0001 and p<0.05 respectively). For our optimized qTOF method, 22
solvent systems were compared on a standard mix of physiochemically diverse metabolites,
followed by COLMeD optimization, yielding a median 29.8% response increase (p<0.0001) over
initial conditions. The COLMeD process elucidated response tradeoffs, facilitating improved
chromatography and MS response without compromising separation of isobars. COLMeD is
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efficient, requiring no more than 20 injections in a given DoE round, and flexible, capable of classspecific optimization as demonstrated through acylcarnitine optimization within the QqQ method.
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2.2 Introduction
An ideal metabolomics platform would profile all the metabolites in a living system.
Complementary approaches such as GC-MS, LC-MS, and NMR can be employed to enhance
analytical coverage of the metabolome, however the high physiochemical diversity in metabolites
and technological limitations confine any individual analyses to a relatively small subset of the
metabolome. Within LC-MS, multiple column chemistries are also increasingly incorporated into
metabolomics workflows to further enhance coverage (Want et al. 2010). Hydrophilic interaction
chromatography methods hold significant promise for comprehensive analysis of polar
metabolites, however reverse-phase methods are routinely used for small polar molecules (New
and Chan, 2008), in part due to a longer history of reproducible chromatography. The choice of
MS detection is also critical for augmenting metabolome coverage. For instance, untargeted highresolution instruments can provide good coverage and sensitivity (Want et al. 2010), while
modern triple quadrupole or ion-trap instruments provide ion-switching and fast-scanning
capabilities for targeted metabolite identification and quantification (Yuan et al. 2012; Gika et al.
2012; Lv et al. 2011). Holistic improvement of both chromatography and detection parameters
requires bespoke methods to address a large multivariate problem space (Gika et al. 2014). This
problem has been previously addressed using genetic algorithms and large-scale Bayesian
networks (Napoles and Steenbergen, 2014; Correa and Goodacre, 2011), however these
approaches do not concurrently optimize numerous parameters inherent in the comprehensive
LC-MS methodology, nor have they been applied to HILIC, which is often sensitive to small LC
parameter adjustments (Nguyen and Schug, 2008; Hao et al. 2008). An alternative approach for
complex method optimization is DoE, which incorporates multivariate modeling of many response
variables simultaneously (Eriksson et al. 2006). DoE allows for the manipulation of several factors
concurrently and efficiently searches for interaction effects, as opposed to simply changing one
factor at a time. Typical DoE workflows start with screening objectives, where the most important
factors and their appropriate ranges are chosen and subsequently optimized iteratively. DoE has
been used in optimizing other steps of the typical metabolomics workflow, including sample

38

preparation and data processing (A et al. 2005; Eliasson et al. 2012; Zheng et al. 2013). LC-MS
methods have also been improved in this manner, however the response of interest has typically
been targeted to one metabolite or a single class of compounds (Zhou et al. 2009; Székely et al.
2012; Kostić et al. 2013; Riter et al. 2005).
Here we demonstrate that a DoE-driven approach has potential for large-scale
metabolomics method development by improving metabolome coverage without overtly
sacrificing individual metabolite chromatography and MS response. Our main objective was to
design and optimize a polar metabolomics platform, while addressing the idiosyncrasies of
targeted and untargeted LC-MS metabolomics. We coin this method comprehensive optimization
of LC-MS methods through DoE (COLMeD) as a workflow procedure and assess the capability of
DoE to improve responses on a diverse set of polar metabolites. We find this workflow is robust
to method development across MS detection methods, tailoring the COLMeD approach to an LCMS ESI+ method using high-resolution qTOF detection subsequent to the initial polarity-switching
QqQ optimization. We show that the results are robust to multiple sample types and can be
tailored in a class-specific manner by specifically optimizing acylcarnitines from the
comprehensive QqQ method. We note improvements over commonly used methods (Yuan et al.
2012; Paglia et al. 2012), and our workflow informed parameter decisions to limit response
tradeoffs. Moreover, we describe a generalized procedure, bearing in mind the utility of this
approach for efficiently optimizing other facets of analytical method development.

2.3 Methods
Chemicals
All chemical standards used in this study were minimally analytical grade and obtained
from commercial sources (Table 2.1). Optima grade acetonitrile and methanol were purchased
from Fisher Scientific (Fair Lawn, NJ) for the mobile phase and standard solutions. Optima
LC/MS ammonium acetate and formic acid and TraceMetal grade ammonium hydroxide were
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used as mobile phase additives and also obtained from Fisher Scientific. All water used in this
study was deionized and filtered (18.2MΩ, 0.22µm).

Preparation of standard solutions and biological samples
Standard solutions for positive mode qTOF DoE were prepared as 1mg/mL stocks in
100% methanol and diluted to 1µg/mL in 3:1 acetonitrile:methanol. All samples were centrifuged
at 18787g for 5 minutes before LC-MS injection. Gibco horse serum (Invitrogen, Grand Island,
NY) and homogenized Drosophila melanogaster samples were prepared using a modified Blighdyer extraction (Bligh and Dyer, 1959). Briefly, 120µL of 2:1 methanol:chloroform was added to
20µL of serum or 40mg of fly tissue, followed by a brief vortex and 15 minute sonication. 40µL of
both chloroform and water were added to the solution, followed by centrifugation at 18787g for 7
minutes to form the bilayer. The top layer, containing the aqueous fraction, was isolated and dried
down overnight. The dried pellet was resuspended in either 100µL or 400µL of 50:50
water:acetonitrile for serum and fly respectively before LC-MS injection.

LC-MS conditions
Chromatographic separations for the ion-switching DoE were performed on an XBridge
BEH Amide column (2.1x100mm, 2.5µm, Waters Corporation, Milford, MA) with a 2.1x5mm
Vanguard pre-column. DoE chromatography for untargeted qTOF analysis was performed on an
ACQUITY UPLC BEH Amide column (2.1x150mm, 1.7µm), with a 0.2µm in-line filter. Both
methods utilized an ACQUITY H-Class UPLC (Waters Corporation). The mobile phases for the
ion-switching analysis were initially taken from Yuan et al., where the aqueous mobile phase
consisted of 95:5 water:acetonitrile with 20mM ammonium acetate and ammonium hydroxide, pH
9, with the organic mobile phase as 100% acetonitrile. Mobile phase A for the qTOF LC-MS
method was comprised of 95:5 water:acetonitrile with 2mM ammonium acetate and 0.2% formic
acid, while mobile phase B consisted of 90:10 acetonitrile:water with 2mM ammonium acetate
and 0.2% formic acid, which was determined through experimental testing as described later in
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the text. Mass spectrometry was performed on either a Waters TQD or Waters G2-S qTOF in
positive ion mode using ESI+, using Leucine-enkephalin for the lock-mass calibration. As a basis
of comparison for our approach, the LC-MS methods described by Yuan et al. (Method 1) and
from a Waters HILIC Application Note (Paglia et al. 2012, Method 2) were followed as published.
Chromatograms were processed using TargetLynx under MassLynx version 4.1. Statistical
analyses and plotting was performed in R version 3.2, and comparisons between DoE rounds
were made via paired Wilcoxon signed-rank tests.

Model generation, design, and optimization in the COLMeD process
DoE serves to discover important predictor variables which contribute to one or many
desired responses to determine optimal factor tuning (Eriksson et al. 2006). To deal with the
complexity of tuning multiple factors to manipulate the many responses in our metabolomics
methods, our DoE-driven COLMeD approach employs a partial least squares (PLS) fitting
algorithm. Specifically, PLS fits a model to the variation of all responses with the variation of the
factors by accounting for their covariance. This method of fitting is more efficient than multiple
linear regression (MLR), which is also common in multivariate optimization problems, since MLR
fits separate regression models for each response. MLR also suffers when handling missing data
points, which we had encountered in our response matrix, given some chromatographic peaks
were not always present depending on the LC-MS factor settings. In our case, dependent
variables are the original analytical responses (e.g. metabolite peak area and chromatographic
values), which are tuned to independent LC-MS factors by transformation into latent variables.
The number of latent variables, or PLS components, were determined through the default
mechanism in MODDE v11 (Umetrics, Umeå, Sweden), whereby components were added to
improve goodness of fit (R2) until the goodness of prediction (Q 2) was compromised by overfitting
the model. The predictive performance of the model was computed via 7-fold cross validation. A
major advantage of this approach is the ability to weigh one response more than another across
DoE rounds, which we utilize heavily in our COLMeD process. For example, responses with
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significant peak area under the curve (AUC) after the first round were downweighted in the
predictive modeling to favor LC-MS settings which improve other features with lower responses.
AUC responses were set to be maximized in the modeling, while the peak widths were tailored
such that peak width objectives were either 4 seconds for the untargeted qTOF method or 15
seconds for the QqQ method, which benefits from slightly wider peaks due to tradeoffs of
scanning over hundreds of MRMs. Additionally, the response objectives can be adjusted round
over round to achieve iterative improvement. After modeling, a new set of experiments are
generated, in the form of LC-MS settings. This process constitutes one round of DoE, which
would be repeated until optimal conditions are met (specific COLMeD processes listed in Table
2.2).
In a regularly shaped design region, central composite or full factorial designs are
typically chosen to explore the edges of the design space. However, D-Optimal designs
generated in MODDE can accommodate experiments with irregular design regions (Eriksson et
al. 2006), which allowed us to impose constraints on our LC-MS settings which were not feasible
or desirable, for example long LC gradients coupled with high flow rates. We tested the edges of
the irregular design space in addition to replicate LC-MS injections in the center of the space to
gauge reproducibility and model validity. In addition, we performed a conserved triplicate injection
at the end of each DoE round as a quality control measure across batches. To rationalize the LCMS parameters for the next round of experiments, we utilized both visual representations of
optimal regions within the design space and a quantitative optimizer function which generated a
list of parameters to yield an optimized solution using the PLS model. In addition to the model
statistics and predictive functions of the PLS model, we also evaluated the VIP value, which is a
multivariate metric used to identify the relative importance of an original predictor variable (i.e.
before transformation) to the model (Eriksson et al. 2006). These values identify non-significant
contributions of LC-MS parameters to the metabolite responses, which allowed us to assign fixed
values and simplify the design space for the next DoE round. We chose to use MODDE software
due to integrated cross-validated model fitting, model fit visualizations, and predictive capabilities.
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Open-source platforms for each of the steps in the COLMeD process could be alternatively used
to build an in-house workflow.

Ion-Switching COLMeD
While the ultimate goal was to optimize both LC and MS conditions, the initial
experimental design space including LC gradients was too large to combine with MS parameters
and therefore required a two-stage approach, outlined in Table 2.2. A screening linear objective
design of LC-only tuning was chosen for this initial round, omitting interaction effects and
requiring only 13 LC-MS injections. Response measurements were taken on multiple sample
types, horse serum and homogenized fly samples, which provided an added measure of
confidence in designing the next round of experiments. The total initial response optimization
consisted of a set of 33 responses in horse serum (Table 2.3), as well as unique responses found
in fly tissue but uncommon in serum in order to enhance overall coverage in the initial screen
(Table 2.4). Measured response variables were chosen based on criteria designed to elucidate a
broad physiochemical range of metabolites and the presence of marginally detectable
metabolites, in addition to measures of peak quality. We tailored the responses to reflect
particular considerations of MRM-based analysis. For example, glutamine and lysine have
overlapping MRMs, thus we fit the PLS model to predict maximal retention time separation. MRM
transitions and voltages were optimized by using pure standards or from the METLIN and HMDB
mass spectrometry databases (Smith et al. 2005; Wishart et al. 2013). For AUC response
optimization, the objective defined in the PLS fitting was set by using the mean AUC from the LCMS injections of that DoE round as a threshold, from which the optimizer and design space plots
were used to find conditions predicted to increase AUC for the subsequent DoE round.
Factors considered for the LC optimization included the initial LC flow rates (0.10.25mL/min, continuous variable) and gradient types (1-4, Figure 2.1, discrete). The gradients
were rationalized from both published (Yuan et al. 2012) and unpublished work. The LC-MS
parameters proposed by Yuan et al. (Gradient 1) served as a starting point to build our
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metabolomics platform, however we felt the COLMeD process could improve response within the
QqQ method as well as and LC solvents as Yuan et al. for the QqQ method, we relaxed the LC
parameters in an exploratory manner before refined tuning in later rounds. The MS parameters
were initially set as close to the published settings as possible while aligned with vendor-specific
voltage parameters. Initial gradient times (10-16min) were purposefully imposed to achieve
reasonably high throughput. The gradient time refers to the time of injection until the wash step.

Modular workflow optimization
After Rounds 2 and 3, we sought to further optimize the method for a specific class of
compounds with shared chemical properties, in which case the parent method could be used to
tune the response for specific compounds, such as carnitines. The analytical factors were
analogous to other rounds of QqQ DoE, but the responses were limited to peak AUCs and peak
widths for carnitine, acetylcarnitine, propionylcarnitine, and butrylcarnitine. The data from DoE
rounds 2 and 3 were combined and used as inclusions in a D-Optimal quadratic design, whereby
only an additional six test runs were needed to finish out the model design. The experimental
space in which the method optimum predictions from Rounds 2 and 3 overlapped with predictions
based off of these additional test runs with good model statistics confirmed the optimized method
and thus completed the class-specific DoE.

Untargeted qTOF COLMeD
Optimizing chromatography for an untargeted method requires additional considerations
due to the large number of unknown responses. Rather than optimizing responses on a serum
sample, which would contain many unknown features, we initially developed the qTOF method on
a standard mix of 48 diverse polar metabolites injected at 1µg/mL (Table 2.1). Prior to DoE, 22
LC solvent systems were compared using the standard mix. These solvents were based on a
literature search and are listed in Table 2.5 (Want et al. 2010; Kivilompolo et al. 2013; Ivanisevic
et al. 2013; Zhou et al. 2013). Mass spectrometry settings were based on data from the ion-
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switching method development, where desolvation temperature and gas flow were set to 500°C
and 1000L/Hr respectively. Unless specified by a particular published method, the gradients were
aligned across each solvent system, with 45°C column temperature. Given the solvents used in
the QqQ method are pH 9, new solvents were required for a qTOF method in positive ionization.
Aggregate measures of peak capacity, peak skew, peak resolution between any two pairs of
peaks, number of peaks, MS response, and peak widths were all compared to choose the initial
LC solvents (Table 2.6). These metrics were used in addition to inspection of chromatography to
choose the best solvents manually. We found that some solvents yielded split peaks and
prohibited detection of all the metabolites in our mix, thus we felt the need to inspect these results
and choose accordingly before proceeding to strictly quantitative optimization of the method using
DoE. After selecting the LC solvents, the COLMeD approach was divided into two parts to
optimize LC and MS settings separately, which was in large part guided by our QqQ COLMeD
findings. Three rounds of DoE were performed for the LC factors (Table 2.7), which included
responses for isobar separations of leucine/isoleucine and alanine/sarcosine, with fixed MS
parameters. For ease of comparison, peak response (AUC), peak width, and peak skew were
converted to rank-based values, whereby each injection was ranked in each of these metrics
across every injection from a given DoE round. The holistic peak metrics used as responses in
the qTOF COLMeD are more amenable to peak-picking methods used in untargeted data
processing algorithms. Our objective with the initial LC DoE was to heavily favor optimization of
chromatography, which naturally derives from the variety of peak quality metrics (peak shape,
width, separation, etc..) chosen compared to a singular readout of pure metabolite response on
the MS. In addition, automated integration of peaks can be difficult when flow rates and gradients
are tuned, which does not change during MS factor tuning. AUC was thus one of several
responses optimized in the LC DoE, but subsequently the sole response variable used in the MS
DoE after chromatography was fixed.
Thus we maintained a similar workflow to the QqQ COLMeD procedure, with additional
fit-for-purpose modifications to the developmental process. After LC optimization, two rounds of
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DoE were performed for the MS parameters in ESI+. Similar to the polarity switching design, the
LC factors consisted of flow rate (0.2-0.5mL/min), gradient slope (4-9, which was calculated by
percent change in solvent B divided by gradient time), and column temperature (30-60°C). By
having a simpler design space with only three factors, we could employ a more complex a DOptimal quadratic model (20 runs). We were able to further simplify the design by eliminating
non-significant factors and perform rounds 2 and 3 as full factorial designs (12 runs each, in a
2x2x3 design). A full factorial design allows for simultaneously testing three levels of each factor
and support a quadratic model. While typically experimentally costly, with only two factors, this
design space can be tested with only 12 injections, including center point replicate injections. This
design is thus identical to the central composite face-centered (CCF) analysis, which is
recommended for full scale investigations and optimization after elimination of less important
factors from earlier DoE rounds (Eriksson et al. 2006). Our criteria for removing factors included
both analysis of coefficient plots and displaying a VIP score below 1. The detailed models
informed tradeoffs in analyte response, while also considering conditions providing sufficient
chromatographic resolution between isobars. The MS factors consisted of sampling cone voltage
(20-40V), desolvation temperature (400-550°C), source temperature (90-150°C), cone gas flow
(20-80L/Hr), and source offset (60-100V). The sole response optimized for the MS DoE was
average AUC rank for each injection on the 48 standards. DoE was completed when we were
able to identify the LC-MS parameters that met our response thresholds, the elucidation of
tradeoffs in the method, and weak PLS model statistics, which indicated a tightly constrained
design space with minimal gains for further improvement.

2.4 Results and Discussion
Round 1: Initial LC screening for polarity-switching method
The initial screening batch for the comprehensive quadrupole method LC conditions
consisted of 13 injections, repeated for both horse serum and fly samples. Predictive design
space plots and optimizer analysis of both data sets yielded similar trends for all three factors
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(Figure 2.2). Notably, lower flow rates and/or longer gradients were predicted to improve
response, with gradients 3 and 4 yielding predicted design space regions with the most response
criteria met. Some differences in the predicted gradient time optimum likely result from slightly
different response lists across sample types. However, given both flow rate and gradient time had
significant impact (VIPs of 1.43 and 1.08 respectively), also supported by analysis of PLS
loadings plot (Figure 2.3), our initial estimates of factor ranges based on a priori rationale and
desirability of run time and flow rates needed to be expanded. The model statistics from Round 1
serum analysis gave us confidence in obtaining the method optimum via expanding these factor
ranges (Table 2.8).

Continued DoE with LC and MS factors
After adjusting the LC factors from Round 1, the MS factors and column temperature
were added to the design. While displaying a relatively weak effect compared to other factors,
gradient 4 slightly outperformed gradient 3 (nonsignificantly), and was arbitrarily selected and
fixed in future designs. Running multiple optimizations predicted flow rates above 0.15mL/min to
improve results. To some degree this prediction contradicts the predictions from Round 1, which
may be resolved with increased sampling. Given that flow rate maintained an important
contribution to the PLS model (VIP = 1.09), the flow rate was restricted to regions of the design
space where the predictive plots and optimization functions overlapped in optimum predictions
(0.15-0.3mL/min). Desolvation temperature also had a large effect on response as demonstrated
by the largest VIP value (1.19) amongst LC-MS factors. Consequently, this factor was restricted
to 300-500°C for Round 3 based on the predictive plots and optimizer function. The predicted
optimal gradient times were variable, however given the desire to increase throughput, 12-18
minute gradients were set for Round 3. Column temperature had less effect on the model
compared to the other factors (VIP=0.89), and these temperatures were restricted to 40-55°C for
Round 3 based on the predictions. Desolvation gas flow was retained as a factor in the
subsequent model despite a minimal contribution (VIP=0.8), albeit restricted to maintain
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compatibility

with

the

desolvation

temperatures

according

to

the

manufacturer’s

recommendations.

Further refinement of design space
The updated factor ranges were used for the fractional factorial design in Round 3,
necessitating 17 runs. Predictions from the model yielded slightly shifted but generally consistent
results with Round 2. Flow rate and desolvation temperature again were the most significant
factors, (VIP of 1.88 and 1.37, respectively). Optimal flow rates gravitated towards the low end of
the 0.15-0.3mL/min range. Conversely, higher desolvation temperatures were predicted to
perform better. Gradient times were consistent from predictions from Round 2, likewise, column
temperature and desolvation gas flow were largely irrelevant, with the factor ranges being
unaffected by the updated predictions. Over the course of the three rounds we noticed marked
improvement in multiple endpoints, including MS response, peak width (towards our goal of
15sec widths at half height), and number of metabolites (Figure 2.4A).

Acylcarnitine-specific DoE
To explore the notion of targeting subsets of metabolites from the comprehensive parent
method, data from rounds 2 and 3 of the polarity switching DoE were combined to generate
predictions for increased AUC and optimized peak width of carnitine, acetylcarnitine,
propionylcarnitine, and butrylcarnitine. Based on this data, lower flow and longer gradients were
expected to improve response and peak width. Analysis of the acylcarnitine-specific LC-MS runs
generated from modeling the data in rounds 2 and 3 revealed consistencies in the predictions and
improved AUC response and peak width with strong PLS fitting (Table 2.8), demonstrating
successful confirmation of the predictions and optimization of a compound class specific method
(Figure 2.5).

Refinement and validation of comprehensive method
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We primarily attributed improvements in the acylcarnitines across Rounds 2 and 3 to
adjustments in desolvation temperature. Given this information, we then evaluated the original 33
responses chosen in the comprehensive method with the acylcarnitine-specific experimental
design to observe tradeoffs between response improvement of the carnitines, which exhibit
positive ionization, versus other metabolites in both ESI+ and ESI- modes (labeled as Round 4 in
Figure 2.4B). While not a true round 4 DoE design for the comprehensive method, we can
leverage this extra information to refine our final COLMeD output. We found that between Round
4 and Round 1, which contained the maximal spread of desolvation temperatures, the median
carnitine AUC increase was 82.2% compared to 54.9% for all other metabolites. We
subsequently adjusted desolvation temperature to 450°C as a final tuning of the comprehensive
method which contains both ESI+ and ESI- metabolites. The final parameters for the
comprehensive QqQ method were 0.15mL/min flow rate, 20 minute gradient time (Mobile phase
B changed from 85-30% over the first 5 minutes and held until the wash step at 20 minutes),
950L/Hr gas flow and 45°C column temperature. The overall COLMeD progression of LC-MS
parameters is listed in Table 2.9. Manufacturer’s notes from Waters suggest 400°C and 800L/Hr
desolvation settings for a 0.15mL/min flow rate, corroborating optimized and safe conditions.
Although the flow rate is below the optimum efficiency for a 2.5µm particle size, the COLMeD
approach optimized our methods to be fit-for-purpose. Additional injections of horse serum were
analyzed at these conditions as a validation measure of the final method (labeled as ‘COLMeD
Final’ in Figure 2.4B). Improvements were noted over Round 1 in both the percent AUC increase
(median increase of 161.5%, p=7.76e-16, Figure 2.4B) and the number of metabolites detected,
from 163 to 188.

Benchmarking the COLMeD result
We compared our final method to two other well utilized methods: a polarity-switching
method utilizing the same solvents and column from Yuan et al., (Method 1) as well as a vendor
published method optimized for high-resolution untargeted qTOF analysis compatible with our
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instrumentation (Waters) used in several metabolomics studies (Want et al. 2010; Paglia et al.
2012; Bruce et al. 2009, Method 2). We observed a total ion current increase in measured
metabolite channels of 105.8% and 57.3% over these two methods respectively, (Figure 2.4C),
with a median 106.1% increase in metabolite response over Method 1 (paired comparison,
p=1.46e-13) and a median 10.3% increase over Method 2 (p=0.042). We were also able to
maintain broad metabolite coverage with the COLMeD output method, yielding 188 metabolites
compared to 181 and 190 in Methods 1 and 2 respectively, meeting our overall objective of
developing sensitive and deep polar metabolomics methods. The coefficient of variation across
replicate injections also decreased for a given metabolite compared to Methods 1 and 2
(p=6.27e-03 and p=7.16e-04 respectively, Figure 2.6), suggesting improved method precision.

Untargeted qTOF DoE
Given

the

difference

between

triple

quadrupole

and

untargeted

qTOF-based

metabolomics, we employed a modified COLMeD approach. Ranked-based metrics (Table 2.6)
and visual inspection of chromatography were used to choose the initial LC solvents between 22
solvent combinations in ESI+ mode before further DoE optimization of chromatography (Table
2.5, 2mM ammonium acetate with 0.2% formic acid chosen as the final additives). Of the six
interaction variables for LC and MS factors in the PLS model for the Round 4 QqQ DoE, only
gradient time with desolvation temperature yielded a VIP score over 1, while four of these six
factors had a VIP score below 0.8. Thus we felt the interaction of LC and MS factors were small
enough to optimize LC and MS on the qTOF separately (Table 2.10). After the first round of DoE,
optimizing LC parameters only, predicted response optimums resided around 0.3-0.4mL/min with
3-5 gradient slope. Both of these factors contributed significantly to the data (VIP values of 1.9
and 1.65), unlike column temperature (VIP=0.62). Consequently, column temperature was fixed
at 40°C for Rounds 2 and 3, which facilitated full factorial designs for optimizing flow rate and
gradient slope (Figure 2.7). Results were consistent after Round 2, and flow rates were focused
to 0.35-0.4mL/min with a gradient slope between 4 and 5. In this process, important tradeoffs
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were noted. For example, 0.35mL/min was the minimum flow rate to maintain a
Leucine/Isoleucine and Alanine/Sarcosine resolution of at least 1.2. Peak capacity also improved
with higher flow rates, but AUC ranks improved towards 0.3mL/min, thus 0.35mL/min was
considered a good compromise for these responses (with a 5 gradient slope as defined in the
methods and 40°C column temperature chosen as the final conditions, Figure 2.8A). The PLS
fitting to data from the Round 1 LC dropped significantly by Round 3, informing us of a highly
constrained design space where there existed little room for improvement (Table 2.8).
Chromatographic parameters improved with minimal sacrifice to response, particularly in regards
to decreasing the spread of peak widths and peak skews (Figure 2.8B). These settings also
closely follow the UPLC linear velocity for the 1.7µm column while maintaining safe
backpressures. Thus for the final LC conditions, the gradient was changed from 100-20.6% B
over 15 minutes at 0.35mL/min, followed by a wash of 100% A for 5 minutes. Mobile phase B was
changed from 0-100% from 20-22 minutes and held for column equilibration until 30 minutes. For
the MS parameters, analysis of the initial linear screening batch produced a compelling model
(Table 2.8) with desolvation temperature as the dominant factor (VIP=2). Positive correlation of
AUC and desolvation temperature is also in line with the QqQ method optimization. Desolvation
temperature was then fixed for Round 2 to reduce design complexity. Source offset was the only
other factor which weighed significantly in the PLS models (VIP=1.75), improving AUC rank at
minimum voltages. The other factors had low VIP scores (all below 0.9) and nonsignificant
coefficient values, though the trends in improving response were consistent in both rounds. Two
rounds of DoE were considered sufficient to improve response to complete the LC-MS
optimization of the untargeted method in a highly efficient manner. Round 2 yielded an average
response increase of 29.8% (p=3.016e-05), while the chosen parameters within the Round 2
factor settings only yielded a 2.9% increase over the average AUC for the entire round, indicating
minimal room for further improvement. Final conditions were 550°C desolvation temperature, 25V
cone voltage, 60V source offset, 120°C source temperature, and 50L/Hr cone gas flow (Figure
2.9).
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2.5 Concluding Remarks
In this study, the COLMeD approach is demonstrated as an efficient and flexible tool to
optimize multiple LC-MS metabolomics methods with different objectives. This may be particularly
useful due to differences between results an individual lab compared to literature parameters.
Improvements from the starting points of the LC-MS design space were noted for metabolite
responses and their chromatography using a limited number of injections. We also noted
improvements in these responses over other established polar metabolomics methods. We do
acknowledge that while all columns tested in this study and the benchmarked methods have an
amide chemistry, the column dimensions vary which may impact the data. A subset of
metabolites with similar chemical properties were further optimized within the comprehensive
method, which could allow for acylcarnitine-specific analyses without needing to switch solvents
or columns. We feel this modular approach can efficiently optimize analyses of other particular
metabolite groups of interest. Tailoring the COLMeD approach for untargeted metabolomics on
the qTOF also yielded improved chromatography and response while maintaining sufficient isobar
separation. Consequently, it is important to note that there are many ways to optimize these
methods within the COLMeD framework. One could optimize only LC factors, using more
thorough designs after the screening round to add confidence in obtaining the method optimum,
followed by a similar workflow for the MS factors, which was the route was taken for the
untargeted qTOF method development. This approach may require more injections and time, but
has the advantage of being amenable to more automated methods for peak analysis once the
chromatography is fixed. Conversely, we felt our combined LC-MS linear model approach for the
polarity-switching method could yield our desired output while minimizing injections, given most of
the coefficients for the interaction variables to be among the lowest in both rounds 3 and 4 of the
QqQ COLMeD process (Table 2.10). A combination of more detailed model designs, along with a
smaller initial design space, will likely yield a stronger predictive model, as we had found with the
separated LC and MS optimizations (Table 2.8). We generally recommend separating LC and MS
optimizations if time allows and additional rigor is required, however without parallel analysis of
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combined versus sequential LC-MS optimizations, we cannot definitively say if the response
gains would be significant. In addition, broader assessments of peak quality and response are
more suitable for optimizing untargeted metabolomics methods. In our case, optimizing these
aggregated metrics met our objective of developing comprehensive metabolomics methods, as
opposed to more focused and quantitative metrics such as limits of detection and response
variance. Others have recently used a Derringer function approach to comprehensively assess
peak characteristics in a multi-analyte mixture (Sampsonidis et al. 2015), similar to what we
employed here. We stress that during optimization of complex methods over many responses,
not every response can be maximally improved and thus requires analysis of tradeoffs. However,
one benefit in utilizing these statistical models is the ability to stress the optimization of more
important metabolites or responses. We also note that in method development for LC-MS
metabolomics, the method optimum is largely defined by the user, and thus the response
selection must be fit for the experimental purpose. Future studies will further validate these
methods with different sample types and responses, such as the compounds found in our
homogenized fly samples but not horse serum. More importantly, we have laid out a thorough
description of the COLMeD workflow from which we hope can be useful in not only LC-MS
metabolomics but other complex method types which require adjusting multiple factors to
optimize multiple responses.
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Table 2.1 Metabolite standards used in qTOF method development, with associated HDMB and
KEGG identifiers
Metabolite

Human Metabolome Database

KEGG

Source

Glycine

HMDB00123

C00037

Fisher Scientific

Taurine

HMDB00251

C00245

Fisher Scientific

Sucrose

HMDB00258

C00089

Fisher Scientific

Alanine

HMDB00161

C00041

Sigma

Serine

HMDB00187

C00065

Sigma

Proline

HMDB00162

C16435

Sigma

Valine

HMDB00883

C00183

Sigma

Threonine

HMDB00167

C00188

Sigma

Aspartate

HMDB00191

C00049

Sigma

Lysine

HMDB00182

C00047

Sigma

Glutamine

HMDB00641

C00064

Sigma

Glutamate

HMDB00148

C00025

Sigma

Histidine

HMDB00177

C00135

Sigma

Phenylalanine

HMDB00159

C02057

Sigma

Citrulline

HMDB00904

C00327

Sigma

Tyrosine

HMDB00158

C00082

Sigma

Guanosine

HMDB00133

C00387

Sigma

Glutathione-reduced

HMDB00125

C00051

Sigma

Adenosine monophosphate

HMDB00045

C00020

Sigma

Adenosine disphosphate

HMDB01341

C00008

Sigma

Adenosine triphosphate

HMDB00538

C00002

Sigma

Folic acid

HMDB00121

C00504

Sigma

Choline

HMDB00097

C00114

Acros Organics

Betaine

HMDB00043

C00719

Acros Organics

Cysteine

HMDB00574

C00097

Acros Organics

Leucine

HMDB00687

C00123

Acros Organics

Isoleucine

HMDB00172

C00407

Acros Organics

Asparagine

HMDB00168

C00152

Acros Organics

Acetylcholine

HMDB00895

C01996

Acros Organics

Methionine

HMDB00696

C01733

Acros Organics

Hypoxanthine

HMDB00157

C00262

Acros Organics

Carnitine

HMDB00062

C00318

Acros Organics

Arginine

HMDB00517

C00062

Acros Organics

Glucose

HMDB00122

C00031

Acros Organics

Fructose

HMDB00660

C10906

Acros Organics

Acetylcarnitine

HMDB00201

C02571

Acros Organics

Tryptophan

HMDB00929

C00078

Acros Organics

Pantothenate

HMDB00210

C00864

Acros Organics
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cyclic AMP

HMDB00058

C00575

Acros Organics

Cortisol

HMDB00063

C00735

Acros Organics

NAD+

HMDB00902

C00003

Acros Organics

Sarcosine

HMDB00271

C00213

Acros Organics

Phosphocreatine

HMDB01511

C02305

Acros Organics

Creatine

HMDB00064

C00300

Acros Organics

Malonylcarnitine

HMDB02095

Not Found

Cambridge Isotopes

Hydroxyisovalerylcarnitine

HMDB13132

Not Found

Cambridge Isotopes

Acetyl-CoA

HMDB01206

C00024

Cambridge Isotopes

Octanoylcarnitine

HMDB00791

C02838

Tocris Biosciences

Palmitoylcarnitine

HMDB00222

C02990

Tocris Biosciences
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Table 2.2 COLMeD Workflow for both QqQ and qTOF Methods
Workflow

QqQ

qTOF

Initial factor range and response
selection

Factors: LC only (round 1),
followed by LC-MS
Responses: Metabolites from
horse serum (Table S2)

Factors: LC and MS optimization
separate
Responses: Standard mix, both
LC and MS response (Tables S5
and S6)

Pilot LC-MS batch

D-Optimal linear screening
design: 13 runs

D-Optimal quadratic design for
LC: 20 runs
D-Optimal linear for MS: 13 runs

Data processing and fitting to
PLS models

Main effect plots and PLS loadings for data assessment

Model analysis and optimum
predictions

Predictive design space plots, and optimizer function for optimum
predictions, VIP > 1 for important factors

Update factor settings and
constrain design space for next
round; change design as needed

1 round for LC (13 runs)
3 rounds for LC-MS (13, 17, 9
runs)
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3 rounds for LC (20, 12, 12 runs)
2 rounds for MS (13, 12 runs)

Table 2.3 List of Responses Optimized in Horse Serum
AUC Response
(maximize)

a

Acetoacetate
Acetylcarnitine
Aconitate
Butrylcarnitine
Carnitine
Choline
Citrulline
Disaccharide
Glucose
Glycine
Hypoxanthine
Malate
Ornithine
Propionylcarnitine
Urea

Peak Width
(15sec)

b

Acetylcarnitine
Arginine
Butrylcarnitine
Carnitine
Choline
Disaccharide
Glycerophosphocholine
Histidine
Lactate
Ornithine
Propionylcarnitine
Serine
Tyrosine

aAUC

Peak Presence
(maximize)

c

Citrate
Fumarate

Peak Quality
(maximize)

d

Histidine
Succinate

RT Differencee
(maximize)
Glutamine/Lysine

represents area under the curve of integrated peak. bWidth defined by full width half height of the peak.
given 0 or 1 based on peak presence. dPeak quality defined qualitatively, whereby 0 is nonexistant peak, 1 is
noisy signal, 2 is defined peak, 3 is Gaussian peak. eRT = Retention Time. Brackets in headings indicate the objective
criteria used in the optimization functions
cResponse

57

Table 2.4 List of Responses Optimized in Fly
AUC Response

a

Peak Width

b

Acetoacetate

Acetylcarnitine

Acetylcarnitine

Arginine

Aconitate

Butrylcarnitine

ADP

Carnitine

ATP

Choline

Butrylcarnitine

Disaccharide

Carnitine

Glycerophosphocholine

Choline

Histidine

Disaccharide

Lactate

Fumarate

Ornithine

Glucose

Propionylcarnitine

Glycine

Serine

Glutathione-Reduced

Tyrosine

Hexose-6-Phosphate
c

Histidine

Peak Quality

Malate

Hypoxanthine

Ornithine
Propionylcarnitine

RT Differenced

Ribulose-5-Phospahte

Glutamine/Lysine

Succinate
aAUC

represents area under the curve of integrated peak. bWidth defined by full width half height of the peak cPeak
quality defined qualitatively, whereby 0 is nonexistant peak, 1 is noisy signal, 2 is defined peak, 3 is Gaussian peak.
dRT = Retention Time
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Table 2.5 Twenty-two solvent combinations used in the qTOF LC method development
Method

Aqueous Solvent

Organic Solvent

1

100% water, 0.1% formic acid

100% acetonitrile, 0.1% formic acid

2

100% water, 10mM ammonium acetate,
0.2% formic acid

95:5 acetonitrile:water, 10mM
ammonium acetate, 0.2% formic acid

3

100% water, 5mM ammonium formate,
5mM ammonium acetate, 0.2% formic
acid

95:5 acetonitrile:water, 5mM
ammonium formate, 5mM ammonium
acetate, 0.2% formic acid

4

100% water, 10mM ammonium formate,
0.1% formic acid

90:10 acetonitrile:water, 10mM
ammonium formate, 0.1% formic acid

5

100% water, 10mM ammonium formate,
0.2% formic acid

90:10 acetonitrile:water, 10mM
ammonium formate, 0.2% formic acid

6

100% water, 10mM ammonium formate,
10mM ammonium acetate, 0.2% formic
acid

90:10 acetonitrile:water, 10mM
ammonium formate, 10mM
ammonium acetate, 0.2% formic acid

7

100% water, 0.2% formic acid

100% acetonitrile, 0.2% formic acid

8

100% water, 5mM ammonium acetate,
0.2% formic acid

90:10 acetonitrile:water, 5mM
ammonium acetate, 0.2% formic acid

9

100% water, 5mM ammonium formate,
5mM ammonium acetate, 0.1% formic
acid

90:10 acetonitrile:water, 5mM
ammonium formate, 5mM ammonium
acetate, 0.1% formic acid

10

100% water, 10mM ammonium formate,
10mM ammonium acetate, 0.1% formic
acid

90:10 acetonitrile:water, 10mM
ammonium formate, 10mM
ammonium acetate, 0.1% formic acid

11

100% water, 10mM Ammonium Acetate,
0.2% formic acid

90:10 acetonitrile:water, 10mM
ammonium acetate, 0.2% formic acid

12

100% water, 10mM ammonium acetate,
0.1% formic acid

90:10 acetonitrile:water, 10mM
ammonium acetate, 0.1% formic acid

13

100% water, 5mM ammonium formate,
0.2% formic acid

90:10 acetonitrile:water, 5mM
ammonium formate, 0.2% formic acid

14

100% water, 1mM ammonium acetate,
0.2% formic acid

90:10 acetonitrile:water, 1mM
ammonium acetate, 0.2% formic acid

15

100% water, 2mM ammonium formate,
0.1% formic acid

90:10 acetonitrile:water, 2mM
ammonium formate, 0.1% formic acid

16

100% water, 2mM ammonium formate,
2mM ammonium acetate, 0.2% formic
acid

90:10 acetonitrile:water, 2mM
ammonium formate, 2mM ammonium
acetate, 0.2% formic acid

17

100% water, 2mM ammonium acetate,
0.1% formic acid

90:10 acetonitrile:water, 2mM
ammonium acetate, 0.1% formic acid

18

100% water, 1mM ammonium formate,
0.2% formic acid

90:10 acetonitrile:water, 1mM
ammonium formate, 0.2% formic acid

19

100% water, 1mM ammonium formate,
1mM ammonium acetate, 0.1% formic
acid

90:10 acetonitrile:water, 1mM
ammonium formate, 1mM ammonium
acetate, 0.1% formic acid

20

100% water, 2mM ammonium formate,
2mM ammonium acetate, 0.1% formic
acid

90:10 acetonitrile:water, 2mM
ammonium formate, 2mM ammonium
acetate, 0.1% formic acid

21

100% water, 5mM ammonium acetate,
0.1% formic acid

90:10 acetonitrile:water, 5mM
ammonium acetate, 0.1% formic acid
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22

100% water, 2mM ammonium acetate,
0.2% formic acid
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90:10 acetonitrile:water, 2mM
ammonium acetate, 0.2% formic acid

Table 2.6 Metrics used to choose the optimal starting LC solvent composition among 22 solvent
possibilities for untargeted qTOF LC-MS optimization prior to DoE
Metric

Description

Objective

Percentage of peaks under
retention 2

The percentage of total peaks detected that had a retention
index under 2, calculated using k=tR-t0/t0, where tR is the
peak retention time and t0 is the void volume

Minimize

Percentage of peaks under
resolution 1.5

Using a combinations function, all possible peak
resolutions were calculated between two peaks, defined by
Rs=2(tR2-tR1)/(wb2+wb1), where R2 and R1 are retention
times of two peaks, and b2 and b1 are base peak widths of
two peaks

Minimize

Average peak resolution

Average of all possible peak resolutions between two peaks

Maximize

Average peak skew

Average skew of all peaks, calculated using MassLynx

Minimize

Average peak kurtosis

Average kurtosis of all peaks, calculated using MassLynx

Maximize

Peak capacity using base width

Number of peaks theoretically to separate in a method,
defined by Pc=1+(tg/wb), where tg is gradient time and wb
is peak width

Maximize

Average AUC

Average AUC for all peaks

Maximize

Number of peaks

Total number of peaks detected for the standard mix of 48
metabolites

Maximize

Average FWHH

Average peak width at half height

Target at 4 seconds
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Table 2.7 Metrics used in the LC qTOF DoE optimization. The objective refers to the objective
criteria used in the optimizer functions
Metric

Description

Objective

AUC Rank

Ranks were given to each injection in the DoE round for
every metabolite’s response, then averaged to give a
composite AUC rank for each injection

Maximize

Average FWHH

Peak width at half height averaged

Target at 4 seconds

Average peak skew rank

Peak skew ranks given to each injection in the DoE round
for every metabolite’s peak, then averaged to give a
composite skew rank for each injection (skew calculated
using MassLynx)

Maximize

Average peak width rank

Peak width at half height ranks given to each injection in
the DoE round for every metabolite’s peak by finding the
difference from the 4 second width objective, then averaged
to give a composite width rank for each injection

Maximize

Leucine/Isoleucine Resolution

Resolution between leucine and isoleucine peaks

Target at 1.5

Alanine/Sarcosine Resolution

Resolution between alanine and sarcosine peaks

Target at 1.5

Percentage of peaks under
Resolution 1.5

Using a combinations function, all possible peak
resolutions were calculated between two peaks, defined by
Rs=2(tR2-tR1)/(wb2+wb1), where R2 and R1 are retention
times of two peaks, and b2 and b1 are base peak widths of
two peaks

Minimize

Percentage of peaks under
retention 2

The percentage of total peaks detected that had a retention
index under, calculated using k=tR-t0/t0, where tR is the
peak retention time and t0 is the void volume

Minimize

Peak capacity using base width

Number of peaks theoretically to separate in a method,
defined by Pc=1+(tg/wb), where tg is gradient time and wb is
peak width

Maximize
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Table 2.8 Model parameters across both QqQ and qTOF COLMeD processes. The number of
inputs corresponds to the predictor variables, while the outputs are the response variables to be
optimized using COLMeD. PLS components indicates the number of components fit to the data
for that DoE round. R2 is the variance explained for the predictor variables in the model, while Q 2
tests the goodness of fit
DoE Round

Inputs

Responses

LC and/or MS
Parameters

PLS
Components

R2

Q2

Round 1 Horse Serum
(QqQ)

37

34

3

5

0.727

0.35

Round 1 Fly (QqQ)

38

35

3

3

0.583

0.242

Round 2 Horse Serum
(QqQ)

39

33

6

6

0.722

0.112

Round 3 Horse Serum
(QqQ)

38

33

5

10

0.781

0.163

Carnitines Horse Serum
(QqQ)

13

8

5

7

0.812

0.381

Round 4 Horse Serum
(QqQ)

38

33

5

9

0.671

0.293

LC Round 1 (qToF)

12

8

3

7

0.946

0.658

LC Round 2 (qToF)

11

8

2

5

0.857

0.312

LC Round 3 (qToF)

11

8

2

2

0.592

0.185

MS Round 1 (qToF)

6

1

5

2

0.932

0.709

MS Round 2 (qToF)

5

1

4

2

0.68

0.298
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Table 2.9 COLMeD factor settings for comprehensive ion-switching analysis.
Factor

Round 1

Round 2

Round 3

Final

Flow rate (mL/min)

0.1-0.25

0.05-0.3

0.15-0.3

0.15

Gradient

1-4

3-4

4

4

Time (min)

10-16

12-20

12-18

20

Desolvation temp (°C)

Not tested

200-650

300-500

450

Desolvation gas (L/Hr)

Not tested

750-1100

800-1100

950

Column temp (°C)

Not tested

30-60

40-55

45
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Table 2.10 VIP scores for all factors after Round 4 of the QqQ COLMeD process, including
interaction variables.
Factor

VIP Score

Flow Rate (LC)

1.61

Desolvation Temperature (MS)

1.43

Gradient Time (LC)

1.37

Gradient Time*Desolvation Temperature (LC*MS)

1.23

Flow Rate*Gradient Time (LC*LC)

1.14

Flow Rate*Desolvation Temperature (LC*MS)

0.97

Desolvation Temperature*Desolvation Flow (MS*MS)

0.86

Column Temperature (LC)

0.83

Gradient Time*Desolvation Flow (LC*MS)

0.79

Flow Rate*Desolvation Flow (LC*MS)

0.74

Flow Rate*Column Temperature (LC*LC)

0.70

Desolvation Flow (MS)

0.69

Desolvation Flow*Column Temperature (MS*LC)

0.64

Desolvation Temperature*Column Temperature (MS*LC)

0.63

Gradient Time*Column Temperature (LC*LC)

0.61
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3

4

Figure 2.1 Depiction of initial LC gradients, blue indicates organic solvent, yellow indicates
aqueous.
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Figure 2.2 (A) Predictive plots displaying design space regions with predicted optimal response,
based on initial LC screening (round 1) with horse serum and fly samples. Green indicates design
space where a maximal number of endpoint response thresholds are predicted to be met. Red
boxes indicate regions predicted to improve responses for the next round. (B) Factor settings
before and after analysis of serum and fly samples using the optimizer function. These
complementary approaches rationalize LC–MS parameters for the next round of experiments.
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Figure 2.3 PLS Loadings plot after Round 1 of the ion-switching DoE, demonstrating the
predicted response improvement by decreasing flow rate and increasing gradient time for
subsequent rounds. In reference to Figure 2.1, 1StepShallow is gradient 2, 1StepSteep is
gradient 3, and the Flat gradient is number 4.
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Figure 2.4 (A) Chromatographic improvement in selected metabolites after three rounds of DoE
in the QqQ COLMeD process. Signal-to-noise (S/N) and peak width (full width half height)
measurements were generated from vendor software after limited peak smoothing and
integration. (B) Percent response increase by metabolite across each round. (C) Cumulative AUC
plots for QqQ COLMeD benchmarking.
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Figure 2.5 (A) Predictive design space plot with optimal response regions for short-chain
acylcarnitines, based on combined results of rounds 2, 3, and acylcarnitine-specific batch. Green
indicates predicted optimal conditions, while the red box represents overlap of optimal prediction
based on only data from rounds 2 and 3, suggesting a well-validated design space. (B) AUC
improvement (in millions of counts) in the acylcarnitine-specific DoE round, in addition to peak
width nearing the objective set at 0.25min. (C) Design space plots depicting regions of improved
acylcarnitine response at 550°C desolvation temperature, and across multiple column
temperatures. Column temperature did not have a significant effect on the model, as shown when
varied from 40-50°C. (D) Factor ranges predicted to yield optimal acylcarnitine response before
and after class-specific DoE. The final conditions were overlaps between predictive design space
plots and optimizer function results.
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Figure 2.6 Density plot comparing the coefficient of variation for a given metabolite across
replicate injections.
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Figure 2.7 Visualization of the design space changes across each LC qTOF DoE round,
including the reduction of 3-D to 2-D design spaces formed after fixing column temperature. The
black plane within the box depicts an initial constraint on the space. The black, blue, and green
spheres represent the parameter settings tested for each round. The final conditions were chosen
within the plane of the green dots.
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Figure 2.8 (A) Response contour plots after round 3 of LC DoE for untargeted qTOF
metabolomics, demonstrating the tradeoffs to be considered in finding a method optimum. (B)
Decreased spread of peak widths and peak skews (with a target objective of 4sec widths and
minimized skews) across three rounds. These improvements are without compromising the MS
response (depicted here as log-transformed AUC values).
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Figure 2.9 4D response contour plot demonstrating design space regions of optimal average
AUC rank for qTOF MS DoE.
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CHAPTER 3 – Circadian- and light-driven metabolic rhythms in Drosophila
melanogaster
Submitted As:
Rhoades, SD, Nayak, K, Zhang, S, Sehgal, A, Weljie, AM. Circadian and lightdependent metabolic rhythms in Drosophila melanogaster using high-resolution
metabolomics.

3.1 Abstract
Complex interactions of environmental cues and transcriptional clocks drive rhythmicity in
organismal physiology. Light directly affects the circadian clock, however little is known about its
relative role in controlling metabolic variations in vivo. Here we employ high time-resolution
sampling in Drosophila to uncover over 14% of detected metabolites with circadian periodicity
under light:dark (LD) cycles. Many metabolites peak shortly after lights-on, suggesting
responsiveness to feeding rather than anticipation as seen in transcriptomics analyses. Roughly
9% of metabolites uniquely oscillate under constant darkness (DD), suggesting clock-driven
metabolite rhythms. Strikingly, metabolome differences between LD and DD were only observed
during the light phase, highlighting the importance of photic input. Clock mutant flies exhibited
only strong ultradian rhythms, including four carbohydrates with circadian periods in wild-type
flies. Additionally, conserved rhythms in amino acids, keto-acids, and sugars across species
provide a basis for exploring the chronometabolic connection with powerful genetic tools in
Drosophila.
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3.2 Introduction
Diurnal patterns in organismal physiology arise from a complex interaction of
environmental inputs, such as light and food, with endogenous circadian clocks. Synchrony of
these clocks with predictable environmental patterns confers a selective advantage, particularly to
maintain metabolic homeostasis amidst anticipatory activity and feeding behaviors (Edery, 2000).
The intersection of metabolism and circadian rhythms is of increasing interest (reviewed by Bass,
2012), especially in light of the pathological correlations with perturbed endogenous clock
function. Major metabolic organs display rhythmic physiology, which includes cyclic insulin
secretion from the pancreas (Perelis et al., 2015), therefore it is perhaps not surprising to find
clock disruptions associated with diabetes, obesity, and metabolic syndrome in genetic mouse
models (Marcheva et al., 2010, Turek et al., 2005). These associations are alarming given the
ubiquity of circadian disruption in modern society, including the high prevalence of shift work and
increased light exposure at all hours of the night. Adiposity, weight, lipid and glucose metabolism
are the most common alterations found in animal studies modeling disruptions in sleep, light, and
feeding (Opperhuizen et al., 2015), although much work remains to delineate impacts of
environmental cues on metabolic variations. Specifically, while the impact of light on
transcriptional clocks is understood (Emery et al., 1998), metabolic variations due to light
exposure have not been directly addressed.
The mechanisms of the core endogenous circadian clock were first described in
Drosophila melanogaster, where the core clock consists of a transcription-translation feedback
loop very similar in structure to mammalian clocks (Glossop and Hardin, 2002). The CLK/CYC
complex binds to E-box elements to drive expression of many gene products, including period
and timeless (reviewed in Hardin, 2011). These protein products (PER and TIM) dimerize and
translocate to the nucleus to repress CLK/CYC activity. Timely degradation of TIM is followed by
turnover of PER, which breaks the repressive arm of the clock and allows CLK-CYC-mediated
transcriptions to resume. This clock mechanism exists across most fly tissues, including
metabolically active organs such as the fat body (functionally similar to the mammalian liver and

76

adipose). While flies have served well to uncover the architecture of circadian processes,
relatively few studies have utilized flies as a model organism in chronometabolic studies. The
interaction of the core clock with metabolic homeostasis has been established through analysis,
including comparative transcriptomics, of the fat body (Xu et al., 2011). Oscillations of transcripts
in the fat body are controlled by clocks in the fat body or the brain (Xu et al., 2011; Erion et al.,
2016; Barber et al., 2016) and most are also influenced by the time of feeding, however the
extent of circadian control on metabolism has not yet been established.
Circadian transcriptomics in mice have shown a striking enrichment of oscillating
transcripts for rate-limiting metabolic enzymes (Panda et al., 2002). Many of these metabolic
enzymes also display ultradian patterns of 8 or 12-hour periods, which may reflect the impact of
feeding and behavior on metabolism superimposed on the canonical 24-hour pattern. Circadian
and ultradian metabolite cycles have recently been discovered in mouse liver using LC-MS
metabolomics with high sampling resolution (Krishnaiah et al., 2017). Metabolomics is an
increasingly popular approach to uncover metabolic rhythms through holistic analysis of
metabolites by MS or NMR (Rhoades et al., 2017). While informative, previous studies have not
incorporated key experimental design considerations in understanding circadian processes. Most
circadian metabolomics studies in animals have employed 4 or 6-hour sampling resolution
(Abbondante et al., 2015, Chaix et al., 2014, Eckel-Mahan et al., 2013), which is adequate to
discern 24-hour periods, but may not be sufficient to discover ultradian metabolic patterns
(Krishnaiah et al., 2017). Additionally, in these studies, tissues or blood are harvested under
light:dark conditions, which does not allow for separation of light and clock-driven metabolic
patterns. True circadian patterns can be ascertained only in constant environmental conditions,
such as DD.
In this study, we sought to profile small polar metabolites with 2-hour resolution in
Drosophila under both LD and DD. Additionally, per mutant flies were analyzed to assess the
importance of the genetic clock in driving metabolite rhythms. To provide a broad spectrum of
metabolites, we used LC-MS, and chose to analyze fly bodies to reduce confounding effects from

77

the brain and eyes. Univariate periodicity algorithms and multivariate statistical models were
employed to discern both metabolite oscillations under a functional clock and broader metabolic
shifts in the context of both light cues and the per mutation. The metabolite rhythms we report
here are conserved across species, suggesting that flies will serve an important role in deriving
mechanistic understanding of the chronometabolic connection.

3.3 Materials and Methods
Drosophila strains
Both fly strains (Drosophila melanogaster), which included Iso31 (isogenic w1118 stock)
and per01 mutants (Konopka and Benzer, 1971), were maintained at 25°C in 12:12hr LD
conditions on standard cornmeal/molasses medium.

Fly entrainment and collection
Male flies were sorted shortly after eclosion and entrained in LD incubators for a
minimum of 3 days before circadian collection, by which all flies were 5-10 days of age. Wild-type
flies were either maintained in LD conditions (WT-LD), or placed in constant darkness for a
minimum of 24 hours before collection to assess light-independent rhythms (WT-DD), while per01
flies were maintained in LD cycles (Per-LD). 12 flies were collected at each time point, in
duplicate. Zeitgeber time (ZT) 0 corresponds to lights on, with lights-off at ZT12.

Metabolite extraction and LC-MS/MS metabolomics
Fly heads and bodies were separated before metabolite extraction. Adapted from the
Bligh-dyer extraction (Bligh and Dyer, 1959), 600µL of cold 2:1 methanol:chloroform was added
to the fly body samples and homogenized in a bead-based tissue homogenizer at 25Hz for 4
minutes (TissueLyser II, Qiagen, Hilden, Germany). 200µL of both water and chloroform was then
added, followed by centrifugation at 18787xg for 7 minutes at 4°C. 350µL of the upper layer,
comprising the aqueous layer, was separated and dried down overnight under vacuum. Samples
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were resuspended in 100µL

of 50:50 water:acetonitrile for LC-MS injection. Liquid

chromatography conditions and mass spectrometer parameters for HILIC analysis for small polar
metabolites were executed as previously reported (Rhoades and Weljie, 2016). 5µL injections
were performed for each sample in duplicate on a Waters ACQUITY H-Class UPLC coupled to a
Waters TQ-S micro mass spectrometer (Milford, MA), utilizing an XBridge BEH Amide column for
chromatographic separation (2.1 x 150mm, 2.5µm).

The LC solvents consisted of 95:5

water:acetonitrile with 20mM ammonium acetate at pH 9 (mobile phase A) and acetonitrile for
mobile phase B. The gradient was changed from 15 to 70% A over 5 minutes at 0.15 mL/min,
followed by an isocratic hold for 10 minutes. The column was washed in 98% A, then reequilibrated in starting conditions for 5 minutes before the next injection. The MS operated in ionswitching mode with a capillary voltage of 3kV for ESI+ mode and 2kV for ESI-. The desolvation
gas flow was set to 900L/Hr and desolvation temperature at 450°C , with the source temperature
set at 150°C. Metabolites were detected using MRMs, with mass transitions and voltages
optimized as previously described.

Data processing and analysis
LC-MS chromatograms were processed using TargetLynx under MaxxLynx version 4.1.
Ion counts were exported and processed in R (version 3.3). QC samples, which consisted of a
pooled sample of all biological samples, were injected at the beginning of the batch for LC column
equilibration and every 8 injections during the analysis to account for instrumental drift. For every
metabolic feature, LOESS was fit to the QC data, which was then used as a normalization factor
for the samples as a function of run order. Additionally, metabolic features which appeared in less
than 50% of the QC samples and displayed a relative standard deviation (RSD) greater than 30%
were dropped from the final dataset. PCA was performed in SIMCA 14.0 (UMetrics, Umeå,
Sweden) to observe data integrity through balanced scores and loadings plots. This criteria
guided additional data normalization measures, which we addressed through total sample
intensity normalization after LOESS correction. Technical replicate values were than averaged
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and analyzed for rhythmicity using the ARSER algorithm (Yang et al., 2010) in the MetaCycle R
package (version 1.1, Gang et al., 2016). Missing values were imputed through mean-imputation
within a single metabolite’s observed values, and each circadian time replicate was spread out
across 48 hours for rhythmicity testing, which was performed twice through shuffling the
replicates to guard against replicate bias. These two ARSER results were then averaged before
filtering lists of significant cyclers, testing period lengths of 20-28, 12, and 8 hours.
For block-testing, values in each of the 3 biological groups were further divided into four
windows, consisting of values from ZT0-6, ZT6-12, ZT12-18, and ZT18-24. These groups were
then tested in a univariate manner, metabolite by metabolite, both across time blocks and
biological groups. The resulting p-values from two-sided t-tests were adjusted through a
Benjamini-Hochberg False Discovery Rate correction using the stats R package (version 3.3,
Benjamini and Hochberg, 1995). For multivariate assessment of global metabolic shifts within and
across biological groups, orthogonal partial least squares discriminant analysis (OPLS-DA)
models were fit in SIMCA 14.0, with model validity assessed through a cross-validation Q2 value
and CV-ANOVA p-value (Eriksson et al., 2006). Plots were made using VennDiagram v1.6,
heatmap3 v1.1, and ggplot2 v2.2.

3.4 Results
Circadian and light-induced rhythms identified in wild-type flies
Rhythmicity tests in WT flies under LD conditions revealed 34 metabolites with period
lengths between 20-28 hours, which represents 14.4% of detected metabolites and contains an
abundance of sugars and acylcarnitines (p<0.05 and q<0.3, Figure 3.1A, Table 3.1). Seven
metabolites exhibited a 12-hour period and eleven exhibited an 8-hour period in this WT-LD. 29
metabolites yielded true circadian patterns in the WT-DD condition, with seven metabolites
overlapping the WT-LD group (fructose, 3-hydroxybutyrate, acetyl-amino sugars, gluconate, an
unknown monosaccharide, ribitol/xylitol, riboflavin) (Figure 3.1B, Figure 3.1C). We were thus able
to identify sets of metabolite rhythms driven by endogenous clocks, LD cycles, or both.
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Ultradian metabolites enriched in per mutants
No circadian metabolites, nor ultradian metabolites of 8-hour periods, were detected in
per flies, however we noted an abundance of metabolites with 12-hour periods (Table 3.1).
Interestingly, the amplitudes for these cyclers were significantly higher than 12-hour cyclers in the
WT-LD condition (p=0.001, Figure 3.2). While no overlapping metabolites arose across 12-hour
cyclers in WT-LD and Per-LD conditions, ten out of fourteen 12-hour cyclers in the Per-LD
condition were found in the 20-28 hour list for WT-LD (2-oxovalerate, fructose, acetyl-amino
sugars,

gluconate,

ribitol/xylitol,

inositols,

N6-acetyllysine,

cAMP,

acetylcholine,

and

aminobenzoates/trigonelline), and cGMP additionally overlapped with WT-DD (Figure 3.3). Thus,
of these fourteen 12-hour cyclers, only three did not also oscillate in WT-LD or WT-DD
(imidazole, bisphosphoglycerate, aconitate). Four metabolites overlapped across all three lists;
these consisted only of carbohydrates (fructose, acetyl-amino sugars, ribitol/xylitol, gluconate)
and may reflect a consequence of complex interactions of light and clock-driven feeding behavior.

Unique phases in significant metabolites across experimental groups
Of the significant cyclers with a 20-28 period in WT-LD, we noted major phases of
metabolites in the morning (ZT4-6) and at the end of the active phase (ZT12). Peak expression
of cycling metabolites in DD was, on the other hand, largely condensed towards the end of the
active phase (Figure 3.4A). The abundance of 12-hr cyclers in Per-LD also had highly condensed
phases, with antiphasic peaks in the early light and dark phases and an absence of the evening
rush seen in the WT-LD (Figure 3.4B). Additionally, the seven metabolites that overlap with WTLD and WT-DD display dramatically different phases under these two conditions and is most
strikingly the case for the sugar compounds (Figure 3.4C).

Light and clock driven alterations in global metabolite profiles
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As expected, the per mutants displayed large global metabolite differences from WT,
irrespective of time, through principal components analysis, while WT-LD and WT-DD samples
had general overlap in their metabolic signatures (Figure 3.5). To gauge global time-dependent
shifts in metabolite signatures, the time points were binned into four blocks of ZT0-6, ZT6-12,
ZT12-18, and ZT18-24. Using univariate testing, the metabolic separation between WT-LD and
WT-DD could only be found during the ZT6-12 window (p<0.05 and q<0.3, Table 3.2), suggesting
a set of metabolites that are driven by light. Within the WT-LD group, strong diurnal patterns were
noted in amino acid and nitrogen metabolism (Figure 3.6A), while medium- to long-chain
acylcarnitines comprised the majority of time-dependent metabolite changes in WT-DD (Table
3.2). Differences between the WT-LD and Per-LD groups were noted across each time block,
driven mostly by changes in amino acid and nitrogen metabolism (Figure 3.6B). These diurnal
pathway enrichments in WT-LD were lost in the per flies, as no metabolites were found to
significantly change within the per dataset across the blocked times. As an additional measure of
global metabolite shifts, OPLS-DA scores plots demonstrated a convergence of WT-LD and WTDD profiles during the dark phase (Figure 3.7). The strongest discriminant model with the most
predictive power across the three groups occurred at ZT6-12 (R2X=0.585, R2Y=0.874, Q2=0.654,
p=0.003), while a significant model could not be fit at ZT18-24 (p=0.24).

Conserved rhythms across published circadian metabolomic datasets
We compared our list of significantly diurnal metabolites from WT-LD to the only currently
published fly metabolomics study, which analyzed small polar metabolites in whole flies under
conditions of cycling light and temperature, and found overlaps in alanine, tryptophan, AMP,
creatine, and lactate (Gogna et al., 2015). Of these metabolites, the phases for alanine and
creatine aligned closely across studies (ZT15 and ZT18 for creatine, ZT13 and ZT16 for alanine),
however the phases of other metabolites generally differed.
For a comparison of significantly circadian metabolites conserved across species, we
separated datasets that utilized LD and constant darkness paradigms (Table 3.3). A majority of
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prior circadian metabolomics studies have employed LD, and we found 15/35 of the WT-LD 20-28
hour cyclers in our study to oscillate in other species, including zebrafish, mice, and humans (Li et
al., 2015, Zwigahft et al., 2015, Giskeodegard et al., 2015, Davies et al., 2014, Chaix et al., 2014,
Hatori et al., 2012, Eckel-Mahan et al., 2012, Dallmann et al., 2012, Ang et al., 2012). These
metabolites include glutamate (found in all 4 species), 2-hydroxyglutarate, 2-aminoadipate,
fructose, 3-hydroxybutyrate, 4-guanidinebutanoate, threonine, citrate/isocitrate, carnitine, inositol,
hydoxyhexadecenoylcarnitine, aminobenzoates/trigonelline, acetylcarnitine, UDP-glucose, and
riboflavin. Only one other study has performed high-resolution small polar metabolite analysis
under constant darkness in mice (Krishnaiah et al., 2017), which yielded 3-hydroxybutyrate,
adenine, and fructose as overlaps to this study. However, many of these studies in mice and
humans sample liver and blood respectively, which will likely differ from systemic metabolic
rhythmicity in the whole fly body.

3.5. Discussion
To our knowledge this is the first report of high resolution circadian metabolomics which
tested key hypotheses regarding the separation of circadian and environmentally-driven
metabolic processes using both genetic clock mutants and constant darkness paradigms. First,
we discovered a unique set of metabolites that continue to oscillate in constant darkness,
clarifying the complex interactions of our endogenous clocks and environmental cues. In our
experimental design, DD sampling did not occur until the flies were exposed to a minimum of 24
hours of darkness, which may have dampened the rhythms but allowed further separation of
metabolite patterns from the impact of light. We suspect that, given many of the overlapping
metabolites with 20-28hr periods across LD and DD were carbohydrates, a continued feeding
rhythm is a major driver in metabolite rhythms, as has been noted in proteomics profiles in mouse
liver (Mauvoisin et al., 2014). These sugars were uniformly increased during the light phase in
WT-LD compared to WT-DD, perhaps as a result of a heightened feeding rhythm under the
presence of light. In addition, we demonstrate a set of light-induced metabolites with large
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enrichments in amino acid and nitrogen metabolism, which is likely correlated to light-induced
locomotor behavior and overlaps with a large enrichment of amino acid rhythms in mice (Minami
et al., 2009). Interestingly, indoleacetic acid and kynurenine were among the few metabolites that
decreased in the presence of light, suggesting an effect of light on dampening certain
neurotransmitter processes. Only one study previously discovered 14 diurnal polar metabolites
with 2-hour resolution in whole adult flies using NMR (Gogna et al., 2015), with one additional
experiment employing lipid profiling at 4-hour resolution (Katewa et al., 2016). Gogna et al.
sought to maximize metabolite rhythmicity by entraining flies in both LD and temperature cycles,
which may establish a control baseline metabolite rhythm, but is insufficient to discern
endogenous circadian processes. Despite adequate sampling resolution, this study did not
employ statistical algorithms to discern periodicity, such as JTK_CYCLE or ARSER (Hughes et
al., 2010, Yang and Su, 2010). We note some overlaps of rhythmic but non-circadian metabolites,
however the phases generally differed, and the relative insensitivity of NMR compared to LC-MS
yielded fewer possible comparisons. Given the impact of environmental cues on metabolite
phases and rhythmicity noted here, the relatively low overlap with Gogna et al. is perhaps not
surprising, and future studies will need to tease out the relative contributions of additional
environmental cues such as temperature and humidity. Additionally, this report analyzed whole
flies, rather than bodies in our study. Contributions of metabolites in the eye and brain may impart
some additional effects to the detected metabolome.
We were surprised to find how many metabolites uniquely oscillated in WT-DD compared
to WT-LD. We can partly attribute this disparity to the fact that six metabolites did not meet our
significance threshold (0.05 < p < 0.10) in the WT-DD but were significant in WT-LD; additional
work will be required to separate statistical power versus biological variance. Within the WT-DD
group, diurnal patterns in acylcarnitines were observed, which corroborates nicely with some
existing metabolomics studies in humans under constant or highly controlled conditions (Ang et
al., 2012, Dallmann et al., 2012, Davies et al., 2014). We speculate that under constant
environmental conditions, rhythms in lipid metabolism may persist but are largely transformed
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under the presence of light, and may partly explain our set of unique rhythms in constant
darkness. Previous transcript analyses in Drosophila heads have also noted close to half of
significantly cyclic transcripts in DD were not found in LD conditions (Wijnen et al., 2006). This
alignment with our metabolomic findings suggests transcriptional and metabolic programs are
largely transformed in the presence of light cycles. Interestingly, this study also uncovered a
similarly large number of cycling transcripts in clock mutants under LD relative to WT flies in LD,
further demonstrating the substantial impact of light on rhythmic processes. However, the lightdriven transcripts displayed 24-hour periods instead of the 12-hour enrichment we report here for
metabolites, which may be a consequence of statistical testing in 2-hour versus 4-hour sampling
resolution. We can confidently speak to the impact of light on the global metabolome given that
metabolite profiles were indistinguishable during the dark phases of the WT-LD and WT-DD
groups by both univariate and multivariate testing.
One drawback in LC-MS is relatively high variance, which may explain a rhythmicity of
over 14% of detected metabolites in our study, compared to upwards of 50%, as reported in
mouse liver (Krishnaiah et al., 2017). However, given peripheral clocks tend to oscillate with
unique phases (Zhang et al., 2014), we would not expect such a high enrichment of circadian
metabolites in whole bodies. In addition, the age of flies in our study ranged from 5-10 days,
which may add some additional variance in the dataset. The mouse liver metabolomics study
incorporated 1-hour sampling resolution, which greatly augments power in circadian testing
algorithms, even over the 2-hour resolution employed here, and may additionally explain
relatively lower enrichment in cyclic metabolites. Given our experimental design and biological
variance, we felt ARSER analysis was more suitable to discern periodicity in the data, although it
has been reported to yield a higher false-positive rate for transcriptomics analyses (Wu et al.,
2016). Future experiments may require higher sampling density and/or replicates, while
remaining mindful of resource allocation for large-scale LC-MS experiments (Dunn et al., 2011).
The abundance of 12-hour cyclers in Per-LD likely derive from light and activity patterns,
which would be otherwise dampened or overridden by an intact clock and may in part explain the
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strong amplitudes of these ultradian rhythms. A dampened secondary peak of feeding in per
mutants (Barber et al., 2016) may explain the uniquely biphasic phase enrichments of circadian
metabolites in WT-LD compared to a strong enrichment of antiphasic phases for Per-LD at ZT4
and ZT16 in Figure 3.4. Previous transcriptomics studies found large phase enrichments in WT
flies at ZT8 and ZT20, which differ slightly from metabolite phases (Ceriani et al., 2002). For WT
flies in constant darkness, the feeding rhythm loses much of its biphasic nature (Barber et al.,
2016), which would corroborate our speculation that the second feeding peak persists without
light and accounts for the condensed metabolite phases towards the end of the subjective day in
WT-DD. These changes in feeding patterns are consistent with alterations in locomotor activity,
which also tends to lose bimodality in DD (Helfrich-Förster, 2000). The large overlap of Per-LD
12-hour cyclers and circadian WT-LD metabolites suggest a complex synergy of circadian and
light-driven processes, with a conserved surge of metabolite phases in the morning. We posit that
while clocks serve an evolutionary advantage in anticipating environmental cues like light, these
cues can themselves trigger adaptive responses in activity and feeding, which would confer an
additional survival advantage in for e.g. seasonal changes of LD cycles.
Drosophila can serve as a practical model to develop mechanistic detail from these
metabolomics studies, with the depth of genetic tools, ease of environmental manipulations, low
cost, and high throughput experimentation. Encouragingly, some conserved circadian metabolites
were found across multiple species, potentially expanding the utility of Drosophila as a powerful
model for chronometabolic studies. A sizable number of human circadian and sleep
metabolomics studies have been performed, which has yielded some conserved metabolite hits
even across analytical platforms (Rhoades et al., 2017). We hope expanded experimental
designs for flies will yield a similar result.
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Table 3.1 Significant metabolites (p<0.05, q<0.3) from ARSER results for each group and period
WT-LD 20-28hr

WT-LD 12hr

WT-DD 20-28hr

Glutamate

Adenine

cGMP

2-Hydroxyglutarate

2-Aminopimelic Acid

Hydroxytetradecanoylcarnitine

Imidazoleacetic Acid

3-Indoleacetic Acid

Hydroxybutrylcarnitine

2-Aminoadipate

Unknown_360.50->85.03_7.04

Lipoamide

2-oxovalerate

Disaccharide

LPC 20:1

Fructose

Thiamine

Riboflavin

3-Hydroxybutyrate

Hydroxytetradecanoylcarnitine

Fructose
Unknown_154.07->137.01_4.11

Hydroxydecenoylcarnitine
WT-LD 8hr

Acetyl-amino Sugars

Unknown_516.30->184.00_6.07

4-Guanidinobutanoic Acid

Cystathionine

Gluconate

Gluconate

Unknown_342.50->85.03_7.00

alpha-Ketoglutarate

Threonine

Unknown_137.03->93.95_4.10

Phenylalanine

Unknown_358.50->85.03_4.58

Unknown_203.15->70.07_6.78

Lauroylcarnitine

Cytosine

Xanthine

Acetyl-amino Sugars

Citrate/Isocitrate

Unknown_152.00->110.00_5.76

Unknown_152.00->135.00_5.27

Unknown_166.05->74.02_5.93

CDP-Choline

Unknown_198.00->181.00_5.29

Oxypurinol

Carnitine

Unknown_112.00->95.00_7.60

Ribitol/Xylitol

Citrulline

Inositols

Lysine

WT-DD 12hr

WT-DD 8hr
Hexose-6-Phosphates

Asparagine
N6-Acetyllysine

Spermine

Hydroxyhexadecenoylcarnitine

WT-DD 20-28hr
Stearoylcarnitine

cAMP

Ribitol/Xylitol

cAMP

Dodecenoylcarnitine

3-Indoleacetic Acid

Fructose

Acetylcholine

Acetyl-CoA

N6-Acetyllysine

Hydroxytetradecenoylcarnitine

Tryptophan

Gluconate

SAM

Unknown_137.03->93.95_4.10

Aminobenzoates/Trigonelline

Riboflavin

3-Hydroxybutyrate

cGMP

Aminobenzoates/Trigonelline

Choline

Acetylcholine

Itaconic Acid

NADPH

Imidazole

UDP-Glucose

Deoxyguanosine

Acetyl-amino Sugars

N-Acetyl-L-Tyrosine

Deoxyinosine

2-oxovalerate

Acetylcarnitine

Adenine

Inositols

NADH

Bisphosphoglycerates

Unknown_198.00->181.00_5.29

Aconitate

Per-LD 12hr

Ribitol/Xylitol
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Table 3.2 Univariate metabolite comparisons between WT-LD and WT-DD or within WT-DD
across time. Direction refers to either relative to WT-LD, or relative to the first of two time blocks
within WT-DD
WT-LD to WT-DD Comparison
Metabolite

Comparison

P-Value

Q-Value

Direction

Dimethylarginine

ZT6-12

3.78E-05

0.008929

↓

Unknown_282.12->150.00_6.38

ZT6-12

0.000187

0.022123

↓

Threonine

ZT6-12

0.000789

0.062044

↑

Deoxyguanosine

ZT6-12

0.005291

0.228265

↑

Unknown Monosaccharide

ZT6-12

0.006958

0.228265

↑

3-Indoleacetic Acid

ZT6-12

0.006966

0.228265

↓

Asparagine

ZT6-12

0.007666

0.228265

↑

Fructose

ZT6-12

0.009898

0.228265

↑

Ribitol/Xylitol

ZT6-12

0.012777

0.228265

↑

Cytosine

ZT6-12

0.014432

0.228265

↑

Unknown_184.07->86.10_4.22

ZT6-12

0.015219

0.228265

↑

Aminobenzoates/Trigonelline

ZT6-12

0.015475

0.228265

↑

N6-Acetyllysine

ZT6-12

0.01598

0.228265

↑

Gluconate

ZT6-12

0.016001

0.228265

↑

2-Aminoadipate

ZT6-12

0.016172

0.228265

↑

Kynurenine

ZT6-12

0.016193

0.228265

↓

2-oxovalerate

ZT6-12

0.016443

0.228265

↑

cGMP

ZT6-12

0.022034

0.274692

↑

3-Hydroxybutyrate

ZT6-12

0.022115

0.274692

↑

Acetyl-CoA

ZT0-6 to ZT6-12

0.000114

0.026987

↑

Unknown_282.12->150.00_6.38

ZT0-6 to ZT6-12

0.000474

0.055991

↑

Hydroxyhexadecenoylcarnitine

ZT12-18 to ZT18-24

0.001167

0.151773

↑

Within WT-DD Comparison by Time
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Unknown_342.50->85.03_7.00

ZT12-18 to ZT18-24

0.001494

0.151773

↑

Stearoylcarnitine

ZT12-18 to ZT18-24

0.001929

0.151773

↑

Lauroylcarnitine

ZT12-18 to ZT18-24

0.003638

0.175813

↑

Hydroxytetradecanoylcarnitine

ZT12-18 to ZT18-24

0.004489

0.175813

↑

Hydroxyhexadecanoylcarnitine

ZT12-18 to ZT18-24

0.00517

0.175813

↑

cis-5-Tetradecenoylcarnitine

ZT12-18 to ZT18-24

0.005835

0.175813

↑

2-Aminoadipate

ZT12-18 to ZT18-24

0.00596

0.175813

↓

Unknown_245.08->113.03_5.56

ZT12-18 to ZT18-24

0.007294

0.191273

↓

Glutamate

ZT12-18 to ZT18-24

0.009185

0.216764

↓

Xanthine

ZT12-18 to ZT18-24

0.012658

0.271562

↑
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Table 3.3 Circadian metabolite hits across studies under WT-LD paradigm
Metabolite

Overlapping Studies

Glutamate

Fly1, Zebrafish1, Mouse4, Human3

2-Hydroxyglutarate

Fly1, Mouse4

2-Aminoadipate

Fly1, Mouse2, Mouse4

Fructose

Fly1, Mouse2, Human3

3-Hydroxybutyrate

Fly1, Mouse4

4-Guanidinobutanoic Acid

Fly1, Mouse5

Threonine

Fly1, Zebrafish1, Mouse2

Citrate/Isocitrate

Fly1, Mouse4, Human3

Carnitine

Fly1, Zebrafish1

Inositol

Fly1, Mouse4, Mouse5

Aminobenzoates/Trigonelline

Fly1, Mouse4

Acetylcarnitine

Fly1, Mouse2, Human4

UDP-Glucose

Fly1, Mouse2

Riboflavin

Fly1, Mouse2

Adenine

Fly1, Mouse4

Citrulline

Fly1, Mouse2, Mouse4

Lysine

Fly1, Fly2, Mouse2, Mouse4, Human4

Xanthine

Fly1, Mouse2

Legend
Fly1 - Rhoades
Fly2 - Gogna
Zebrafish1 - Li
Mouse1 - Zwighaft
Mouse2 - Abbondante
Mouse3 - Chaix
Mouse4 - Hatori
Mouse5 - Eckel-Mahan
Human1 - Giskeodegard
Human2 - Davies
Human3 - Dallmann
Human4 - Ang
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Figure 3.1 Identification of metabolites expressed rhythmically in fly bodies. (A) Metabolites that
significantly cycle with 20-28hr periods in WT-LD (p<0.05, q<0.3, ARSER algorithm). (B)
Metabolites that significantly cycle with 20-28hr periods in WT-DD (p<0.05, q<0.3, ARSER
algorithm). (C) Density of circadian periods by group, whereby ARSER testing occurred at 8, 12,
or 20-28hr searches.
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Figure 3.2 Amplitudes for each significant metabolite within each tested period and group.
Amplitude values were derived from ARSER calculations. Per-LD 12hr cyclers displayed a
significantly higher fold change than WT-LD 12hr cyclers (p=0.001).
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Figure 3.3 Effects of light and the clock on the pattern of cycling metabolites (A) Time-course
concentrations of the four carbohydrate species which oscillate with 20-28hr periods in WT and a
12hr period in per. (B) Overlapping cycling metabolites across all three groups with unique
periods.

94

Figure 3.4 Radial plot indicating phases for significant 20-28hr cyclers in WT-LD and WT-DD (A)
and 12hr cyclers in all three groups (B), as calculated by ARSER. C. Phases of the seven
circadian overlaps in WT-LD and WT-DD.
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Figure 3.5 Principal components scores plot for all samples. Variance explained for the first two
components were 27.7% and 10.5% respectively.
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Figure 3.6 (A) Metabolite set enrichment analysis for metabolites which altered significantly in
WT-LD across time-block testing (p<0.05, q<0.3) (B) Metabolite set enrichment analysis for
metabolites which altered significantly across WT-LD and Per-LD, considering all four timeblocks.
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Figure 3.7 OPLS-DA scores for discriminant analysis of all three groups in each of the four time
windows. Significant models were fit to ZT6-12 (B, R2X=0.585, R2Y=0.874, Q2=0.654, p=0.003)
and ZT12-18 samples (C, R2X=0.458, R2Y=0.488, Q2=0.265, p=0.02) but not ZT0-6 (A, p=0.12)
nor ZT18-24 (D, p=0.24), noting the convergence of metabolite profiles in WT-LD and WT-DD at
the end of the dark phase in ZT18-24.
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CHAPTER 4 – In vivo circadian isotopolomics platform uncovers unique diurnal
flux patterns perturbed under sleep deprivation
4.1 Abstract
Basic research in circadian rhythms has recently benefitted from a diversity of highthroughput systems-level approaches, however they invariably describe snapshots of a dynamic
process. Furthermore, the metabolic connections to sleep are largely undefined, and new
approaches are necessary to unearth the impact of sleep perturbation on diurnal reaction
kinetics. Here, a novel in vivo platform is developed to detect stable isotope labeling patterns in
Drosophila across circadian time. The impact of perturbed sleep/wake cycles on metabolic flux is
observed using fumin flies, a genetic model of hyperactivity and sleep deprivation. Microcapillary
injections of

13C

6

glucose into flies at a safe and tolerable dose provide a unique method to study

acute metabolic flux in downstream oxidative pathways using bespoke liquid-chromatography
mass spectrometry (LC-MS) metabolomics methodology. Carbon tracing from glucose into serine
displayed a robust circadian rhythm, which is lost under sleep deprivation. Glutamine labeling
patterns, likely reflective of TCA cycle activity, demonstrated an ultradian cycle in wild-type flies
but gained circadian rhythmicity in fumin mutants. Labeled glutathione displayed a striking 8-hour
ultradian pattern that is lost under sleep deprivation, which may stem from altered redox defense
mechanisms in response to perturbed sleep/wake cycles. Global changes in isotopolome patterns
in wild-type flies were most noticeable in the morning hours, suggesting a catabolic rush to meet
the requirements of energy production during the active phase. Herein a new means of analyzing
circadian flux is presented, overcoming limitations in interpretability of chronometabolic processes
from prior ‘omic analyses.
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4.2 Introduction
Research in circadian rhythms and sleep has recently benefitted from a diversity of
systems-level approaches, including transcriptomics, proteomics, and metabolomics (Zhang et
al., 2014, Mauvoisin et al., 2014, Krishnaiah et al., 2017, Rhoades et al., 2017). Metabolite
concentrations are particularly promising to derive the phenotypic outputs of the clock and sleep
status, as metabolites are viewed as products of active physiological processes, and
interpretations from other ‘omics technologies can be confounded by the variable lag between
transcription and translation of a given gene product and circadian cycles in post-translational and
epigenetic modifications (Krishnaiah et al., 2017, Lamia et al., 2009, Feng et al., 2011). However,
while metabolites may couple more closely to organismal phenotypes than other systems-level
approaches, any of these techniques are inherently snapshots of a dynamic system. Much like
taking a picture of a highway versus measuring the cars’ velocities, static metabolic profiling may
give clues into differential pathway activities, but cannot be used to truly ascertain metabolic flux
(Zamboni et al., 2015). Flux is a more cogent assessment of the metabolic phenotype, and is
highly conserved across species to maintain enzymatic efficiency under thermodynamic and
osmotic constraints (Park et al., 2016). Despite the inherently transitory nature of circadian and
sleep processes, few studies have focused on analyzing the rates of metabolic reactions or
pathways with respect to time. New approaches must be employed to add this kinetic dimension
to our understanding of the chronometabolic connection.
Metabolic flux cannot be directly observed in an active biological system, however one
common approach to infer flux is to analyze metabolism of stable isotope tracers to downstream
products over specified time intervals. The objectives in isotope-tracer experimentation have
largely shifted from biochemical discovery in the mid-20th century towards characterizing
metabolic phenotypes, particularly in recent comparative analyses of cancer metabolism.
Observation of the Warburg effect has driven numerous isotope labeling studies which
incorporate glucose and analyze isotope enrichments in the pentose phosphate pathway (PPP)
and TCA cycle (Fan et al., 2014, Fan et al., 2013). Some tracer studies have been recently
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extended to one-carbon metabolism and amino acid and lipid synthesis as ancillary metabolic
networks become increasingly apropos to disease phenotypes (Ducker et al., 2016, Munger et
al., 2008), which are now also understood as important pathways in sleep and circadian
physiology (Rhoades et al., 2017). However, no sleep and circadian studies have studies have
employed isotope tracing analysis to corroborate static measurements of metabolites and
transcripts in these pathways. In addition, labeling studies are typically performed in vitro, given
the costs and complexity of in vivo experiments in mice and humans (Fan et al., 2011).
Realistically, sleep and circadian processes are a complex integration of internal oscillators with
external environmental cues, including light and feeding, which cannot be adequately modeled in
vitro. While quantitative flux modeling is considerably more difficult in vivo, and currently
infeasible in non-steady state eukaryotic systems (Wiechart and Noh, 2013), comparative
analysis of qualitative labeling patterns across experimental conditions may still yield fruitful
insight into metabolic phenotypes, while maintaining appreciable temporal resolution to discern
metabolic cycles.
Drosophila are a boon to sleep and circadian research given their classical sleep
characteristics, highly conserved genetic clock mechanism, and relative ease of high-throughput
genetic screens (Hendricks et al., 2000). While metabolomic analyses in flies are sparse, many
major nutrient sensing pathways and insulin signaling mechanisms found in mammals are also
found in flies (Geminard et al., 2009, Fernandez et al., 1995). We therefore reasoned that flies
would serve as a good model to assess dynamic metabolic processes across circadian time and
under sleep deprivation. Previous studies have added isotope tracers to fly media (Musselman et
al., 2013, Katewa et al., 2016), however these studies cannot discern flux at the acute timescale
required for circadian analysis. Fortunately, these previous experiments informed us of the
tradeoffs in our experimental design. Quantitative flux modeling in eukaryotes typically assumes
isotopic equilibrium (Wiechert and Nöh, 2013), which was not obtained in flies until 24 hours of
feeding (Musselman et al., 2013). This observation restricted our objectives to gauging relative
flux changes acutely across circadian time, as quantitative flux modeling would not be feasible.
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Nonetheless, our hypothesis is that we could develop a new platform for isotope tracing in flies,
which would uncover relative changes in both core and secondary metabolic activity downstream
from glucose. In addition, the metabolic consequence of sleep loss around the circadian cycle is
assessed by comparison to a fumin mutant fly strain, an established genetic model of sleep loss
through dopamine-driven hyperactivity. In these experiments, new tracer incorporation
mechanisms are developed and validated, existing LC-MS methods are expanded to analyze
numerous labeling possibilities in amino acid metabolism, and data processing pipelines are built
to deal with both high-dimensionality datasets and periodic patterns common in large-scale
circadian metabolomics experiments (Rhoades et al., 2017).

4.3 Materials and Methods
Drosophila strains
Both fly strains (Drosophila melanogaster), which included Iso31 (isogenic w1118 stock)
flies and fumin mutants as characterized previously (Kume et al., 2005), were maintained at 25°C
in 12:12 LD conditions on standard cornmeal/molasses medium.

Entrainment and tracer injection design
Within one day after eclosion, 15 males were sorted into a new vial for entrainment to LD
rhythms for a minimum for 3 days. All flies were between 5-7 days old at the time of injection.
One vial was taken every four hours under LD conditions (ZT0, 4, 8, 12, 16, 20) and placed on ice
for anesthetization 15 minutes prior to injections. The injection solution consisted of 1M
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glucose with a 50x dilution of a blue dye (McCormick, FD&C Blue Dye No. 1), for visualization of
uptake and signal normalization, in PBS and injected into the thorax using glass capillaries (3.5” x
1.14mm diameter, Drummond Scientific, Broomall, PA). After injection flies were moved to empty
vials without food and placed back in the appropriate light or dark 25°C incubator to metabolize
the glucose tracer. After one hour, flies were snap-frozen before metabolite extraction. Five
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separate days of injections were performed as biological replicates for both WT and fumin
mutants. Any flies which died after the injections were discarded.

Geotaxis and locomotion assays
For geotaxis climbing assays, after three days under LD entrainment, 5-7 day-old WT or
fumin flies were anesthetized on ice for 15 minutes at ZT0 or ZT12, followed by a control (no
injection), PBS, or 1M glucose injection. Flies were then placed in new vials without food for one
hour. Climbing activity was measured by timing an individual fly’s time to climb 4cm, measured in
triplicate. 5-8 flies were used per group. For locomotion assays, the same procedure was taken,
except flies were placed in 5 x 65mm glass tubes with 5% sucrose immediately after injections
and monitored under Activity Monitoring System devices (DAMS) from Trikinetics (Waltham, MA)
for a minimum of 24 hours in 25°C LD incubators. Locomotion data was analyzed using custom
MATLAB (Mathworks, Natick, MA) scripts (Yuan et al., 2006), and plotting and statistics were
performed in R (version 3.3). Comparisons were made using a Student’s one-sided or two-sided
t-test when appropriate with FDR adjustments for multiple testing in the locomotion data, using
p<0.05 and q<0.2 as a threshold for significance (Benjamini and Hochberg, 1995). One-sided
tests were performed with an assumption that injections would decrease locomotion activity or
climbing rate compared to sham control.

Metabolite extraction and LC-MS/MS measurements
Fly heads and bodies were separated before metabolite extraction. Adapted from the
Bligh-dyer extraction (Bligh and Dyer, 1959), 600µL of cold 2:1 methanol:chloroform was added
to the fly samples and homogenized in a bead-based tissue homogenizer at 25Hz for 4 minutes
(TissuLyser II, Qiagen, Hilden, Germany). 200µL of both water and chloroform was then added,
followed by centrifugation at 18787xg for 7 minutes at 4°C. 350µL of the upper layer, comprising
the aqueous layer, was separated and dried down overnight under vacuum. Samples were
resuspended in 80µL of 50:50 water:acetonitrile for injection onto the mass spectrometer. Two
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LC-MS/MS analyses were performed to consider both positive and negative ionizing metabolites
in ESI. Chromatographic separations for both methods were performed on a Waters ACQUITY HClass UPLC coupled to a Waters TQ-S Micro MS (Milford, MA), utilizing an ACQUITY UPLC BEH
Amide column (2.1 x 150mm, 1.7µm). LC conditions for the positive-ionizing method were
performed as described previously (Rhoades and Weljie, 2016), where the solvents consisted of
95:5 water:acetonitrile with 2mM ammonium acetate and 0.2% formic acid (mobile phase A), and
90:10 acetonitrile:water with 2mM ammonium acetate and 0.2% formic acid (mobile phase B).
The gradient was changed from 100 to 20.6 % B over 15 min at 0.35 mL/min, followed by a wash
of 100 % A for 5 min. Mobile phase B was changed from 0 to 100 % from 20 to 22 min and held
for column equilibration until 30 min. For the negative-ionizing method, solvents consisted of 95:5
water:acetonitrile with 20mM ammonium bicarbonate, pH 9 (mobile phase A) and 90:10
water:acetonitrile with 20mM ammonium bicarbonate, pH 9 (mobile phase A). The gradient was
changed from 100 to 20.6 % B over 15 min at 0.4 mL/min, followed by a wash of 100 % A for 5
min. Mobile phase B was changed from 0 to 100 % from 20 to 22 min and held for column
equilibration until 30 min.
Given the nature of LC-MS/MS, MRMs were used to measure metabolites of interest. To
observe isotopologues of a given metabolite, whether it be glucose or downstream products of
glucose metabolism, MRMs were set up to include the multiple daughter isotopomers of a given
parent isotopologue. For example, alanine M+1 MRMs were set up to consider that an M+1
parent isotopolgue could yield an M0 or M+1 daughter ion, depending on the carbon lost in
fragmentation. Alanine M+1+1 and alanine M+1+0 (i.e. an alanine with one labeled carbon in the
parent compound, with one or zero carbons labeled in the daughter ion respectively) signals were
then summed to yield a parent alanine M+1 isotopologue signal.

Data processing and normalization
Chromatograms were processed using TargetLynx under MassLynx version 4.1 and
exported as ion counts to be processed in R (version 3.3). For each sample, technical duplicates
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were injected, along with QC samples every 10 injections, which was comprised of a pool of all
samples and used to correct for analytical drift. Before QC-based corrections, a ratio matrix was
derived from the raw data. For every metabolite, the ratio of each isotopomer to the unlabeled
(M0) metabolite was stored, such that natural abundance isotope correction could be performed
after QC correction. For every metabolic feature, a linear regression function fit to the QC data
was used as a normalization factor for the samples as a function of run order (Dunn et al., 2011).
Technical replicates were then averaged, and each sample was normalized to the injected blue
dye (MRMs for unique m/z’s found in the dye were tuned for ESI+ and ESI- analyses, Table 4.1),
after which daughter isotopomer values were then summed to yield single parent isotopologues
(e.g. alanine M+1+1 and alanine M+1+0 to form alanine M+1) in both the processed data matrix
and the ratio matrix. The processed matrix was then rescaled back to ‘raw’ isotopologue
distributions through division by the ratio matrix, so that natural

13C

abundance isotope correction

could be performed, based on previous methods (Moseley, 2010). Values were then converted to
relative abundance by dividing an individual isotopologue value to the sum of all detected
isotopologues for a given metabolite.

Rhythmicity analysis and statistics
PCA was performed using SIMCA-P v14 (Umetrics AB, Umeå, Sweden) as a
visualization of successful QC-based data correction (i.e. tight clustering of QC samples around
the origin in Principal Component space) and to remove any outlier observations residing outside
the Hotellings’ T2. Supervised clustering was performed using OPLS-DA with 7-fold cross
validation as performed in SIMCA-P.
Rhythmicity testing of isotopologue relative abundances or metabolite pool sizes was
performed with JTK_CYCLE under the MetaCycle package in R (Hughes et al., 2010, Wu et al.,
2016) to test for 12 or 24-hour period lengths. Given the biological replicates consisted of
separate days of injection and sacrificed flies (as opposed to resampling the same flies),
JTK_CYCLE was modified to run 500 permutations of the data to guard against day-to-day bias.
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Of the four or five replicate days of injections, for each injection ZT, two replicates were randomly
chosen to serve as duplicates, while two of the remaining data points were randomly selected as
a second day of testing, yielding a 48-hour dataset for circadian wave-fitting. In this way, a
distribution of adjusted p-values could be derived from JTK_CYCLE analysis to mitigate daily
technical variance. The default cosine function was used to assess significance, reported as the
median p-value of the 500 permutations.
To test for non-circadian time-dependent changes in relative abundances or pool sizes,
univariate tests were performed in a pairwise manner. A Bartlett’s test was first used to decide
between parametric (Student’s T-Test, F>0.05) or nonparametric (Wilcoxon text, F<0.05) tests of
means. A single time point was either tested to all other time points within genotypes, or
compared across genotypes at the equivalent time point. A Benjamini-Hochberg (Benjamini and
Hochberg, 1995) correction was performed to account for multiple testing using the ‘stats’
package in R.

4.4 Platform Rationale
Aligning technical approach with biological objectives
The workflow for the in vivo isotope tracer platform is outlined in Figure 4.1. Each step in
this process required careful consideration of separating biological variance from unwanted
technical and analytical variance, all with the prevailing objective of understanding dynamic
metabolic processes across circadian time. The injections serve to mimic a both pulse-chase
experiment and acute feeding bout, through injection of an isotope tracer and collection of the
flies after a fixed time interval. Feeding flies a tracer through their food source with respect to
circadian time would require enforcing appreciable feeding at the time point of interest, most likely
through a fasting paradigm, which may confound interpretation of the results. A feeding approach
may still be useful to answer questions regarding control of fasting/refeeding responses by the
circadian clock but is outside the scope of this project. In order to remove the influence of
continued feeding, these flies were placed in vial without food during the glucose incubation
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period. Of note, these flies were anesthetized on ice, rather the preferred method of carbon
dioxide. Initial anesthetizations under carbon dioxide revealed increased lactate M+3 compared
to ice, which most likely reflects increased glycolysis under hypoxic conditions. While cold
exposure may also exhibit some confounding metabolic influences, hypoxic conditions likely alter
physiology more quickly than ice exposure. The duration of tracer exposure is critical to
understand the acute response to nutrients under circadian cycles. One hour of incubation with
the labeled glucose was considered a tradeoff between sufficient sampling resolution for
circadian analysis and obtaining appreciable isotopic enrichments for LC-MS detection. Given the
genetic clock can respond quickly to environmental stimuli (Myers et al., 1996), shorter incubation
times would be ideal, but come at a cost of fewer detectable isotopologues. In time, with
improved metabolomics technologies, shorter incubation periods with higher time resolution can
provide additional clarity to metabolite flux cycles.

Analytical strategy
LC-MS metabolomics has traditionally been bifurcated into untargeted analyses on a
high-resolution mass spectrometer and targeted analyses on a quadrupole or ion-trap instrument
(Cajka and Fiehn, 2016). This untargeted versus targeted chasm has been crossed with recent
advancements in MS instrumentation, facilitating analysis of hundreds of small polar metabolites
on quadrupole instruments with an MRM approach (Rhoades and Weljie, 2016, Yuan et al.,
2012). The difficulties of metabolite identification are substantially alleviated with fragmentation
information, leading to faster biological interpretations of these datasets. These analytical
advancements can also provide deeper analyses of isotope labeling patterns, but encounter
some unique limitations under this current study design. Isotope enrichment analyses on GC-MS
benefit from increased chromatographic separation, and thus only the parent isotopologue mass
is required to uniquely identify metabolites. However, fragmentation is required for sufficient
specificity of a given metabolite on LC-MS operating at unit mass resolution.
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A glucose tracer with only one
than from

13C

6

13C

produces significantly fewer uniquely labeled products

glucose. While fewer labeled carbons entails a simpler LC-MS analysis, singly

labeled glucose will not probe metabolism as deeply as

13C

6

glucose. However, with fully labeled

glucose, many more MRMs must be considered. For instance, to analyze serine M+2, MRMs
must be incorporated to consider

12C

or

13C

carbons in the daughter ion. The possibilities scale

considerably with an increasing number of carbons, thus requiring hundreds of MRMs for even
tens of metabolites (Choi et al., 2012). During this method development process, MRMs were
trimmed based on both realistic expectations of labeling patterns from
error. For example, one may expect to find AMP M+5 from

13C

6

13C

6

glucose and trial and

glucose, but not M+10.

Additionally, some isotope enrichments were undetectable in e.g. lysine from pilot labeling studies
and were removed from the LC-MS analysis to improve S/N for other observable metabolites.
However, future experiments which utilize other tracers will need to test for new enrichment
possibilities, especially if one is to design these experiments as an “untargeted” isotopolomics
approach.

Data processing and correction measures
Reducing unwanted variance in large-scale circadian metabolomics experiments is a
nontrivial endeavor (Dunn et al., 2011). Preparation and run order should be randomized to
reduce bias, and QC samples incorporated to account for analytical drift, which typically comprise
of a pool of the biological samples or a standard mix. The QCs can be used to both correct for
drift and remove spurious metabolites with highly response variance. This approach is common in
metabolomics, including large circadian metabolomic experiments with high sampling resolution
(Krishnaiah et al., 2017). These procedures can be integrated into large-scale isotope enrichment
analyses but must be tailored to address unique challenges. Analytical drift correction requires
fitting regression curves to the quality control samples, after which correction factors are imputed
and applied to the non-QC samples. Since this approach is performed for each metabolic feature
individually, every variable will then be normalized to a scale that centers around 1. For
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downstream multivariate statistical analysis, this approach is acceptable, however isotope
enrichments must account for naturally occurring

13C

and undergo natural abundance correction

(Moseley, 2010). If every isotopologue is treated as a separate metabolic feature and corrected to
its own QC values, the scale of the isotopologue signal to the unlabeled metabolite is lost. One
method to correct for natural abundance would be to use the ratio of the raw ion counts of a given
isotopomer to the unlabeled M0 signal as a rescaling factor after QC correction. Once
isotopomers are summed to form the isotopologue data matrix, natural abundance correction
could be performed to arrive at a final normalized concentration.
An obvious criticism of this platform is the intentional disregard of the fragment labeling
information embedded in the isotopomer MRM analysis. Positional labeling information is
significantly more specific to reaction activities than parent isotopologues, however can only be
obtained from NMR analysis or extensive MS/MS methods, for example the 47 tandem mass
isotopomers which were used to obtain complete isotopomer distribution analysis in aspartate
(Choi et al. 2012). Prodigious additional work will be required to extend the labeling platform
described here and translate fragment labeling formation into significant biological inference.

Relative abundance as unique variables for periodic and multivariate statistical analysis
Under this platform, every isotopologue is treated as a unique variable for statistical
analysis. However, the endogenous pool size of a given metabolite likely varies across both
circadian time and experimental conditions. We observed that when plotting the corrected
isotopologues against their M0 signals, the values generally moved in tandem, implying that
metabolite pool size changes drove the variance in isotopologue signals. Additional scaling was
necessary to account for the pool size fluctuation and treat each isotopologue as a unique
variable. Each isotopologue was converted to a relative abundance metric by dividing the
isotopologue signal by the sum of all the given metabolite’s isotopologues (Buescher et al., 2015).
This approach seemed reasonable to gauge qualitative flux comparisons across time and
genotypes, however may suffer from some inaccuracy if full isotopologue distributions are not
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detectable. For example, while it is unreasonable to expect large AMP M+10 signals, if appreciate
labeling collectively occurs in M+6 though M+10 isotopologues, and only AMP M0 through M+5 is
analyzed, the relative abundance calculation will not completely account for pool size, but is still
likely to be reasonably accurate for this particular experimental design.
After extracting relative abundances, each isotopologue can be tested for significant
rhythmicity. A unique design feature in this Drosophila injection platform is the replicated
sampling across multiple days. Rather than a continuous collection interval, which is common in
cell or mouse experiments, replicate injections were performed on separate days, as five
replicates on a single day of injections is infeasible (15 flies were injected at each time point for
each replicate, which would take roughly 15 minutes). To guard against false positives and dayto-day variance, replicates were randomly permuted, while maintaining the circadian time order,
and subsequently retested for periodicity. This approach is not common practice in the circadian
field, but should be considered given the same animal is not typically resampled continuously and
is instead sacrificed as a replicate data point. In addition, these statistical algorithms benefit from
replicates across multiple days of testing, thus replicates data points were sampled to produce a
time-series of two replicates across two days.
Metabolomic data analysis benefits from dimensionality reduction approaches such as
PCA and OPLS-DA (Kotlowska, 2014). PCA is particularly useful to assess the quality of data
normalization measures and outlier detection, and served similar functions in this highdimensional isotopolomic dataset. Additionally, OPLS-DA has not been used in isotope analysis,
but is particularly useful here to compare isotope enrichment profiles across genotypes and
circadian time. As a dimensionality reduction technique, OPLS-DA can also guard against the
influence of collinear X variables, which is inherent in the analysis of relative abundances. Given
the influence of feeding and light on behavior and metabolism, isotope patterns which exhibit
diurnal but noncircadian patterns would be otherwise unnoticed without these additional analyses.
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4.5 Results
Glucose injection does not alter activity patterns
Supraphysiological doses of glucose may have unintended consequences on behavior
and activity, thus we sought to inject a glucose bolus which would strike a balance between
analytical detection and normal physiological response. After testing a range of concentrations
(up to 3M), 1M glucose injections were deemed an adequate tradeoff of detectable isotope
enrichment and animal safety, as flies empirically recovered at roughly the same rate from
anesthetization as non-injected controls. Post-injection climbing assays did not reveal any
significant changes between sham, PBS, and glucose injections in WT flies at ZT0 nor ZT12
(Figure 4.2). The only observable changes in climbing ability occurred across genotypes, at ZT0
between WT and fumin flies for PBS injections (p=0.003), and at ZT12 for PBS and glucose
injections (p=0.027 and p=0.014 respectively). The locomotion activity of the WT flies decreased
within the first half hour time bin for both PBS and glucose injections at ZT0 (p<0.001) and for
glucose injections at ZT12 compared to the sham injection (p=0.001), however was not significant
between PBS and glucose injections (Figure 4.3). All comparisons were additionally insignificant
in the fumin mutants. These locomotion assays revealed an expected consequence of the
injection injury when compared to a sham injection, however glucose did not impart any
significant changes compared to the PBS injection control, demonstrating an appropriate dose for
our experimental objectives. The injections were well tolerated, as less than one percent of all
injected flies in the circadian experiments were killed.

Amino acid metabolism demonstrates significant rhythmicity is and perturbed with sleep
loss
Serine M+3 relative abundance displayed significant circadian rhythmicity in WT flies
(p=0.02) with a 24-hour period and a peak at ZT4, which was lost in fumin mutants (p=1, Figure
4.4A). Additionally, the relative abundance was significantly higher at ZT4 in WT over fumin flies
(p=0.005), reflecting increased morning flux into serine from glucose carbons. The serine pool
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size was also significantly circadian (p=0.01, Figure 4.4B) in WT flies and dampened in fumin
flies. Of note, the serine pool size did not significantly change between ZT0, ZT4, and ZT8,
supporting the notion of increased carbon flux into serine amidst a stable pool size during the
active phase. Glutamine M+2 displayed a significant 12-hour period in WT flies (p=0.03) and a
24-hour circadian cycle in fumin mutants (p=0.004, Figure 4.5A), however no significant genotype
comparisons could be made as peak phases were in the morning hours for both genotypes.
Interestingly, the glutamine pool demonstrated a 24-hour period in WT (p=0.001) but tested
insignificant in fumin (Figure 4.5B). The glutamine pool size in WT flies did not increase from ZT0
to ZT4, unlike glutamine M+2 relative abundance (p=0.01), suggesting increased flux into
glutamine carbons under steady-state metabolite levels.

Glutathione M+2 exhibits ultradian patterns in WT that are lost in short-sleep mutants
GSH M+2, a product of glutathione biosynthesis from amino acid precursors, exhibited a
clear ultradian pattern in WT flies but not fumin mutants (Figure 4.6A). Since 4-hour sampling
resolution is inadequate to test 8-hour ultradian periods, pairwise time comparisons were made
within WT samples, revealing significant relative abundance changes between ZT4-8, ZT8-12,
and ZT12-16 (p<0.02). GSH pool sizes yielded a similar time course, however dropped
significantly at ZT12, as ZT0-12, ZT4-12, and ZT8-12 pairwise comparisons were significant
(p<0.02). We reason the source of the M+2 signal comes from glycine, as the WT glycine pool
size also displayed significant changes between ZT0-12, ZT4-12, and ZT8-12 (p<0.02). The
glycine M+2 signal was too weak and variable to yield statistically significant results, but also
aligns temporally with GSH M+2 relative abundance (Figure 4.6B).

Isotopolome yields unique profile in the early active phase
Univariate pairwise comparisons across genotype revealed 40 significant isotopologues
(p<0.05, q<0.2, Table 4.2), with 38 occurring at ZT4. Unique metabolites in this list consisted of
AMP, erythrose-4-phosphate, malate, glucose-6-phosphate, citrate, GSH, glutamate, ribose-5-
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phosphate,

glucose,

serine,

alanine,

asparagine,

fructose-1,6-bisphosphate,

succinate,

leucine/isoleucine, ornithine, proline, and lactate. Although a significant model could not be fit for
discriminant analysis of all time points as unique Y variables, a scores plot from an OPLS-DA
model to the WT samples visually confirmed a unique isotopolome at ZT4 (Figure 4.8A).
Additionally, discriminant analysis of ZT4 observations to all other time points in the WT samples
yielded a significant model (R2X=0.175, R2Y=0.938, Q2=0.426, p=0.016), as well as discriminant
analysis by genotype (R2X=0.178, R2Y=0.809, Q2=0.51, p=1.29e-06, Figure 4.8B). As this LC-MS
platform predominantly features smaller molecules as products of carbohydrate oxidation, rather
than anabolic fates to glycogen and lipids, this data suggests a unique fluxomic profile in
oxidative pathways early in the active phase under LD and normal sleep/wake cycles.

4.6 Conclusions
The amalgamation of systems-level oscillations in transcripts, proteins, and metabolites
presents a formidable degree of complexity in the circadian systems. Theoretical constructs
which aim to decipher metabolic flux rhythms based on phase offsets of key metabolic enzymes
have recently been published (Thurley et al., 2017), but do not experimentally measure
metabolite fluxes. Although tracer studies have been performed in cell models of circadian
disruption (Papagiannakopoulos et al., 2016), stable isotope metabolomics has yet to be
performed in a model that incorporates both the environmental and genetic drivers of the clock.
Herein a novel platform is established to inject stable isotope tracers into Drosophila, and
subsequently analyzed using custom LC-MS methodology and data-processing procedures. The
injections were well-tolerated, and yielded insignificant changes in activity between glucose and
PBS injections, suggesting a reasonable dose to study circadian physiology.
Flux into amino acid metabolism from glucose carbons exhibited a significant circadian
pattern in WT flies, with a higher morning flux compared to sleep-deprived flies. Serine M+3
represents a new circadian biometric variable and likely results from a branch point from
glycolysis (Pizer, 1963). Previous studies have analyzed steady-state pools of serine across
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circadian time (Dallmann et al., 2012), however could not state the source of the constituent
carbons. Serine has recently garnered attention in cancer metabolic studies, as it sits at the
nexus of lipid biosynthesis, one-carbon metabolism, amino acid biosynthesis, and redox defense
(Mattaini et al., 2016). Interestingly, these major metabolic processes have all been implicated in
circadian rhythms or sleep (Katewa et al., 2016, Krishnaiah et al., 2017, Rhoades et al., 2017,
Inoue et al., 1995), suggesting serine production from carbohydrates may be an important
preceding step under circadian control. Future studies should consider tracking the fate of serine
carbons into downstream products to clarify a particular role for rhythmic serine flux. This analysis
may further elucidate if cyclic serine labeling derives from a temporal offset of downstream
branch points, or cyclic rediversion of upstream carbohydrate carbons. Additionally, novel tracer
designs have recently been developed to define compartmentalized reactions in glycine/serine
metabolism and may add additional interpretability to the results noted here (Lewis et al., 2014).
Serine is currently of interest in cancer metabolism, serving as precursor for biomass production.
While adult flies may not require the same degree of anabolism as cancer cells, rhythms in
oxidative and reductive metabolism have been noted elsewhere (Peek et al., 2013, Katewa et al.,
2016), and support a hypothesis that circadian clocks serve to temporally separate catabolic and
anabolic processes to promote metabolic efficiency (Bass, 2012).
Serine M+3 lost rhythmicity in fumin flies, suggesting altered diurnal demands in amino
acid metabolism. WT flies under LD and functional clocks can anticipate energetic demands and
nutrient availability and may consequently shuttle the carbohydrates consumed in the morning
into secondary pathways such as amino acid anabolism. With perturbed sleep/wake patterns, the
fumin mutants may require additional energy from amino acid catabolism, thus breaking the
possible roles of cyclic serine production for anabolic purposes. Isotopically-labeled amino acid
injections would further elucidate cycles of amino acid catabolism and anabolism under sleep
deprivation. Glutamine M+2 also marks a previously undiscovered ultradian output. Given 12hour cycles are likely driven through LD entrainment, noted for steady-state metabolite levels in
Chapter 3, glutamine M+2 may reflect to feeding and activity rhythms. Oxidative metabolism has
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been previously shown oscillate with ultradian cycles in cells and liver ex vivo (Peek et al., 2013),
thus glutamine M+2 could serve as an alternate readout of metabolic flux through central energy
and amino acid metabolism. A circadian rhythm was noted for glutamine M+2 in fumin mutants.
This finding may suggest an ultradian profile in central energy metabolism regulated by clocks,
sleep/wake patterns, and feeding cycles, however in the absence of normal activity cycles, shifts
towards a circadian profile aligned with an intact genetic clock.
Glutathione levels and glutathione biosynthetic enzymes were previously reported to
exhibit a diurnal pattern in Drosophila heads (Beaver et al., 2012), but did not demonstrate
periodicity in active glutathione biosynthesis. GSH M+2 displayed a stark ultradian pattern in WT
flies, however the glutathione pool size demonstrated a similar temporal pattern, which may
suggest a steadier flux of carbons into a transient steady-state level than would be suggested by
M+2 relative abundance alone. Nonetheless, glutathione pool sizes did not alter significantly in
the light phase, suggesting a degree of rhythmic flux. Although glycine M+2 enrichments were too
low to accurately detect at every time point, the temporal overlap between glycine and glutathione
supports the hypothesis that the glycine addition via glutathione synthetase represents the
ultradian step in glutathione biosynthesis, as glutamate and cysteine isotopologues did not
display a similar pattern. Of note, glycine M+2 did not temporally overlap with serine M+3. While
glycine M+2 may still form from serine M+3, rhythmicity in substrate rediversion may be
responsible for the temporal offset of these isotopologues. Interestingly, Beaver et al. reported
rhythms in fly heads for glutamate cysteine ligase activity, and found no temporal pattern in
glutathione synthetase, however head and body mechanisms of glutathione biosynthesis and
redox defense may differ. Additionally, GSH M+2 cycles were lost in fumin mutants, which likely
stems from altered ROS production under sleep deprivation, perhaps consistent with the loss of
ROS cycling noted in clock mutants (Krishnan et al., 2008).
A global isotopolome shift at ZT4 in WT flies suggests increased carbohydrate
metabolism, which may stem from increased feeding and activity after lights-on. Given many of
the metabolites detected in this method comprise small compounds instead of larger anabolic
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products, these results may reflect a role for glucose in a morning ‘catabolic rush’. Anabolic
products, including glycogen, lipids, and proteins, would likely be formed towards the onset of
dusk in anticipation of fasting and decreased activity, as has been previously noted (Tsai et al.,
2010). Additional analytical methods would be required to analyze anabolic fates for glucose
carbons. Alternatively, the results from Chapter 3 highlight the importance of light-induced
metabolome profiles, which may be mirrored here in a LD paradigm. Future experiments should
consider isotopolome analysis under constant conditions to separate environmental and clockdriven flux profiles.
The stark difference in the ZT4 isotopolomes across genotypes may reflect altered
metabolic demands after sleep deprivation. Locomotor activity in fumin mutants is considerably
higher than WT at night rather than after lights-on, mirrored by high nighttime dopamine levels
(Kume et al. 2005). Additionally, light has been shown to inhibit dopamine’s wake-promoting
effects through upregulation of inhibitory dopamine receptors (Shang et al., 2011), further
promoting the notion that altered glucose metabolism may stem from a response or
compensation to nighttime hyperactivity. Additional models of sleep perturbation will clarify the
relative importance of high dopamine levels versus alternative means of sleep deprivation.
This platform has unearthed a new dimension of circadian clock outputs, however may
be confounded by some aspects of the current experimental design. Considering the diurnal
activation of stress pathways (Spencer et al., 1998), the cyclic metabolic outputs noted here may
be influenced by stress responses to the injection injury. Additionally, this experiment subjected
flies to cold, followed by a light exposure necessary to perform the injections. These additional
stressors and cues may not only influence metabolism, but reset the clock, mitigating the effect
size on diurnal flux. The clock itself may also gate the degree of response to environmental
signals, which has been observed by differential photic induction of gene expression in subjective
morning versus night (Sutin and Kilduff, 1992). One hour of labeling may be sufficiently long to
alter the clock phase after a brief light exposure, however likely did not completely reset the clock
given the significantly circadian isotopologues observed here. The hour incubation period
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ultimately stemmed from a tradeoff of isotope enrichment with acute flux analysis. Many of the
isotopologues included in the LC-MS analysis yielded relatively high variance and low S/N, thus
additional advancements in instrumentation would be required to shorten the label incubation
period to alleviate concerns of stress and light exposure while maintaining broad coverage of the
isotopolome.
While unprecedented in scope, this current analysis cannot detect particular
isotopologues of interest. Given glycine M+2 does not temporally align with serine M+3, other
downstream metabolites from serine carbons would likely also oscillate with a 24-hour period,
including one-carbon metabolites and lipid synthesis products such as sphingosines and
phosphatidylserines. Substantially more sensitive methodology will be needed to detect these
isotopologues, as the serine M+3 relative abundance in this study never exceeded 12%. MRMs
for GSH only considered M0 through M+5, rather than the full isotopologue distribution, in an
effort to increase MS dwell times and decrease analytical variance in other isotopologues.
Dedicated methods which account for all possible MRMs of glutathione may further elucidate the
source of glutathione labeling patterns and corroborate previous enzyme expression data.
The open-circulatory system in Drosophila provides a unique advantage in the
interpretation of this study design. While mammalian physiology is highly compartmentalized, the
bathing of the fly’s organs in the hemolymph likely leads to a more rapid mixing of tracer and
subsequent exposure to the periphery, and may be amenable to single-compartment kinetic
models in future study designs (Wolfe and Chinkes, 2005). In mammals, glucose labeling
patterns may be largely driven by glucose uptake, rather than intracellular reaction rates. In this
Drosophila paradigm, this concern is mitigated by an assumed mixing of glucose through the
hemolymph, however rhythms in glucose uptake would need to be validated through tissuespecific enrichment analysis. The fat body is the largest and most metabolically active organ in
the fly, and is likely responsible for much of the observed labeling patterns. However, fat body
transcripts do not necessarily align temporally with whole-body or head transcripts (Keegan et al.,
2007, Xu et al., 2011), which will likely decrease the number of observable circadian
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isotopologues from body analysis. A combination of new LC-MS methodology and fly preparation
and extraction protocols will be required to discern tissue-specific labeling patterns, as many
isotopologues noted even in body analysis displayed low S/N. Additionally, the metabolic source
of a given isotopologue is poorly understood. While serine M+3 likely derives from glycolysis
branching, metabolic paths leading to glutamine M+2 are less clear, and realistically may have
many

sources

when

one

considers

the

complex

network-structure

of

metabolism

(Chokkathukalam et al., 2014). Additional bioinformatic approaches which track carbon flow
throughout genome-scale metabolic networks will be required to understand the possible
metabolic paths which lead to these experimental results, and is the subject of Chapter 5. These
uncertainties may also be alleviated through additional MS/MS platforms which effectively utilize
fragmentation labeling patterns. Ultimately, our current understanding of biochemistry has not
kept pace with the advances in systems-level technologies, particularly in secondary metabolism
(Hackett et al., 2016). Regardless, this acute labeling platform opens new doors for
understanding circadian, sleep, and nutrient processing mechanisms. Apropos, a recent interest
in the benefits of time-restricted feeding vis-à-vis the circadian clock raises questions regarding
the temporal distribution of nutrient processing (Longo and Panda, 2016). Experimental designs
which consider feeding paradigms, alternative isotope tracers, and clock disruptions have
pragmatic applications in nutrition, therapeutics, and social determinants of health, and may
improve the management of altered feeding and sleep schedules common in e.g. shift work.
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Table 4.1 MRM transitions for injection dye used in signal normalization

Compound

Parent Mass

Daughter Mass(es)

Dye1 (ESI+)

453.00

217.00, 326.00

Dye2 (ESI+)

579.00

288.00

Dye3 (ESI-)

225.00

200.00

Dye4 (ESI-)

373.20

170.00, 333.00
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Table 4.2 Significant isotopologues (p<0.05, q<0.2) across genotype
Isotopologue

Time Comparison

P-Value

Q-Value

AMP M0

4hr

4.74E-06

0.000783

AMP M+1

4hr

1.35E-05

0.001113

Erythrose-4-Phosphate M0

12hr

4.97E-05

0.008204

Malate M+1

20hr

5.42E-05

0.008939

Glucose-6-Phosphate M+6

4hr

0.000503

0.027657

Glucose-6-Phosphate M0

4hr

0.000976

0.040243

Citrate M+1

4hr

0.001445

0.047686

GSH M0

4hr

0.002447

0.062446

Ribose-5-Phosphate M0

4hr

0.0029

0.062446

Hexose M+6

4hr

0.003028

0.062446

AMP M+2

4hr

0.003663

0.067158

Serine M+3

4hr

0.005092

0.08402

Asparagine M+1

4hr

0.005982

0.08973

Hexose M0

4hr

0.006779

0.093208

Alanine M+3

4hr

0.009335

0.118477

Ribose-5-Phosphate M+4

4hr

0.010308

0.121487

Asparagine M0

4hr

0.013238

0.139188

Asparagine M+4

4hr

0.014246

0.139188

AMP M+5

4hr

0.014341

0.139188

Serine M+2

4hr

0.016467

0.150951

Glutamate M+4

4hr

0.018159

0.157693

Fructose-1,6-Bisphosphate M+3

4hr

0.021071

0.163972

GSH M+5

4hr

0.021837

0.163972

Alanine M0

4hr

0.021863

0.163972

Hexose M+3

4hr

0.02347

0.164591

Glucose-6-Phosphate M+3

4hr

0.02394

0.164591
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Succinate M+2

4hr

0.025768

0.168292

Leucine/Isoleucine M+5

4hr

0.026519

0.168292

Asparagine M+2

4hr

0.028571

0.168367

Glucose-6-Phosphate M+5

4hr

0.028571

0.168367

AMP M+3

4hr

0.029997

0.169458

Ornithine M+1

4hr

0.031106

0.169458

Ornithine M0

4hr

0.031838

0.169458

Proline M+4

4hr

0.037125

0.187679

Proline M+5

4hr

0.038418

0.187679

Lactate M+1

4hr

0.038673

0.187679

Lactate M+3

4hr

0.04137

0.194402

Serine M0

4hr

0.044428

0.194402

Hexose M+5

4hr

0.044693

0.194402

Succinate M+4

4hr

0.044771

0.194402
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Figure 4.1 Workflow for in vivo circadian isotopolomics platform. After Drosophila injections and
LC-MS analysis, data is normalized to QC samples and injection dye signal, followed by
isotopomer summation to yield the isotopologue matrix. These values are then scaled according
to ratios of individual isotopologue ion counts to the unlabeled M0 metabolite before natural 13C
abundance correction. Data is exported as relative abundance to the total metabolite signal.
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Figure 4.2 Geotaxis assay at ZT0 (A) and ZT12 (B), measured in time to climb 4cm one hour
after injections (n=5-8). Boxplots are colored by genotype (Fmn – fumin; WT – wild-type). No
significant changes were noted within genotype at either time point.
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Figure 4.3 Locomotion assay by genotype and time. Glucose and PBS injections decreased
activity compared to sham injection in WT at ZT0 (A, p<0.001), and for glucose at ZT12 (B,
p=0.001), while no differences were noted in fumin mutants at either time point (C, D).
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Figure 4.4 Relative abundance for serine M+3 (A) and normalized concentration of serine pool
size (B) by genotype across time. Serine M+3 exhibited a significant 24-hour period in WT
through JTK_CYCLE analysis (p=0.02) and significantly increased over fumin (Fmn) flies at ZT4
(p=0.005). Serine pool size did not significantly change between ZT0 and ZT8 in WT,
demonstrating an increased flux of glucose carbons into serine.
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Figure 4.5 Relative abundance for glutamine M+2 (A) and normalized concentration of glutamine
pool size (B) by genotype across time. Glutamine M+2 exhibited a significant 12-hour period in
WT (p=0.03) and 24-hour period in fumin (Fmn) flies (p=0.004) through JTK_CYCLE analysis.
Glutamine pool sizes displayed a significant 24-hour period in WT (p=0.001).
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Figure 4.6 Relative abundance for GSH M+2 (A) and glycine M+2 (B) by genotype across time.
GSH M+2 relative abundances significantly altered for WT in pairwise comparisons of ZT4-8,
ZT8-12, and ZT12-16 (p<0.02), while relative abundances did not significantly change at any
pairwise timepoint comparison for fumin flies. Glycine M+2 did not yield any significant changes,
however displays an ultradian pattern which overlaps with GSH M+2 and suggests glycine as the
carbon source for flux into GSH biosynthesis.
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Figure 4.7 OPLS-DA scores plots. All time points were modeled as Y variables within WT
samples to demonstrate unique ZT4 isotopolomic profile (A, ns), and a pairwise model by
genotype, with all timepoints considered (B, R2X=0.178, R2Y=0.809, Q2=0.51, p=1.29e-06).
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CHAPTER 5 – In silico isotopologue-mapping to trace metabolic pathways at
genome-scale
5.1 Abstract
Isotope tracers have greatly enhanced metabolic research, however as metabolomic
analyses probes deeper into secondary metabolism, the interpretability of increasingly complex
isotope enrichment patterns remains limited. Herein is described a novel computational approach,
termed the IsoPathFinder, which considers all possible paths from the input isotope tracer to the
isotopologue of interest through atom-resolved reaction networks at a genome scale. This
algorithm is flexible, capable of rebuilding tracer-based metabolic networks from any tracer of
interest and subsequently searching for any user-specified isotopologue. As a proof of concept,
this approach uncovered possible routes to rhythmic isotopologues observed in Chapter 4.
Canonical serine biosynthesis paths were calculated alongside two thermodynamically-favorable
alternative paths through pyruvate M+3, which utilize an oscillating pyruvate kinase enzyme and
confirm a glycolytic contribution to serine flux. 7246 paths were discovered for glutamine M+2,
thus requiring a trimming procedure based on physiological relevance, expression datasets, and
thermodynamics, to yield a subset of the eight likeliest paths. Most of these paths contained the
TCA cycle, which confirms suspected cataplerotic feeding of the TCA cycle into amino acid pools.
The shortest paths to GSH M+2 derived from glycine M+2, as expected. Additional routes via
cysteine M+2 were discovered at longer path lengths, and may be driven from cyclic activity in
glutamate cysteine ligase. This approach is presented as a proof of concept to confirm known
biochemistry and propose new metabolic mechanisms, and opens doors for additional
experimentation and metabolic discovery through simulation of alternative isotope tracers.
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5.2 Introduction
The isotopologue data presented in Chapter 4 presents a set of novel findings regarding
diurnal patterns in metabolic flux, generated from a bespoke technical and analytical
metabolomics platform. On its own, this approach provides a clearer assessment of metabolic
phenotypes over static measurements such as transcriptomics and steady-state metabolomics.
However, we are far from fully understanding the enzymatic processes which produce observable
isotopologues amidst the complex network of metabolism. Only a small fraction of the vast
possibilities in metabolism are ever considered with current implementations of experimental
designs and analytical assays, and subsequent interpretations on the scaffolds of restricted
canonical biochemical pathways. While glucose tracing experiments have revealed glycolysis is
in fact a major active hub of metabolic flux networks (Park et al., 2016), there remains vastly
unexplored territory in alternative fates of isotope tracers. Bioinformatic tools have been recently
developed to abstract labeling patterns from high-resolution MS metabolomics data (Huang et al.,
2014, Capellades et al., 2016), however considerable work remains in metabolite identification
and biological interpretation. Additionally, attributing labeling information to specific reaction
activities is difficult without atomic detail, which would require NMR or extensive MS
fragmentation (Choi et al., 2012). The rapid growth of reaction annotation and metabolite
identification presents a unique opportunity in systems-level biomedical research to unbiasedly
explore all enzymatic possibilities in silico. Only recently has computing power been
commensurate to predict fluxes to scale (Ebrahim et al., 2013), however these computational
platforms do not yet exhibit the granularity of atomic resolution. No tool currently exists to track
carbon transfers for every reaction in large metabolic networks and subsequently reconstruct all
possible metabolic routes which lead to observable isotopologues. These two objectives served
as the motivating factors for development of a new computational approach for in silico metabolic
reaction modeling described here.
The findings in rhythmic amino acid and glutathione metabolism highlighted in Chapter 4
would benefit from such an approach. For example, carbon flow into glutamine M+2, serine M+3,
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and GSH M+2 may have many sources, and while glycolysis and TCA cycle are likely
contributors to these isotopologues, other possibilities are yet unexplored. In addition to
developing a novel approach to explore alternative routes, a means to predict the most likely
routes is presented through the incorporation of previously published datasets (Xu et al., 2011,
Gill et al., 2015, Tepper et al., 2013), This new platform has shed light on the immensely complex
nature of metabolism, however can generate hypotheses with heightened probabilities of the
metabolic paths which contribute to observable data. This algorithm is designed with the intention
of flexibility to both build sets of labeling possibilities from any input tracer of interest and search
for paths to any isotopologue of interest, and is presented here as a proof of principle to both
corroborate prior biochemical knowledge and provide novel alternative paths to significantly cyclic
isotopologues from Chapter 4.

5.3 Algorithm and Workflow
Materials
All in silico reaction modeling and path searches were developed within Jupyter
notebooks (v4.2.3) in Python v3.5. Scripts were run under a Ubuntu 15.10 virtual machine on an
Intel Xeon E5-2650 system (24 cores, 2.1GHz) with 64GB of memory. Files which include the
simplified molecular-input line-entry system (SMILES) formatted atom-mapping reaction
solutions, fly-specific metabolic models, and reaction links from MetaCyc ‘RXN’ format to enzyme
commission (EC) numbers were obtained from MetaCyc (Caspi et al., 2016). Conversions of
SMILES format to common names for metabolites were generated from the PubChemPy Python
module (v1.0.3) using a custom script, which ultimately sources information from the PubChem
database (Kim et al., 2016). Additional metabolite naming mechanisms were manually changed
to user-defined names for ease of interpretation, for example 617-45-8 to Aspartic acid (listed by
chemical abstracts service (CAS) as the first synonym entry for the SMILES conversion of
Aspartic acid in PubChem). Additional SMILES atom-mapping reactions were manually added or
curated for completeness of central energy metabolism, including glycolytic and TCA cycle
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reactions. Results from the in silico reaction modeling were converted into queriable dictionaries
and used to construct metabolic paths under the IsoPathFinder algorithm. The list of all possible
labeling paths was trimmed using multiple data sources: significantly circadian enzymes from
Drosophila transcript studies were derived from Xu et al., 2011 and Gill et al., 2015, and
estimated Gibbs free energies for each enzyme were based on calculations from Tepper et al.,
2013.

Enumerating all possible isotope transfers
The general workflow for isotope reaction modeling, followed by reconstruction of
metabolic routes, is outlined in Figure 5.1. Reactions which contain atom-mapping solutions of
metabolites in SMILES formats, from the MetaCyc database of annotated Drosophila enzymes,
were used to compile the starting metabolic network. Atom-mapping solutions consist of
annotated reactions where atoms are numbered for all reactants and matched to atoms in all
products, for example the 1’ carbon of glucose to the 1’ carbon of glucose-6-phosphate from the
hexokinase reaction. Some enzyme and metabolite annotations were manually curated for
accuracy and interpretability, including glycolysis and TCA cycle. While the objectives here
included holistic and unbiased reaction modeling, given the

13C

6

glucose tracer employed in

Chapter 4, any metabolite routes which fan out from central carbon metabolism would not be
accurate without thorough curation of these core reactions. All possible carbon transfers were
executed in an iterative round-by-round fashion, where the user specifies the labeled metabolite
of interest (e.g.

13C

6

glucose), followed by a trimming procedure of the model to produce the

starting set of reactions which contains the tracer. As the input tracer is defined by a SMILES
string, the user may additionally specify positional labeling, such as 1,2-13C glucose. The carbons
from the tracer are then matched to the carbons in the products of the starting reaction set, and
subsequently ‘labeled’. These simulations are then stored as a Python-formatted dictionary,
where the keys for the first round of reactions are the newly labeled products, and the values
contain both the labeled reactants and the enzyme(s) which catalyzed the reaction (Figure 5.2).
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These results can then be queried in the IsoPathFinder algorithm to build metabolic routes which
originate from the input tracer and are exported as a .csv file (Figure 5.2C). The list of newly
labeled products is then used to seed the second round of reactions. As in the first round, all
reactions which contain any of these newly labeled compounds are selected from the network,
followed by mapping all labeled carbons onto new products. In this way, the process can be
repeated until the desired number of reactions is calculated. Initially, 30 rounds of reactions were
deemed sufficient, especially given the possibility of glycolysis and multiple cycles through the
TCA cycle. While 30 rounds may produce experimentally observable labeling patterns, the
possible routes calculated in the IsoPathFinder algorithm quickly became computationally
intractable, for example the more than 100,000 path possibilities for glutamine M+2 after 15
reactions. Consequently, all 30 rounds were never considered, as extensive code optimization
and removal of many unrealistic reactions were necessary to even reach path lengths of 15. For
instance, many reactions contained carbon dioxide, which is unlikely to appreciably contribute to
observable labeling patterns in Chapter 4, and was thus excluded from the list of labeled
compounds. Additionally, labeled compounds which did not have a match of SMILES format to a
common name in the PubChem database were dropped. Future implementations of this
approach may benefit from simulating reactions which contain multiple labeled reactants,
however would present both a more difficult computational problem to solve and a substantially
greater set of possible labeling reactions to interpret.

IsoPathFinder algorithm
After simulating all possible isotope transfers and rebuilding a new isotopically-labeled
metabolic network, routes are built working backwards from the user-defined isotopologue of
interest to the initial input tracer in round one. For example, if serine M+3 were found in round
ten, all reactants which mapped to serine M+3 in round nine would be returned, followed by a
search for all reactants which led to those product metabolites in round eight, etcetera. These
routes were then appended to a repeated construction of paths for serine M+3 starting in round

133

nine, followed by starting from each of the preceding rounds until serine M+3 was not produced
(for example, no reactions catalyze glucose M+6 to serine M+3 in round one). Currently this
algorithm is capable of building paths for a maximum length of 15, however shorter paths can be
defined by the user. Code optimization and/or computing clusters will be required to run longer
path searches, as path searches of length 15 could take hours on a single computer. Some
routes contained metabolites repeatedly across multiple reactions, which were removed to both
further trim the number of possibilities and remove futile cycling. As a broader objective to
achieve widespread usage, this program is designed to take a user input and build paths on any
commonly observed isotopologue of interest, whether it be derived from experimental data or for
purely in silico experimentation.

Reaction trimming
Given the number of possibilities, unlikely metabolite routes were trimmed using
additional rationale and prior datasets. Some PubChem identifiers did not match to common
names or other databases, such as metabolite ‘AC1N7ZT6’. Paths which contained these IDs
were manually trimmed if no alternative naming mechanism could be found. Additional steps
were suited to meet the experimental objectives of deriving significantly rhythmic metabolic flux
possibilities. Routes were trimmed which did not contain a circadian enzyme from two previous
Drosophila transcriptomics studies (Xu et al., 2011, Gill et al., 2015). This approach may yield
misleading results, as cyclic enzymes are not necessary to generate rhythms in metabolic flux
(Thurley et al., 2017). However, this approach removed an appreciable number of paths and
eased the interpretation of these results. Gibbs free energies were previously calculated for all
annotated reactions (Tepper et al., 2013), based on an expanded formulation of the group
contribution method (Mavrovounioitis, 1990). While these estimates may not be identical to in vivo
enzyme kinetics for flies, these estimates were found to hold reasonably true when compared
across other databases of enzyme thermodynamics (Goldberg et al., 2004). In addition, metabolic
flux and enzyme efficiency are highly conserved processes under strong evolutionary pressure
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(Park et al., 2016), which alleviates the concern of inaccurate free energies across species.
These estimated Gibbs free energies were summed across all enzymes for each of the
IsoPathFinder

paths,

and

subsequently sorted

by thermodynamic

favorability.

Future

improvements to this algorithm may consider incorporating reaction irreversibility to further trim
possibilities a priori. Unfortunately, even these steps cannot trim the possible routes to down to
one, however by significantly reducing the possibilities and shifting probabilities towards a subset
of paths, validation experiments can be designed to test relatively fewer hypotheses.
Separate Jupyter notebooks perform each aspect of this approach: enumeration of all
possible isotope transfers from any input tracer of interest, path-building towards the isotopologue
of interest, and reaction trimming based on the research objectives. These three scripts are
available upon request.

5.4 Results
IsoPathFinder uncovers shortest set of paths from

13

C6 glucose to serine M+3 through

glycolysis
The shortest path length to serine M+3 from fully labeled glucose consisted of nine
reactions, with sixteen total unique paths. After trimming two paths which contain a carboncarbon lyase of bacterial or plant origin (EC 4.1.1.39), eleven paths with a net positive ΔG, and
one additional path without a circadian enzyme, two paths remained (Table 5.1). These paths
included glycolysis, followed by conversion of pyruvate M+3 to serine M+3. Pyruvate kinase (EC
2.7.1.40), discovered to transcriptionally oscillate in fly bodies by Gill et al., was contained in both
of these paths, thus providing predictions for the shortest thermodynamically favorable path to a
rhythmic flux into serine carbons (Figure 5.3). Notably, the canonical serine biosynthesis pathway
did not contain a cyclic enzyme, nor yielded a negative ΔG, and was removed from the initial set
of paths. No unique paths of ten reactions were calculated with this algorithm, which may stem
from a requirement of an additional intermediate before an eleventh reaction step. A path search
of eleven reactions yielded 2262 unique paths. After trimming procedures, 61 paths remained.
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Whereas the preceding metabolite in the four paths of length nine was pyruvate M+3, now 3hydroxypyruvate, alanine, acetyl-serine, and cystathionine M+3 were alternative isotopologue
sources. Interestingly, alanine M+3 demonstrates similar a similar temporal pattern to serine M+3
(Figure 5.4), providing additional evidence these paths may be relevant for the rhythmic flux
noted in Chapter 4. However, isotopologues for hydroxypyruvate, acetyl-serine, and cystathionine
were not included in this LC-MS analysis, but are discovered here from the IsoPathFinder
algorithm as additional targets for future analyses. Most of these paths use glycolysis, however
ten of these paths included the gluconeogenic enzyme phosphoenolpyruvate carboxykinase,
catalyzing phosphoenolpyruvate M+3 to oxaloacetate M+3. Pyruvate M+3 was formed from
oxaloacetate M+3 from the cyclic enzyme pyruvate carboxylase (EC 6.4.1.1).

Likeliest paths to glutamine M+2 derive from TCA cycle
Path lengths of fourteen steps were the shortest routes which yielded feasible routes to
glutamine M+2 after trimming procedures, and produced 7426 paths. After trimming procedures,
including removal of paths with non-physiological isotopologues such as ethylene and methylaspartate M+2, eight paths remained. For all paths, the preceding isotopologue to glutamine
consisted of glutamate M+2, formed by alpha-ketoglutarate M+2. While glutamate M+2 did not
significantly oscillate, the labeling pattern followed closely to glutamine M+2, corroborating these
paths (Figure 5.5). The net ΔG in these paths ranged from -273kJ to -297kJ (Table 5.2), which
were considerably more favorable than the highest value observed for serine M+3 paths (-68kJ),
and contained upwards of seven cyclic enzymes. Half of these paths contained the TCA cycle,
which included the most favorable path with a relatively high number of cyclic enzymes
(glucosamine 6-phosphate synthase, pyruvate kinase, aconitase, isocitrate dehydrogenase,
ornithine transaminase, and citrate synthase). The remaining paths did not include the TCA cycle,
but instead formed alpha-ketoglutarate M+2 from 2-hydroxy-4-oxopentadioic acid M+2. However,
given relatively fewer circadian enzymes in these remaining paths, we speculate the most likely
paths to glutamine M+2 include the TCA cycle (Figure 5.6).
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Glutathione biosynthesis likely an extension of rhythmic flux into serine M+3
A path search for GSH M+2 yielded 23 paths of eleven steps, which was trimmed down
to two unique paths (Table 5.3). Each of these paths were a direct extension of the four shortest
paths found for serine M+3, which now included a formation of glycine M+2 before GSH M+2
production via glutathione synthase. A path search up to twelve steps yielded an additional 24
paths after trimming, which all utilized glycolysis and contained glycine M+2 as the only preceding
isotopologue (from serine M+3). Thirteen steps were necessary to find cysteine M+2 as an
alternative source for GSH M+2 synthesis, which utilized a cyclic gamma-glutamylcysteine
synthetase enzyme not found in glycine M+2 paths. GSH M+2 production from glycine were the
shortest and most thermodynamically favorable paths, and represent the most likely paths to
GSH M+2 (Figure 5.7).

5.5 Conclusions
The rapid expansion of stable isotope applications in recent years can greatly benefit
from a commensurate tool which reconsiders all possible enzymatic processes now annotated in
the post-genomic era. The approach outlined here represents the first attempt to map
isotopologue data onto genome-scale metabolic networks at atomic resolution through a two-step
bioinformatic approach. The first step calculates every carbon-transfer from an input tracer of
interest in an iterative round-by-round manner. These simulations require a database with an
extensive set of atom-mapping reaction solutions, which has only recently been developed and
annotated (Caspi et al., 2016). Fortunately, while there exists room for improvement, MetaCyc
represents a substantial effort by an active research community to compile such detail. To
address the uncertainties described in Chapter 4, MetaCyc reactions were additionally curated
around central energy metabolism to ensure proper tracking of glucose carbons, and reactions
which did not appear likely to contribute to observable metabolic flux in Drosophila were removed,
including bacterial enzymes. The microbiome connection to host physiology is of intense interest,
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including flies (Shin et al., 2011), however given the bolus injection paradigm employed in
Chapter 4, likely does not contribute appreciably to the observed isotope enrichments. Thus, with
minimal additional work, existing databases can be effectively leveraged to explore new aspects
of metabolism. Once all carbon transfers were simulated, both for all atom-mapping solutions
from MetaCyc for general use and all fly-specific reactions for this study, this new scaffold of
‘labeled’ metabolism can be probed to discover all possible connections of the input tracer to the
isotopologue of interest. This path-building step is designed to receive user input to calculate
paths towards any commonly detected isotopologue, and can have broad applicability in isotopebased research. The IsoPathFinder produced many more possible paths through this new
metabolic network than expected and ran into computational and interpretability constraints. The
extent of this complexity is simultaneously exciting and humbling, but unfortunate given a
metabolic path length of even 20 reactions seems physiologically feasible but cannot be achieved
with this method. Additional algorithmic improvements will be necessary with a concurrent means
to trim unlikely paths to alleviate the computational burden.
This algorithm uncovered a set of paths which trace carbons from glucose to serine
through the shortest and most thermodynamically favorable paths. These paths utilize glycolysis
and pyruvate kinase to form serine M+3 via serine deaminase (EC 4.3.1.17), however, some
notable alternatives were trimmed. Serine biosynthesis is known to occur through 3phosphoglycerate, catalyzed by phosphoglycerate dehydrogenase (Pizer, 1963). These paths
were discovered with the IsoPathFinder, however were trimmed given a lack of circadian enzyme
expression and a positive ΔG. Transcription may not necessarily correlate with reaction activities,
and circadian enzyme expression may not be necessary for rhythms in metabolic flux (Thurley et
al., 2017), especially considering the possibility that a cyclic pyruvate kinase enzyme may
produce rhythmic flux upstream in glycolysis. An additional twelve paths were calculated without
cyclic enzymes and thermodynamic trimming, which included the canonical serine biosynthetic
pathway. Phosphoserine M+3 is the immediate precursor to serine in this pathway, but was not
analyzed in the LC-MS platform described in Chapter 4. Additional experiments with expanded
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LC-MS analyses may provide additional evidence for the relative sources of cyclic carbon to
serine. Akin to metabolite pools, any given isotopologue is likely the product of multiple reactions,
thus we can speculate that both these major paths may contribute to the findings in Chapter 4,
especially given pyruvate M+3 did not yield a similar temporal pattern to serine M+3. Additional
precursor isotopologues were discovered at paths of eleven reactions, including alanine M+3,
which does resemble serine M+3 patterns. However, these paths may not provide significant
additional biological insight, as the alanine M+3 is derived from pyruvate M+3 and would likely
produce a similar metabolic phenotype to the shorter paths which do not contain alanine.
Gluconeogenic reactions were contained in some of these extended serine M+3 paths,
which is not compatible with active glycolysis but may have interesting biological explanations.
Organisms mobilize energy stores in anticipation of active states (McGinnis and Young, 2016),
and likewise produce sugar via gluconeogenesis to further meet this energetic demand (Kida et
al., 1980). The isotopologues representative of gluconeogenic flux, such as glucose-6-phosphate
M+2, M+3, and M+4 (Wolfe and Chinkes, 2005), did not exhibit significant diurnal variance.
However, with a supraphysiological glucose bolus, gluconeogenic flux may be overridden by
glycolysis. Interestingly, glucose-6-phosphate M+2 and M+3 relative abundances were
significantly increased during the light phase in WT compared to fumin flies (p<0.03), implying
altered energetic demands in central energy metabolism. This computational approach thus
provided evidence for cyclic serine flux through glycolysis, and revealed new alternatives to
canonical biochemistry serine biosynthesis. Understanding both source and fate of serine
carbons is important given its connection to numerous metabolic processes, and warrants
additional experimentation through expanded LC-MS analyses and computational flux predictions
(Mattaini et al., 2016).
Paths to glutamine M+2 which passed the trimming procedures were not observed until
path lengths of fourteen reactions, and consequently produced numerous possibilities. These
paths were rationally trimmed to predict glutamine production through the TCA cycle. Notably,
these paths were very thermodynamically favorable compared to those for serine M+3 and GSH
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M+2, and contained a series of circadian enzymes in the TCA cycle, which further increases the
likelihood of these paths exhibiting cyclic activity in vivo. This approach also provided a link to
overlapping isotopologue patterns from glutamate to glutamine M+2, which is particularly striking
given 15 separate enzymes catalyze this last step in the glutamine M+2 paths. Alphaketoglutarate M+2 preceded glutamate M+2 in all these paths, however did not cycle. Alphaketoglutarate M+2 does exhibit significant but non-circadian diurnal changes in WT flies, thus
raising the possibility of a cyclic contribution to glutamate and glutamine carbons through
alternative mechanisms such as substrate rediversion. Paths which do not utilize the TCA cycle
still utilize carbons through glycolysis and pyruvate, suggesting an important role for central
carbon metabolism to downstream amino acid pools. Alternative paths uniquely contained 2hydroxy-4-oxopentanedioic acid M+2, which was not detected on this LC-MS platform. As noted
with serine M+3 paths, glutamine M+2 sources may not require cyclic enzymes, and alternative
possibilities should not necessarily be omitted without additional experimentation. This procedure
nonetheless trimmed a substantial number of possibilities, providing a more tractable set of
hypotheses and shifting the probabilities towards more likely paths through the TCA cycle.
Steady-state glutamate pools robustly oscillate in flies (Chapter 3), with conserved
rhythms in mice and humans (Hatori et al., 2012, Dallmann et al., 2012). Given the large pools of
glutamine and glutamate, cyclic M+2 patterns may reflect a sink of carbons from upstream
reactions in nitrogen and central energy metabolism. However, glucosamine-6-phosphate
(GlcN6P) synthase, one enzyme which catalyzes the final step in glutamate M+2 to glutamine
M+2, has been shown to oscillate in flies (Gill et al., 2015), and may reflect more active biological
roles of amino acid flux. Hexosamine synthesis triggers protein modifications by Nacetylglucosamine (GlcNAc), which produces a circadian pattern of Bmal and Clock
GlcNAcylation (Li et al., 2013). Manipulating GlcNAc levels can perturb both glucose homeostasis
and circadian period length, perhaps serving as a metabolic sensor to coordinate with core clock
functions (Kaasik et al., 2013, Kim et al., 2012). Additional experiments may consider the
interaction of hexosamine and amino acid flux in relation to the core clock protein modifications.
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Acetyl-CoA M+2 was featured in the TCA-dependent paths to glutamine M+2. Acetyl-CoA
sits at the nexus of numerous intracellular processes, serving roles in both oxidative and
reductive metabolism and epigenetic regulation as an acetyl source. As both oxidative
metabolism and macromolecule biosynthesis have been shown to oscillate (Peek et al., 2013,
Katewa et al., 2016), one may expect to find cyclic acetyl-CoA production. Additional LC-MS
analyses would be required (Basu et al., 2011), as acetyl-CoA M+1 and M+2 were not detectable
on the platform described in Chapter 4. Tracking acetyl-CoA carbon fates could shed light on the
dynamic epigenome which has been previously observed through cycles in histone deacetylase 3
activity (Feng et al., 2011). A dependency on the clock would also be expected, as livers from
Clock knockout mice show significantly altered acetylation profiles for enzymes in glycolysis, TCA
cycle, and amino acid metabolism (Masri et al., 2013).
As expected, glutathione biosynthesis is most likely driven by glycine M+2 addition to
glutamyl-cysteine via glutathione synthetase. This enzyme has not been found to oscillate in flies,
however may still yield rhythmic glutathione synthesis through rhythmic substrate availability, as
this last step in glutathione biosynthesis is rate-controlling. Glycine M+2 yielded a similar ultradian
pattern to GSH M+2, however serine M+3 demonstrated a decoupled rhythm. As serine carbons
feed other major metabolic pathways, temporal offsets in substrate rediversion likely produce the
uniquely ultradian glycine and glutathione patterns. An extended path search revealed alternative
paths to glutathione biosynthesis through cysteine M+2. While these paths were less
thermodynamically favorable than glycine M+2 paths, they may be worth considering as
glutamate cysteine ligase has been shown to not only oscillate transcriptionally, but also display
diurnal patterns in enzyme activity (Beaver et al., 2012). Both glycine and cysteine exhibit
relatively high variance on this LC-MS platform, which precludes cogent insights to glutathione
carbon sources. Alternate metabolomic methods which accurately detect all glycine and cysteine
isotopologues, and additional isotopologue products of serine metabolism, may further clarify the
connection between amino acid and redox metabolism. These studies may additionally benefit
from isotopically-labeled amino acid injections in Drosophila. The IsoPathFinder algorithm
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ultimately provided supporting evidence to the expected source of glutathione carbons from
glucose via glycolysis and amino acid metabolism.
While any of these speculations regarding functions of rhythmic flux into specific
isotopologues may be appealing, substantial additional information will be required. As labeling
patterns provide a clearer assessment of flux than transcript and protein levels, ideally data for
every isotopologue along each path would provide a stronger basis for path selection, however is
currently infeasible on this LC-MS methodology. For instance, given the extensive branching
around acetyl-CoA, labeling patterns in histone acetylation and larger lipids would be required to
gauge possible temporal offset in flux through other major branches of metabolism. There yet
exists a large gap in enumerating paths to e.g. rhythmic glutamine M+2 production and
understanding what role any or all individual isotopologues along those paths serve in
chronometabolism. Consequently, we want to stress a conservative interpretation of these
predictions from the IsoPathFinder algorithm, given the unexpected multitude of possible paths
after merely fifteen reaction steps. Additional datasets may support the likelihood of a subset of
these possibilities, however are prone to false negatives without considerably more detailed
experiments with analytical detection methods commensurate to the number of variables
embedded in these metabolic networks.
The significantly rhythmic isotopologues observed in Chapter 4 were processed in the
IsoPathFinder algorithm to produce expected paths from glucose based on prior biochemical
knowledge (Pizer, 1963, Buescher et al., 2015, Chaneton et al., 2012). Given the input glucose
tracer, most paths utilized glycolysis, however the overabundance of glycolytic paths raises some
concerns. During development of IsoPathFinder, glycolytic and TCA cycle atom-mapping
solutions required manual curation. Substantial work would be required to manually curate all
atom-mappings, however may be necessary to probe deeper into secondary metabolism. The
objectives in the development of this new tool included unbiased assessment of isotopologue
sources at genome-scale, however ultimately became subject to biased path-searching in central
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energy metabolism. This current implementation has considerable room for improvement,
however is presented here as a foundation for additional experiments and simulations.
This algorithm, despite the sheer complexity uncovered, still represents a relatively
simplistic purview, as only one labeled reactant is considered per reaction and does not include
bimolecular combinations. Additionally, while the LC-MS method utilized in this platform performs
fragmentation analysis, this data is essentially discarded given the incomplete positional carbon
information. While isotopomer analysis

would

greatly specify enzyme activities

over

isotopologues and trim many of the IsoPathFinder possibilities, significant technological
advancements are needed to observe complete isotopomer distributions at a systems-level. The
current version of this algorithm does store results for each isotopomer separately, before
converting labeled SMILES names to common isotopologue names. Consequently, small
modifications to the program would allow path-tracing for any isotopomer of interest, and may
initially serve as a purely in silico approach to simulate metabolic networks with greater
specificity. However, positional information from LC-MS or NMR datasets will require exact
isotopomer matching to SMILES formats before integration with the IsoPathFinder simulations.
As an intermediate step, partial information on positional labeling can be currently incorporated
into the IsoPathFinder program. For instance, the alanine M+2 isotopologue has three possible
isotopomers. Under the current LC-MS platform, alanine M+2+2 represents one of these
isotopomers, while alanine M+2+1 represents the remaining two isotopomers. The IsoPathFinder
can be adjusted to consider any subset of isotopomer distributions.
The greatest potential for metabolic discovery with this approach likely resides in synergy
between expanded experimental designs, metabolomic analyses, and IsoPathFinder-derived
paths from non-glucose sources. As an example, the data from Chapter 4 prompted simulations
with a

13C

3

serine input tracer to define a set of unique isotopologues which can guide additional

experimentation to discover the fate of the cyclic carbon flux into serine M+3 (Figure 5.8). Of
potentially greater benefit to metabolic discovery, in silico simulations of labeling possibilities can
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rationalize novel isotope tracer experiments a priori and guide metabolomic methods towards the
biological questions of interest.
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Table 5.1 IsoPathFinder paths nine reactions deep from
trimming procedures

Reaction

13C

6

glucose to serine M+3 after

1

2

alpha-D-Glucose M+6

alpha-D-Glucose M+6

['EC-4.3.1.17']

['EC-4.3.1.17']

Hexose-6-Phosphate M+6

Hexose-1-Phosphate M+6

['EC-2.7.1.1', 'EC-2.7.1.147']

['EC-3.1.3.10',’EC-2.7.1.6’,’EC-2.4.1.231’]

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

['EC-2.7.1.11']

['EC-2.7.1.10']

Glycerophosphoric acid M+3

Glycerophosphoric acid M+3

['EC-4.1.2.13']

['EC-4.1.2.13']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

['EC-1.2.1.12']

['EC-1.2.1.12']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-2.7.2.3']

['EC-2.7.2.3']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

8

['EC-4.2.1.11']

['EC-4.2.1.11']

Pyruvate M+3

Pyruvate M+3

9

['EC-2.7.1.40']

['EC-2.7.1.40']

Serine M+3

Serine M+3

Gibbs Sum (kJ)

-47.73306331

-30.18725196

Number of Circadian ECs

1

1

Circadian ECs

['EC-2.7.1.40']

['EC-2.7.1.40']

1
2
3
4
5
6
7
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Table 5.2 IsoPathFinder paths fourteen reactions deep from 13C6 glucose to glutamine M+2 after
trimming procedures. Note not all ECs are displayed for the sake of brevity

Reaction

1
alpha-D-Glucose M+6

alpha-D-Glucose M+6

1

['EC-2.7.1.1', 'EC-2.7.1.147']

['EC-2.7.1.1', 'EC-2.7.1.147']

Hexose-6-Phosphate M+6

Hexose-6-Phosphate M+6

['EC-2.7.1.11']

['EC-2.7.1.11']

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

['EC-4.1.2.13']

['EC-4.1.2.13']

Glycerophosphoric acid M+3

Glycerophosphoric acid M+3

['EC-1.2.1.12']

['EC-1.2.1.12']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

['EC-2.7.2.3']

['EC-2.7.2.3']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-4.2.1.11']

['EC-4.2.1.11']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

8

['EC-2.7.1.40']

['EC-2.7.1.40']

Pyruvate M+3

Pyruvate M+3

9

['EC-1.2.4.1', 'EC-1.2.1', 'EC-1.2.7.1', 'EC2.3.1.54']
Acetyl-CoA M+2

['EC-2.2.1.6']
Acetohydroxybutyrate M+2

10

['EC-2.3.3.8','EC-2.3.3.1']

['EC-2.2.1.6']

Citrate M+2

Pyruvate M+2

11

['EC-4.2.1.3']

['EC-4.1.3.16']

Isocitrate M+2

2-Hydroxy-4-oxopentanedioic acid M+2

12

['EC-1.1.1.42', 'EC-1.1.1.41']

['EC-2.6.1.23']

alpha-ketoglutarate M+2

alpha-ketoglutarate M+2

13

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

14

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

Gibbs Sum (kJ)

-297.2240567

-293.8480185

Number of
Circadian ECs
Circadian ECs

6

3

['EC-4.2.1.3', 'EC-2.7.1.40', 'EC-2.3.3.1',
'EC-2.6.1.13',...]

['EC-2.6.1.16', 'EC-2.7.1.40', 'EC-2.6.1.13']

2
3
4
5
6
7

2
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Reaction
1
2
3
4
5
6
7
8

3

4

alpha-D-Glucose M+6

alpha-D-Glucose M+6

['EC-2.7.1.1', 'EC-2.7.1.147']

['EC-2.7.1.1', 'EC-2.7.1.147']

Hexose-6-Phosphate M+6

Hexose-6-Phosphate M+6

['EC-2.7.1.11']

['EC-2.7.1.11']

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

['EC-4.1.2.13']

['EC-4.1.2.13']

Glycerophosphoric acid M+3

Glycerophosphoric acid M+3

['EC-1.2.1.12']

['EC-1.2.1.12']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

['EC-2.7.2.3']

['EC-2.7.2.3']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-4.2.1.11']

['EC-4.2.1.11']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

['EC-2.7.1.40']

['EC-2.7.1.40']

Pyruvate M+3

Pyruvate M+3

9

['EC-1.2.4.1', 'EC-1.2.1', 'EC-1.2.7.1', 'EC2.3.1.54']
Acetyl-CoA M+2

['EC-6.4.1.1', 'EC-2.1.3.1', 'EC-1.1.1.38']

10

['EC-1.2.1', 'EC-1.2.7.1', 'EC-2.3.1.54',
'EC-1.2.4.1']
Pyruvate M+2

['EC-2.3.3.1']

11

['EC-4.1.3.16']

['EC-4.2.1.3']

2-Hydroxy-4-oxopentanedioic acid M+2

Isocitrate M+3

['EC-2.6.1.23']

['EC-1.1.1.42', 'EC-1.1.1.41']

12

Oxaloacetate M+3

Citrate M+3

alpha-ketoglutarate M+2

alpha-ketoglutarate M+2

13

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

14

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

Gibbs Sum (kJ)

-293.8480185

-290.5400044

Number of
Circadian ECs
Circadian ECs

3

7

['EC-2.6.1.16', 'EC-2.7.1.40', 'EC2.6.1.13']

['EC-4.2.1.3', 'EC-2.3.3.1', 'EC-2.7.1.40',
'EC-6.4.1.1',...]
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Reaction
1
2
3
4
5

5

6

alpha-D-Glucose M+6

alpha-D-Glucose M+6

['EC-3.1.3.10','EC-2.7.1.6','EC-2.4.1.231']

['EC-3.1.3.10','EC-2.7.1.6','EC-2.4.1.231']

Hexose-1-Phosphate M+6

Hexose-1-Phosphate M+6

['EC-2.7.1.10']

['EC-2.7.1.10']

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

['EC-4.1.2.13']

['EC-4.1.2.13']

Glycerophosphoric acid M+3

Glycerophosphoric acid M+3

['EC-1.2.1.12']

['EC-1.2.1.12']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

['EC-2.7.2.3']

['EC-2.7.2.3']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-4.2.1.11']

['EC-4.2.1.11']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

['EC-2.7.1.40']

['EC-2.7.1.40']

Pyruvate M+3

Pyruvate M+3

9

['EC-1.2.4.1', 'EC-1.2.1', 'EC-1.2.7.1', 'EC2.3.1.54']
Acetyl-CoA M+2

['EC-1.2.4.1', 'EC-1.2.1', 'EC-1.2.7.1', 'EC2.3.1.54']
Acetyl-CoA M+2

10

['EC-2.3.3.1','EC-2.3.3.8']
Citrate M+2

['EC-1.2.1', 'EC-1.2.7.1', 'EC-2.3.1.54', 'EC1.2.4.1']
Pyruvate M+2

['EC-4.2.1.3']

['EC-4.1.3.16']

Isocitrate M+2

2-Hydroxy-4-oxopentanedioic acid M+2

6
7
8

11

['EC-1.1.1.42', 'EC-1.1.1.41']

['EC-2.6.1.23']

alpha-ketoglutarate M+2

alpha-ketoglutarate M+2

13

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

14

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

Gibbs Sum (kJ)

-279.6782453

-276.3022071

Number of
Circadian ECs
Circadian ECs

6

3

['EC-4.2.1.3', 'EC-2.7.1.40', 'EC-2.3.3.1',
'EC-2.6.1.13',...]

['EC-4.2.1.3', 'EC-2.3.3.1', 'EC-2.7.1.40', 'EC6.4.1.1',...]

12
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Reaction
1
2
3
4
5
6
7
8
9
10
11

7

8

alpha-D-Glucose M+6

alpha-D-Glucose M+6

['EC-3.1.3.10','EC-2.7.1.6','EC-2.4.1.231']

['EC-3.1.3.10','EC-2.7.1.6','EC-2.4.1.231']

Hexose-1-Phosphate M+6

Hexose-1-Phosphate M+6

['EC-2.7.1.10']

['EC-2.7.1.10']

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

['EC-4.1.2.13']

['EC-4.1.2.13']

Glycerophosphoric acid M+3

Glycerophosphoric acid M+3

['EC-1.2.1.12']

['EC-1.2.1.12']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

['EC-2.7.2.3']

['EC-2.7.2.3']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-4.2.1.11']

['EC-4.2.1.11']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

['EC-2.7.1.40']

['EC-2.7.1.40']

Pyruvate M+3

Pyruvate M+3

['EC-2.2.1.6']

['EC-6.4.1.1', 'EC-2.1.3.1', 'EC-1.1.1.38']

Acetohydroxybutyrate M+2

Oxaloacetate M+3

['EC-2.2.1.6']

['EC-2.3.3.1']

Pyruvate M+2

Citrate M+3

['EC-4.1.3.16']

['EC-4.2.1.3']

2-Hydroxy-4-oxopentanedioic acid M+2

Isocitrate M+3

['EC-2.6.1.23']

['EC-1.1.1.42', 'EC-1.1.1.41']

alpha-ketoglutarate M+2

alpha-ketoglutarate M+2

13

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

['EC-2.6.1.39', 'EC-1.4.1.3', 'EC-1.4.1.13',
'EC-2.6.1',...]
Glutamate M+2

14

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

['EC-2.6.1.85', 'EC-6.3.5.4', 'EC-2.4.2.14',
'EC-1.4.1.13',...]
Glutamine M+2

Gibbs Sum (kJ)

-276.3022071

-272.9941931

Number of
Circadian ECs
Circadian ECs

3

7

['EC-2.6.1.16', 'EC-2.7.1.40', 'EC-2.6.1.13']

['EC-4.2.1.3', 'EC-2.3.3.1', 'EC-2.7.1.40',
'EC-6.4.1.1',...]

12
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Table 5.3 IsoPathFinder paths eleven reactions deep from
M+2 after trimming procedures

Reaction
1

13C

6

glucose to reduced glutathione

1

2

alpha-D-Glucose M+6

alpha-D-Glucose M+6

['EC-2.7.1.1', 'EC-2.7.1.147']

['EC-3.1.3.10',’EC-2.7.1.6’,’EC-2.4.1.231’]

Hexose-6-Phosphate M+6

Hexose-1-Phosphate M+6

['EC-2.7.1.11']

['EC-2.7.1.10']

1,6-di-o-phosphonohexopyranose M+6

1,6-di-o-phosphonohexopyranose M+6

3

['EC-4.1.2.13']

['EC-4.1.2.13']

4

Glycerophosphoric acid M+3
['EC-1.2.1.12']

Glycerophosphoric acid M+3
['EC-1.2.1.12']

1,3-Bisphosphoglycerate M+3

1,3-Bisphosphoglycerate M+3

2

5

['EC-2.7.2.3']

['EC-2.7.2.3']

3-Phosphoglycerate M+3

3-Phosphoglycerate M+3

['EC-5.4.2.12']

['EC-5.4.2.12']

2-phosphoglyceric acid M+3

2-phosphoglyceric acid M+3

['EC-4.2.1.11']

['EC-4.2.1.11']

phosphoenolpyruvate M+3

phosphoenolpyruvate M+3

8

['EC-2.7.1.40']

['EC-2.7.1.40']

Pyruvate M+3

Pyruvate M+3

9

['EC-4.3.1.17']

['EC-4.3.1.17']

10

Serine M+3
['EC-2.1.2.1', 'EC-2.1.2']

Serine M+3
['EC-2.1.2.1', 'EC-2.1.2']

Glycine M+2

Glycine M+2

6
7

11
Gibbs Sum (kJ)
Number of Circadian ECs
Circadian ECs

['EC-6.3.2.3']

['EC-6.3.2.3']

Glutathione Reduced M+2

Glutathione Reduced M+2

-82.5341937

-64.98838235

1

1

['EC-2.7.1.40']

['EC-2.7.1.40']
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Figure 5.1 Workflow for genome-scale reaction modeling to trace isotopologue paths from 13C6
glucose. Atom-mapping solutions for Drosophila reactions in the MetaCyc database are trimmed
to reactions which contain glucose. Those glucose carbons are then ‘labeled’ and mapped to
carbons in the product metabolites. These results are exported, followed by an additional reaction
round using the newly labeled metabolites, until all reactions are calculated. These results can be
strung together to build paths from the isotopologue of interest back to the 13C6 glucose tracer in
Round 1 in the IsoPathFinder algorithm.
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Figure 5.2 (A) Code example to simulate the first set of reactions from 13C6 glucose, starting from
a subset of reactions which contain glucose, to carbon-labeling of reaction products, followed by
exporting results in a Python dictionary and a list of newly labeled compounds to seed the next
reaction round. (B) Example dictionary, where the keys consist of product metabolites which
received a 13C label, and the values are the reactants and enzymes which catalyzed the reaction.
(C) Example of user input to the IsoPathFinder algorithm to build paths to serine M+3, using the
dictionaries depicted in (B).
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Figure 5.3 Two major paths to serine M+3 from glucose M+6, calculated by the IsoPathFinder.
The canonical serine biosynthesis pathway (blue) did not contain any cyclic enzymes and yielded
a positive ΔG, while the alternative path (red) through pyruvate M+3 contained a cyclic enzyme
based on previous expression datasets, and was more thermodynamically favorable. Diagrams
generated using iPath2 (Yamada et al., 2011).
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Figure 5.4 Temporal overlap of alanine and serine M+3 relative abundances in WT flies, from
isotope tracer experiments described in Chapter 4, which was revealed through exploration of
longer paths to serine M+3.
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Figure 5.5 Temporal overlap of glutamine and glutamate M+2 relative abundances in WT flies,
from isotope tracer experiments described in Chapter 4. All paths to glutamine M+2 from
IsoPathFinder analysis included glutamate M+2 in the preceding step.
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Figure 5.6 Most likely path to glutamine M+2 from glucose M+6 through the TCA cycle,
calculated by the IsoPathFinder and trimmed by thermodynamic favorability and circadian
enzyme expression from previous studies. Diagrams generated using iPath2 (Yamada et al.,
2011).
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Figure 5.7 Most likely and shortest path to GSH M+2 from glucose M+6 through glycine M+2,
calculated by the IsoPathFinder (red). Longer paths were calculated through cysteine M+2
(green). Note cysteine M+2 itself could not be connected to glutathione production with this
KEGG-based visualization tool (pink). Diagrams generated using iPath2 (Yamada et al., 2011).
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Figure 5.8 Isotopologues one reaction removed from a simulated 13C3 serine tracer (red),
proposing additional experiments and LC-MS analyses to confirm the fate of cyclic carbon flux
into serine from 13C6 glucose noted in Chapter 4. Diagrams generated using iPath2 (Yamada et
al., 2011).
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CHAPTER 6 – Overview

6.1 Project Summary
The motivation for this work stems from our incomplete understanding of the intersection
of clocks, sleep, and metabolism, and the realization that new tools are necessary to unearth
these connections and track inherently dynamic physiological processes. While gross metabolic
parameters such as glucose homeostasis have been extensively studied vis-à-vis disrupted
circadian rhythms and sleep, mechanistic detail cannot be obtained from these measures.
Considerably deeper and more complex analyses are required to uncover the extent of diurnal
variance in metabolism. Metabolomics has recently emerged as an approach to holistically probe
metabolic processes and integrate both endogenous and exogenous influences on host
physiology. As with other high-throughput ‘omic technologies, metabolomic analyses rely on
instrumentation with multiple tunable parameters which impacts the accurate detection of
numerous variables, and requires efficient and rational optimization procedures. In Chapter 2,
new LC-MS metabolomics methodology was developed in an iterative, data-driven manner.
Design of experiments is commonly employed in process design and engineering, however has
never been leveraged to build new LC-MS metabolomics methodology.
These methods can facilitate holistic metabolite profiling in appropriate models of
circadian rhythms, highlighted in Chapter 3 by metabolomic analyses in Drosophila. In this
project, we discovered a dependency of circadian metabolite rhythms on intact genetic clocks,
and a set of metabolite rhythms driven by environmental cues. Given cycles in physiology arise
from a complex interaction of environmental cues and genetic factors, this study represents an
important novel paradigm which separates the impact of daily light cycles and intrinsic clocks on
metabolism. Additionally, metabolomic profiling in Drosophila at sufficiently high sampling
resolution necessary for ultradian rhythm analysis had not been previously performed, and
advances flies as a model to uncover new basic mechanisms in chronometabolism.
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LC-MS metabolomics methods can thus be effectively developed to discern metabolic
cycles, however these methods do not provide clear insight into reaction kinetics, presenting an
additional challenge in obtaining cogent metabolic mechanisms. The LC-MS methods described
in Chapter 2 were modified to address this limitation through isotope enrichment detection from a
novel

13C

6

glucose bolus injection platform in Drosophila, described in Chapter 4. Current

technological limitations prevent quantitative metabolic flux modeling across a circadian timeseries in vivo, however deep isotopolomic profiling provided relative pathway fluxes in amino acid
metabolism and redox across circadian time and sleep status. This approach not only represents
a new isotope-tracing tracing paradigm in Drosophila, but also an unprecedented scope of
isotopologue analysis over prior metabolic flux study designs. Multivariate modeling on
isotopologues had not been previously utilized to obtain a fluxomics assessment of an in vivo
system, which revealed a global shift in carbohydrate oxidation early in the active phase of flies.
This platform can have broad applicability in defining the metabolic consequence of clock and
sleep disruption, as well as translatable experimental designs regarding nutrient processing and
feeding paradigms to promote metabolic health.
The interpretability of systems-level ‘omics analyses lag behind advancements in
instrumentation. While Chapter 4 outlines a novel approach to gauge metabolic flux, the source of
many of these isotopologues cannot be fully explained by predefined biochemical pathways. The
new metabolic variables discovered in Chapter 4 require a new means of interpretation,
presenting yet another challenge in deriving true metabolic phenotypes. Fortunately, with the
advent of genome-scale reaction annotation, all reactions can be considered which produce
these detectable isotopologues. A new computational approach is developed which enumerates
all possible isotope transfer events with atomic detail from an input

13C

6

glucose tracer, and

subsequently reconstructs all paths which connects the input tracer to the user-defined
isotopologue of interest, outlined in Chapter 5. As a proof of concept, this algorithm calculated
paths to notable isotopologues obtained in Chapter 4, including serine M+3, glutamine M+2, and
GSH M+2. After a series of rational trimming procedures, a subset of those possible routes
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remained, which provide supporting evidence for suspected sources of each of these
isotopologues, as well as propose alternative mechanisms that warrant further experimentation.
This tool simulated downstream isotopologues from a

13C

3

serine tracer, as an example of the

potential utility to guide the researcher to test specific hypotheses through appropriate tracer
experiments and metabolomics methodology. This approach represents a new hypothesisgenerating bioinformatic tool built in an open-source platform for widespread use. Notably, the
extent of possibilities calculated with this algorithm presents a degree of complexity which may
require a shift in perspectives to consider metabolomic datasets in terms of updated probabilities,
as attributing observable metabolite data to a single source or reaction is likely to be false. As
technology and computational tools continue to improve, a new era of discovery can form to truly
shed light on the complex nature of chronometabolism. The efforts outlined in this thesis work
formed a logical progression of problem-solving endeavors, ultimately producing new analytical
methodology, metabolic modeling algorithms, and most importantly, novel biological insight. Much
work remains to improve the largely underdetermined platforms with which we probe metabolism,
however this thesis work represents but a small effort to “make measurable what is not so.”

6.2 Future Directions
In this work, there exist a multitude of opportunities to both improve methodologies and
provide additional biological insight. The DoE approach outlined in Chapter 2 not only produced
new metabolomics methodologies, which drove much of the results obtained in Chapters 3 and 4,
but also itself addressed a need to rapidly develop new methods in a data-driven manner. This
approach is important, as no single method is adequate to detect the entire metabolome, and
certain subsets of metabolites which cannot be detected with our current methods may be
necessary to test additional hypotheses. For example, improved detection methods for sugars
and would add clarity to the results obtained in Chapter 3, while improved sensitivity of amino
acid isotopomers would greatly enhance reaction specificity for the predictions generated in
Chapters 4 and 5. Algorithmic improvements to the IsoPathFinder approach, alongside improved
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database curation and LC-MS methods, can also augment this new platform of isotope-based
metabolic discovery.
The approaches presented in this work also provide ample space for novel
chronometabolic insight with translatable potential. Future studies from Chapter 3 should seek to
determine the clock-dependent role of per in circadian metabolism through analysis of other
genetic clock models, and separate the impact of clocks and feeding rhythms on metabolite
cycles. Perturbed metabolic homeostasis has been noted in mice with dysfunctional clocks, which
may be alleviated through certain behavioral and feeding paradigms. Given the ease of genetic
manipulation in flies, and the relatively low cost of experimentation, our ability to improve health
outcomes amidst altered sleep and feeding cycles with practical benefits for human health may
be augmented by future Drosophila metabolomic studies. Simply acquiring metabolomic data
from the combinatorial explosion of genetic mutants, environmental influences, and feeding
paradigms will likely lead to an uninterpretable excess of data. However, metabolomics may
serve as a purview of underlying mechanisms for experiments that aim to improve metabolic
outcomes under paradigms of desynchrony. These experiments may also benefit from an altered
perspective in the utility of metabolomics and systems-biology research. One major goal in
biomedical research is to improve outcomes. If one is to think of metabolomics as a metabolic
fingerprint of a biological system, a prevailing objective should be to define the biometric
fingerprint, and derive means to shift a diseased fingerprint towards a healthy one. With this
perspective in mind, metabolomics may serve to gauge the success of efforts to restore metabolic
homeostasis under conditions of altered feeding and activity patterns.
Apropos to feeding, the isotope tracer approach in Chapter 4 can more directly answer
questions regarding diurnal variation in nutrient oxidation and reduction, and may provide detailed
mechanisms to the consequence of dysfunctional clocks and the benefits of time-restricted
feeding. The platform itself will benefit from additional metabolomics methods, as only a relatively
small number of metabolites are analyzed in the current analysis given the number of isotopomer
MRMs required per metabolite. Experiments which seek to test specific hypotheses, for example
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cycles in isotopologue products of serine M+3, will need to modify the existing method to
accurately detect all necessary isotopologues with greater sensitivity. Nonetheless, this platform
lays a foundation for greatly expanded experimentation, most notably additional isotope tracer
injections to probe pathways in amino acids and lipids relevant to circadian metabolism.
Additionally, greater reaction specificity will be obtained with proper utilization of fragmentation
data, although will require significant methodological improvements. The IsoPathFinder approach
can readily assimilate isotopomer data, however would still benefit from algorithmic improvement
to search for longer path lengths. Nonetheless, this algorithm can effectively simulate isotope
tracer experiments to guide experimental designs in previously unexplored aspects of
metabolism, generating a series of future directions too numerous to fully mention here.

6.3 Deeper Metabolic Phenotyping
Even with the relatively simplistic approach in the IsoPathFinder algorithm, the paths
enumerated for serine, glutamine and GSH may not represent the full extent of possibilities, as
longer paths are easily envisioned. Even after paring unlikely paths through the assimilation of
previously published datasets and thermodynamic considerations, the number of possible
metabolic routes remains humbling. While scientific efforts typically strive for absolutism in data
interpretation, all too often alternative hypotheses are discarded or unconsidered. As we continue
to uncover the extent of possibilities in genome-wide networks, our current analytical tools confine
us to increasingly underdetermined observable systems. If the IsoPathFinder results remotely
represent the extent of possibilities in metabolic systems, we are left with a considerable weight
of uncertainty in our experimental results. Advancements in metabolomics technologies may yet
meet this challenge, however there are benefits to shifting our philosophy from absolutism to
probability distributions. As an example, if the 7246 initial paths to glutamine M+2 are viewed as
equally likely, additional data can increase posterior probabilities towards a smaller subset of
paths. Even so, attributing experimentally observed results to any one of these paths with high
certainty is difficult and perhaps unrealistic. With this perspective in mind, I have sought to
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maintain a relatively conservative interpretation of the results obtained in Chapters 4 and 5, as
substantial follow-up experimentation would be required to definitively claim the contribution of a
particular metabolic pathway to observable organismal phenotypes. Encouragingly, these
approaches can be leveraged to test new hypotheses with greater specificity, with the hope that
widespread usage of this tool can empower isotope-based metabolic studies in a new era of
systems-level biomedical discovery.
In these objectives, I have attempted to shed some light on some unmet needs, both in
our understanding of human health, and in deficiencies to define and interpret organismal
phenotypes. We currently live in an environment extremely disparate from our origins. Great
minds in recent history have driven incredible innovations to enhance the quality of life in
developed countries, across medicine, transportation, communication,

and

information

technology. These advancements have ushered in an era of new societal norms, but have quietly
come at some cost to our health. Thomas Edison likely would have never imagined the ubiquity of
lights at all hours of the night, including those from our handheld devices. The advancements in
communication and information technology have granted our work access to personal time early
in the morning or late at night, and we have reached a point where sleep restriction from work
demands is commonplace, fueling a notion that busy lives are imperative for productivity. These
behavioral aberrations correlate closely with disrupted sleep and eating patterns, and
consequently desensitize our perceptions of shift work, once considered unethical. Scientists are
struggling to clearly define the consequences of these lifestyle shifts on pace with the
advancements in technology. Even if only infinitesimally, I hope to add some understanding to the
way in which nutrients are metabolized across circadian time, and the impact of restricted sleep
on nutrient processing. In the field of biomedical research, tremendous developments have been
made across analytical chemistry, mathematics, and computer science to better define ourselves,
both in health and disease. I believe we are just scratching the surface in uncovering the
genotype-phenotype relationship. Our definitions of human phenotypes must shift away from
reductionism and towards systems-level fingerprinting, through a combination of ‘omics, lifestyle,
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and real-world evidence datasets. In doing so, we need to maintain an open mind and separate
ourselves from the concepts developed in the 20th century, particularly in defining the ‘metabolic
phenotype’. In my work, I have attempted to remain unbiased in forging new metabolic pathway
dynamics from systems-level datasets, and hope the analytical and computational tools
presented in this work can be used broadly, or spark the creation of better tools. We must expand
the scope of our search beyond what was once thought to be the solved intracellular
metabolome, for in metabolism, as in life, ‘panta rhei’.
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